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Zusammenfassung 
Der Bedarf der Systembiologie, die als das Verständnis und die Vorhersage von intrazellulären 
Abläufen verstanden wird, für neue Methoden und Technologien zur Untersuchung des 
Zellmetabolismus auf allen Ebenen steigt beständig. Beginnend vom Genom, über dessen 
Transkription zu Proteinen, bis hin zur Regulation der Metabolitpools über diese Proteine als 
finale Reaktion auf bestimmte Stimuli werden spezifische metabolische Zustände betrachtet. 
Massenspektrometrie setzt hier an um intrazelluläre Informationen auf Metabolom-, Peptidom- 
und Proteomlevel zu gewinnen und daraus Schlüsse für die Bioprozessoptimierung zu ziehen. 
Zu Beginn wurde eine ZIC-HILIC Tandem-Massenspektometriemethode etabliert um die 
Quantifizierung von 50 polaren Metaboliten des zentralen Kohlenstoffmetabolismus ohne 
zusätzliche Derivatisierungsschritte zu gewährleisten. Die Detektionslimits wurden, unter 
Berücksichtigung der „wrong-way“ Ionisierung, durch Nutzung einer alkalischen mobilen 
Phase erhöht, sodass auf Basis dessen metabolische Flussanalysen durchgeführt und damit 
Ansätze für Metabolic Engineering Ziele betreffend der Titeroptimierung ausgemacht werden 
können. Darüber hinaus wurde erstmals die leistungssteigernde Aufnahme von Dipeptiden in 
CHO Zellen durch die Quantifizierung intrazellulärer Dipeptidpools mithilfe 
massenspektrometrischer Methoden genauer beschrieben. Die Bestimmung von 
Aufnahmeraten zeigte zwei verschiedene Mechanismen für die Dipeptidaufnahme in CHO-
DP12 Zellen. Die anschließende Spaltung der Dipeptide innerhalb der Zellen resultierte in der 
Verstoffwechselung der freiwerdenden Aminosäuren oder deren Ausschleusung aus der Zelle. 
Ein tiefergehendes Verständnis dieser Vorgänge fördert die Bioprozessoptimierung im Sinne 
der Supplementierung von Medien mit Dipeptiden. Zusätzlich wurde die Degradation eines 
monoklonalen Antikörpers, produziert in CHO Zellen, anhand einer neuen Methode 
nachverfolgt. Ausgehend vom stabilen isotopenmarkierten Zustand mit Aminosäuren wurde 
ein produktionsähnlicher Zustand zur Analyse herangezogen. Die Identifizierung von 
intrazellulären Peptiden, entstanden bei der Proteolyse von Anti-Interleukin-8 monoklonalen 
Antikörpern, durch hochauflösende Massenspektometrie erlaubte zum ersten Mal die 
Quantifizierung der intrazellulären Degradation eines Antikörpers. Indem die Anreicherung 
von 13C- markiertem L-Lysin in den Antikörperfragmenten während der exponentiellen 
Wachstumsphase der Zellen gemessen wurde, konnten die spezifischen Degradationsraten des 
Antikörpers berechnet werden. Dieser Ansatz kann dazu genutzt werden, unter Bedingungen 
hoher Produktivität den Verlust durch intrazelluläre Proteolyse zu quantifizieren und 
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kontrollieren. Mittels der in dieser Dissertation vorgestellten massenspektrometrischen 
Methoden kann der Zellmetabolismus vom Metabolom bis hin zum Proteom quantitativ 
untersucht werden. Das hierbei gewonnene Verständnis und die Möglichkeit der Vorhersage 
des biologischen Systems der Zelle kann weiterführend zur Bioprozessoptimierung genutzt 
werden. 
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Summary 
 
Systems biology as the understanding and prediction of how intracellular machinery works, 
needs new technological support in order to observe cell metabolism at all its levels. From 
organism genome, to its transcription to proteins and how these proteins regulate metabolite 
pools as final response to determined stimuli, are needed to have a close look into specific 
metabolic states. Mass spectrometry is used here to obtain intracellular information at a 
metabolomics, peptidomics and proteomics level for specific questions concerning 
bioprocesses optimization. First, a ZIC-HILIC tandem mass spectrometric method was 
established to allow the intracellular quantitation of about 50 polar metabolites of the central 
carbon metabolism without extra derivatization steps, increasing detection limits using alkaline 
mobile phase, considering “wrong-way-around” ionization, as a basis to perform metabolic 
flux analysis, needed to evaluate metabolic engineering approaches over titer production.  Also, 
culture performance boosting dipeptide uptake was for the first time revealed by intracellular 
dipeptide pools quantification in CHO cells, by means of high resolution mass spectrometry, 
with which tracking its uptake rates, shows the presence of two possible mechanisms for 
dipeptide uptake in CHO-DP12 cells. Dipeptide metabolization inside the cell was additionally 
revealed, as amino acids coming from the dipeptides uptake are directly metabolized or 
expelled out of the cell proving that,  in order to optimize mammalian cells bioprocesses, by 
means of dipeptide medium supplementation, there is a need to understand specific dipeptide 
uptake and metabolization. Furthermore, protein turnover of a reference molecular antibody, 
produced in CHO cells, was also chased by a novel methodology. Out of the traditional stable 
isotope labeling with amino acids (SILCA), production like conditions were evaluated, the 
intracellular mAb degradation was for the first time partially quantified, as intracellular 
peptides produced by Anti-interleukin-8 monoclonal antibody proteolysis were identified by 
high resolution mass spectrometry and the measurement of 13C- labeled L-lysine incorporation 
in the mAb fragments, during exponential cell growth, allowed the calculation of mAb specific 
degradation rates, where this approach would lead to quantify how much product is lost by 
intracellular proteolysis and how this loss could be controlled under high productivity 
conditions.  By means of mass spectrometry, considering the approaches disclosed in the 
present dissertation, improved bioprocesses optimization could be reached as we are able to 
quantitatively observe cell metabolism, from metabolomics to proteomics, allowing further 
understanding and prediction of biological systems. 
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Introduction 
Understanding of Biological Systems to optimize their Industrial potential. 
 
This dissertation was motivated by the application of mass spectrometry on systems biology 
studies focused on the improvement of biotechnological processes. Even when at his point 
most of the models describing biological systems are rather rudimentary, appearance of high-
throughput technologies that allow gathering even more significant data at larger scale, are 
starting to promote a more detailed description and prediction of entire systems. This new 
technology has been applied in the last years to a large variety of fields that go from drugs 
discovery to industrial biotechnology between other sectors (Brenner, 2004).     
 
Systems biology 
 
As a highly interdisciplinary field, “Systems Biology” emerges, in the last decade, as the 
understanding of biological systems based on molecular interactions, combining experimental 
and computational approaches to describe biological systems in an integrative approach. 
Systems biology requires a complete molecular characterization of the organism, including 
biomolecules interaction and how they affect cell function, understanding of transport systems 
dynamics and the evaluation of molecular response to external and internal perturbations. It is 
said that all these parameters integrated in mathematical models should enable the prediction 
of organism behavior, which will finally end, in the development of strategies for cell 
manipulation. Once the picture is complete, the application of this knowledge can be used to 
afford advances in drugs development, disease treatment and optimization of biotechnological 
processes (Bruggeman and Westerhoff, 2007). 
Biological complexity involves biochemical networks with dynamic interactions. Metabolic 
control and regulation involves interaction at different levels: from DNA transcription, protein 
expression to metabolic pathways. 
Cells contain thousands of distinct metabolic substrates that should be considered, and for such 
an approach, the development of technology and the application of higher output analytical 
platforms and methodologies to gather and interpret this data remains as a challenge (Likić et 
al., 2010). 
 __________________________________________________________________________________ 
2 
 
Tools unraveling intracellular behavior. 
 
The ‘Omic’ technologies embrace data sources for understanding biological systems. The 
integration of genomics, transcriptomics, proteomics and metabolomics makes ‘systems 
biology’ feasible. 
With varying levels of complexity different technologies decipher parts of cell metabolisms; 
and for each level, different methodologies have been applied (Figure 1). 
 
Figure 1. Metabolism levels and their measurement methodologies. A. genomics, 
transcriptomics, proteomics and metabolomics. B. Analytical technics used to obtain 
information about each metabolic level. Figure from (Likić et al., 2010) complemented with 
the analytical techniques applied at each metabolic level. 
 
The genome gives the base of the information, as the catalog of possible proteins that could be 
synthetized in the cell (gene sequence and gene function). Genome becomes dynamic in the 
transcription, were the gene expression is afforded through the production of mRNAs carrying 
the protein synthesis data code. Cell response to stimuli is translated by the need to increase 
the concentration of certain proteins (enzymes) or start producing others; this is where different 
mRNA abundances can be specifically quantified. Microarray technologies are able to 
simultaneously measure the expression level of thousands of genes within a particular mRNA 
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sample, when the measurement is done under different conditions, it resembles their effect over 
the cell machinery (Pettersson et al., 2009). Profiling of mRNA to extract genotype-phenotype 
relationships has been used to identify genetic targets for strains improvement as a metabolic 
engineering tool (Jewett et al., 2005). Transcriptomics represent a relative value about how 
many mRNA (specific for each protein) are present in the cell, but it doesn’t give information 
about protein functionality, elevated mRNA levels do not necessary mean that enzyme 
activities are higher, implying that there is no strict proportional relation between mRNA 
abundance, protein levels and metabolic reactions (Loring, 2006; Wolf, 2013).  
Proteomics trends to quantify the intracellular expressed proteins, given a close look to which 
processes are favored in the cell.  Proteome analysis focuses in comparative expression 
analysis, proteome profiling, identification of posttranslational modifications and the study of 
protein-protein interactions (Chandramouli and Qian, 2009).  
In proteomics, even when ELISA (enzyme-linked immunosorbent assay) could be used to 
quantify specific proteins, preferred techniques look to increase the output of the experiments 
with profile information. Methodologies using Mass Spectrometry allow gathering information 
of thousands of proteins from one sample, where MALDI (Matrix-assisted laser 
desorption/ionization) and ESI (electro spray) are the more common ionization sources coupled 
to a TOF (time of flight detector). Protein separation are achieved by Gel Electrophoresis (GE), 
but more strait forward technics coupled liquid chromatography to a mass spectrometer 
detector, allowing peptide mapping of trypsin digested protein mixes (ESI-Q-TOF) (Ning et 
al., 2011). 
In between, proteomics and metabolomics, “Peptidomics”, evaluate the possibility that 
peptides also have an important role in cell metabolisms. Peptidomics is defined as the 
comprehensive characterization of endogenous peptides present in biological samples 
including bioactive peptides. Peptide identification and quantification by high resolution LC-
MS/MS have been applied to study neuropeptides, which play important roles in cell-cell 
signaling (Gelman et al., 2012).  
Metabolomics, as the final downstream product of cell metabolisms, embracing the dynamics 
of metabolic reactions required for growth, maintenance and normal cell function. Vibrational 
methods such as NMR (Nuclear magnetic resonance), FT-IR (Fourier transform infrared 
spectroscopy) and RAMAN are used as high-throughput short analysis time methodologies 
which are appropriate for general comparisons as signals can be related to defined molecular 
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functional groups. The principal limitation of vibrational methods is their low sensitivities that 
cannot reach intracellular levels for when the samples size is limited to small cultures with few 
biomass availability (Dunn et al., 2005). 
As metabolites present a high diversity in their chemical and physical properties, LC-MS is 
preferred to achieve quantification of specific metabolites (target analysis) or metabolic 
profiling (identification and quantification of multiple metabolites) where quantification with 
tandem mass spectrometry (MS/MS) is commonly used to obtain absolute concentrations of 
targeted metabolites and high resolution mass spectrometry for profiling and analyzing as much 
metabolites as possible at the same time. Metabolism quenching, extraction of intracellular 
metabolites and optimal chromatographic separation still remains a challenge as no universal 
method have been described (Dettmer et al., 2007).  
In this dissertation the use of mass spectrometry as main tool to gather information for systems 
biology is presented, giving as results a new metabolomics analytic methodology, novel 
information about the mAb intracellular degradation and dipeptide uptake in mammalian cells. 
Mass spectrometry was used to improve the universality of intracellular metabolite 
quantification, as a hydrophilic liquid chromatography for polar metabolites was established 
using a MS/MS target approach. 
High resolution mass spectrometry (ESI-Q-TOF) was used to evaluate the proteome and 
peptidome of IgG (Immunoglobulin G) producing CHO cells, allowing the tracking of the 
intracellular protein degradation of the produced monoclonal antibody (Anti-IL8), 
notwithstanding in the literature no degradation was quantified. 
Oligopeptides were also tested as mammalian cells medium supplement and their extracellular 
and intracellular fate tracked via ESI-Q-TOF measurements; while so far no information about 
CHO cells dipeptide uptake was published. 
In the next sections, liquid chromatography coupled to mass spectrometry principles will be 
described and the state of the art of each specific performed approach will be specified. 
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Liquid chromatography coupled to mass spectrometry as an universal tool for polar intracellular 
metabolites quantification  
 
Regarding systems biology, the ideal bio-analytical method would be an approach capable to 
measure, at the same time, metabolites with diverse chemical and physical properties, been 
able to distinguish and identify all of them, considering the fact that quantification has to be 
done even at very low concentrations (Dettmer et al., 2007). 
Biological matrices represent a challenge as cellular extracts are multicomponent samples 
where compounds can interfere with signal generation for specific analytes. 
Liquid chromatography coupled to mass spectrometry emerge as the most suitable technology 
to apply. A first separation in the chromatography system eliminates interferences and analytes 
resolution improving identification and quantification. Once separated, the mass spectrometer 
identifies compounds by their mass, achieving detection even in the atomolar concentrations 
level. 
Liquid chromatography coupled to mass spectrometry (LC-MS) represent a combination of 
techniques that can be specifically selected to obtain the desired metabolic information. 
Separation of compounds by chromatography may diverge depending in metabolites polarity, 
molecular weight or functional groups. Meanwhile the desolvation and ionization process 
could be achieved by an electrostatic filed (ESI), chemical ionization (APCI) or 
photoionization (APPI) depending on individual molecule properties. Once the metabolites are 
ionized, the mass spectrometer is able to filtrate the signal to obtain the ions of interest, 
identifying the molecules for their exact mass (high resolution mass spectrometers) or by their 
fragmentation patterns (tandem mass spectrometry, MS/MS) (Feng et al., 2008). 
Chromatographic separation of metabolites may deal with molecule diversity. In 
metabolomics, peptidomics and proteomics compounds separation is achieved using reverse 
phase (RP), capillary electrophoresis (CE), aqueous normal phase (ANP) or the recently 
introduced hydrophilic interaction chromatography (HILIC) (Pesek et al., 2008). 
For proteomics and peptide mapping, reverse phase is of common use. Because of their 
structure, peptides and proteins present separation in non-polar stationary phases as C18, C8 
or C4. Peptides presents narrow retention windows eluting in less than 1% non-polar mobile 
phase changes of non-polar mobile phase component (for example acetonitrile), giving sharp 
peaks and higher chromatographic resolution. 
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In metabolomics, the need to separate efficiently organic acids, sugar phosphates, nucleotides 
or amino acids, all present in the same intracellular matrix, denotes a challenge that has to be 
solved. 
Polar compounds cannot be directly separated by reverse phase chromatography, using counter 
ions or high pH mobile phases makes reverse phase methodologies ESI-MS incompatible, they 
use high concentrations of nonvolatile components that cause ion suppression and contaminate 
ionization chambers. Specific derivatization protocols are needed to make compounds less 
polar in order to present retention and derivatization protocols apply only for specific molecular 
functional groups mining target diversity of the method requiring extra sample preparation 
efforts (Oldiges et al., 2007). 
Capillary electrophoresis can be coupled to MS detectors, as an option to liquid 
chromatography, but the retention potential of metabolites is narrowed to charged compounds 
with amino, hydroxyl, or phosphate groups and is objected that detection limits are higher as 
the obtained with LC-MS methodologies (Staub et al., 2009; Hernández-Borges et al., 2004). 
In this context hydrophilic interaction chromatography (HILIC) has been introduced in 
metabolomics as its retention mechanism achieve resolution of polar molecules, charged and 
neutral. HILIC presents full compatibility with MS systems as ammonium acetate or 
ammonium formate volatile buffers are used in the mobile phase. Moreover, non-silica based 
materials are used to produce resistant columns to acid and alkaline pH giving extra selectivity 
using zwiteionic solid phases (Ab et al., 2006). 
As part of this dissertation, in cooperation with Atilla Teleky, HILIC was considered to 
generate a methodology able to separate more than 50 key metabolites comprising coenzymes, 
amino acids, organic acids, nucleotides and sugar phosphates.  Resistance to high pH mobile 
phases of a ZIC-HILIC (Zwitterionic hydrophilic interaction chromatography) stationary phase 
was used to boost metabolites sensibility, all the mass spectrometer parameters were optimized 
for tandem MS/MS measurements and the quantitative method validated with intracellular 
targeted metabolites quantification. 
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Mass spectrometers  
 
In bioanalytical forums the discussion about which mass spectrometers coupled to liquid 
chromatography by an electro spray ion source interface would be the optimal tool to reveal 
intracellular cell behavior. The two main categories discussed are triple quadrupole (QQQ-MS) 
and high resolution (HR-MS) mass spectrometers (Feng et al., 2008). 
Usually QQQ-MS are generally preferred because of their lower market price. Also, this system 
presents relatively easier manipulation. Once the chromatographic method is optimized, 
transitions are established for each metabolite. From the ion source, ionized molecules are 
sorted by mass, and just one m/z (precursor ion) is selected by the first quadrupole. Then, a 
collision energy (selected as kinetic energy of N2 molecules) is applied in the collision cell 
(second quadrupole), where the precursor ions are fragmented into daughter ions. From the 
fragments formed as the molecules collide just one daughter ion is selected (third quadrupole) 
and is the only m/z that should produce a signal for the selected retention time. A transition is 
then called when assigning a pair:  precursor-ion/daughter-ions. 
As the main advantage from the QQQ-MS, the matrix is physically separated in the 
measurement; just ions belonging to one specific metabolite transition should be recorded as a 
signal. Consequently, the noise of the measurement tends to zero increasing detection limits 
capabilities. In principle, the chromatographic separation has to be able to isolate matrix 
components that cause ion-suppression, if it could not be achieved that way, as for complex 
intracellular extracts where coelution of multiple metabolites in intercellular samples is 
impossible to avoid, ion separation, due to specific transitions selection, in the QQQ-MS is 
able to quantify selected metabolites with low detection limits (Gross, 2011). 
High resolution mass spectrometers are based in the principle that even when no fiscal ion 
separation is made (as the signal filter system of the QQQ) the system is able to recognize m/z 
differences of milidaltons (for ions with the same charge). For example, a Q-TOF platform is 
able to separate the m/z signals for molecules that differ in 0.0001 m/z unites, which is less than 
the mass of one electron. The signal for two molecules that coelute, with a difference of one 
electron in their molecular structure, would be differentiable and each molecule would be 
quantifiable by a HR-MS (Xian et al., 2012). 
HR-MS also is able to have a mass accuracy better than 1 ppm, which means, that the measured 
mass for a metabolite will have an error in the order of milidaltons. That makes it possible to 
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identify intracellular substances with their measured mass, as defined combination of elements 
in their molecular formulas have a specific total m/z value.  
Tandem experiments are also important in HR-MS, With a Q-TOF (quadrupole-time of flight) 
instrument it is also possible to fragment a selected molecule and have an accurate mass for all 
its fragments. This is an advantage for peptide mapping, where peptides fragmentation occur 
with known patterns allowing the elucidation of peptides sequences (Kiefer et al., 2008). 
Through high resolution and mass accuracy, metabolites eluting at the same time could be 
distinguished and independently quantified, surprisingly, it could be possible that with HR-MS 
chromatographic separation is not necessary, were it has been demonstrated that with special 
software to analyses the data, real-time metabolomics profiling has been achieved to observe 
metabolites signals having a continuous flow of bioreactor cultures directly coupled to a ESI-
QTOF instrument, even when no absolute quantification is performed, real time metabolome 
analytics is a fine tool to control and improve bioprocesses (Link et al., 2015).  
In the present work, quantification of intracellular metabolites was achieved using a QQQ-MS 
system where its low detection limits were tested for at least 90 intracellular metabolites of 
interest, allowing quantification of metabolites pools with highly accurate measurements. 
Identification of intracellular peptides deriving from the proteolysis of an expressed 
monoclonal antibody and quantification of intracellular dipeptides was performed using HR-
Q-TOF instrumentation, as intracellular peptidomics complexity and intracellular peptide 
identification required of the mass accuracy faculty and high resolution power. 
 
Application of mass spectrometry in bioprocesses improvement. 
 
As a tool to describe chemical networks of biochemical reactions at the intracellular level mass 
spectrometry became in the last years the technology of preference. Using these knowledge to 
improve the production of substances with commercial value as dietary supplements, 
neutraceutics, biopharmaceuticals, biopolymers or fuel sources places mass spectrometry as an 
analytic technique that has to be incorporated into the bioprocess optimization methodologies. 
Multi-omics data including genomics, transcriptomics, fluxomics, and proteomics may be 
required to model the metabolism of potential cell factories and detailed knowledge on carbon 
flux distributions is crucial for the understanding and targeted optimization of cellular systems 
(Wittmann, 2002; Trauchessec et al., 2014). 
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In the present dissertation mass spectrometry was used to improve the quantification of 
intracellular metabolites by the generation of a new analytic methodology, in the evaluation of 
dipeptides as promoters of molecular antibody production and the quantification of intracellular 
molecular antibody degradation as product loss evaluation. The further detail on each topic will 
be covered on the next sections. 
 
Quantification of intracellular key metabolites in bacterial cultures. 
 
As advanced molecular biology tools have been developed, changing metabolic pathways have 
been used in order to improve microorganism production of specific molecules with 
economical potential. Classical metabolic engineering targets the decrease of rate-limiting 
steps in a certain pathway, overexpression of gene coding for critical enzymes and even the 
introduction or deletion of pathways follow the idea of “cell factories” improvement. 
Meanwhile, the inverse metabolic engineering, tends to identify the desired phenotype first and 
evaluate which genetic modifications are needed in the host organism to achieve the production 
objective. Either way, using direct or inverse metabolic engineering there is a need to 
intrinsically evaluate changes in metabolic fluxes to obtain information about the real effects 
in the metabolism of the modified phenotype (Stephanopoulos, 1999; Keasling, 2010; Nielsen, 
2001. 
Metabolic fluxes represents the final outcome of cellular regulation, analysis of metabolic 
fluxes distribution provides accurate information about metabolic state. Indirect calculation of 
metabolic fluxes involve the isotopomers target MS quantification of extracellular and 
intracellular metabolites generated from feeding cells with isotopically stable labeled substrates 
(2H, 13C, 15N and others).  Samples are taken over time and quenched. Intra- cellular and 
extracellular metabolites are extracted, separated and analyzed with respect to their 
concentrations and labeling states (Kim et al., 2008). 
Here a new analytical methodology is presented, alkaline ZIC-HILIC MS/MS, which together 
with computational advances would allow the direct measurement of metabolite pools in 
stimulus response experiments allowing flux analysis during rapid transients giving more 
accurate information about organism function in response to genetic modifications or changes 
in culture conditions. 
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Dipeptides uptake in mAb producing CHO cells. 
 
Biopharmaceutical US market reached sixty billions of dollars in 2012 with an 18% increment 
respect to 2011, from which 27% of new approved biopharmaceuticals are molecular 
antibodies (mAb), mainly produced in Chinese Hamster Ovary (CHO) cells lines (Aggarwal, 
2014). 
As the biopharmaceutical demand increase, protein therapeutics requires also productivity 
enhancement. In 1986, CHO batch cultivations achieved 50 mg/L product formation and for 
the time being productivities reached 2-5 g/L in 12 day cultivations, a 100 fold increment in 
three decades, were the maximum cell-specific productivities reported until now are of 100 
pg/cell/day (Tabuchi and Sugiyama, 2013a). 
A combination of strain engineering and process optimization are responsible for the actual 
manufacturing improvement. Developments in resistant cells with higher viability and faster 
growth rates have been generated by introducing cyclins (cycle control genes), anti-apoptotic 
or growth factor genes (e.g. insulin like growth factor). Amplification using dihydrofolate 
reductase (DHFR) gene and methotrexate (MTX) as selection agent made possible to obtain 
cells that contain a thousand copies of the integrated plasmid, achieving 10 to 20-fold increment 
in cell specific productivities (Omasa et al., 2010). Extended batch cultures and perfusion 
reactors are the favorite high-yielding processes, where continuous mode operations, with or 
without cell retention, are optimized for each specific biopharmaceutical production (Jain and 
Kumar, 2008). As bioreactors optimization, and strain engineering, culture medium has been 
also in continuous development, and it is stated that different medium formulations are 
necessary for each specific manufacturing process and cell line. 
Design of defined medium composition for animal cell cultivation is recently favored as other 
possibilities than bovine serum supplemented medium (Butler, 2005). Bovine serum contains 
hormones, growth factors and trace elements that promote rapid cell growth, nevertheless 
serum variable composition had an impact in process performance variability (due to lot-to-lot 
changes) and world alert about virus contaminations (“Bovine spongiform encephalopathy” 
disease; (Wessman and Levings, 1999)) make serum based culture medium not suitable for 
human oriented biopharmaceuticals production. 
As viable components, dipeptides have been considered as medium supplements, where 
advantages and different productivity effects have been obtained in mammalian cell cultures. 
Availability of L-glutamine, especially important for dihydrofolate reductase (DHFR) deficient 
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CHO mAB producers, can be enhanced when using L-alaninyl-glutamine (AQ) in medium, as 
the dipeptide present higher heat-stability in comparison to the amino acid alone (Minamoto et 
al., 1991). Also L-glycil-L-glutamine (GQ) have been tested in murine hybridoma cell cultures 
showing improved cell yield (Christie and Butler, 1994).  
Other issues for improvement is about amino acids solubility. As an aromatic amino acid, L-
tyrosine can be dissolved in culture medium just in low concentrations, its availability can also 
be increased by using L-tyrosine dipeptides which have 250 fold higher solubility (Furst, 1998). 
Comprehensive studies about impact over CHO cells phenotype have been made with L-
tyrosyl-L-lysine (YK), L-tyrosyl-L-histidine (YH), L-tyrosyl-L-alanine (YA), L-tyrosyl-L-
valine (YV) where these tyrosine containing dipeptides had a positive effect over culture 
viability and mAb production (G. K. Grimble, 1994).  
Between other studies reported also beneficial effects of L-lysine containing peptides (Imamoto 
et al., 2013). 
Considering that just the combination of proteogenic amino acids gives four hundred 
possibilities for new medium supplements little research has been made with respect to 
dipeptide supplementation.  
So far, there is no clear evidence about dipeptides incorporation by the cell.  Mechanistic 
understanding of intracellular functioning and fate is still missing.  In 1994 fractionation studies 
of Christie and Butler (1994) about AQ and GQ utilization in murine hybridoma cells 
concluded that extracellular hydrolysis is likely to be involved. On contrary (Kang et al., 2012) 
recently anticipated that ‘…the observed fast clearance may reflect rapid transport of dipeptides 
into the cell rather than hydrolysis…’ Apparently, the picture of dipeptides utilization, their 
functioning and fate inside the cells is rather unclear. 
The mechanisms of dipeptides utilization by CHO cells have been studied in focus of 
understanding production boosting properties. Using high resolution mass spectrometry L-
glutmanine containing dipeptides like L-alaniyl-L-glutamine (AQ) and L-glycyl-L-glutamine 
(GQ) were studied as well as tyrosine containing compounds L-alanyl-L-tyrosine (AY), L-
glycyl-L-tyrosine (GY) and L-prolinyl-L-tyrosine (PY).  For comparison other peptides were 
applied too: L-alanyl-L-cysteine (AC), L-alanyl-L-proline (AP), and L-prolinyl-L-cysteine 
(PC). 
In the present dissertation, with the advantages of mass spectrometry, extracellular and 
intracellular dipeptides fate was followed in other to shed some light about uptake mechanisms 
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and their constituent amino acids metabolisms. High resolution mass spectrometry allowed the 
identification and quantification of dipeptides at the intracellular level contributing to the 
hypothesis that dipeptides are indeed intracellularly uptake and then metabolized in CHO cells 
mAb producers. 
 
Evaluation of intracellular mAb degradation. 
 
Even when protein therapeutics production using mammalian cells is well established, there 
are factors to consider that so far, have been just assumptions, and from which no direct 
information exist. Between these matters, the question: how much product (mAb) is degraded 
in the cell?  Emerge as a complex problem to solve, as the concept about intracellular protein 
degradation mechanism is relatively new.  
The first evidence of protein degradation was obtained by Schoenheimer and Urey. The first 
being, the biochemist interested in metabolic pathways and the second, being the chemist who 
discovered deuterium and heavy water preparation (D2O) and was able to prepare heavy 15N-
amino acids for Schoenheimer experiments. They were able to prove that just 50% of heavy 
nitrogen (15N) administrated to rats as tyrosine was recovered in urine, and more interesting, 
from the tyrosine incorporated into body proteins a fraction of 15N was found as amino groups 
(-NH2) in other amino acids, transferred from the labeled tyrosine, giving the idea that proteins 
are degraded in the cells and their components reutilized in new proteins (Schoenheimer et al., 
1938). 
The further discovery of the lysosome by Christian de Duve, gave the scientific community an 
organelle able to degrade intracellular and extracellular proteins  (Duve and Wattiaux, 1966). 
Nevertheless the discovery of the lysosome, the explanation was not satisfactory, as 
experimental observations where still unclear: proteins had different half-lives, there were 
different effects over protein degradations when lysosomes inhibitors were applied, and it was 
clear that protein degradation needed energy to proceed (Ciechanover, 2013).  
It wasn’t until ubiquitin-proteasome discovery that an overview of the intracellular protein 
degradation was available.  It was clarified that ubiquitin (or ATP-dependent proteolysis factor 
1, APF1 as called before its identification), is covalently conjugated to protein substrates by an 
isopeptide bond formation (requiring ATP), and that multiple ubiquitination lead to protein 
degradation (Pickart, 2001). The enzymatic cascade carrying out ubiquitination (E1, ubiquitin-
activating enzyme, E2, ubiquitin carrier protein and E3, ubiquitin protein ligase) was 
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discovered by Hershko, Ciechanover and colleges. Where E3 is the specific-binding enzyme, 
explaining the diversity of protein half-lives (Ciechanover et al., 1980).  
The whole picture was complete with the discovery, by Hough and colleagues, of a high-
molecular-mass protease that degraded, using ATP, ubiquitin conjugates. This protease became 
to be known as the 26S proteasome (Hough et al., 1986). 
The 26S proteasome is a multi-subunit enzyme complex. It consists in a catalytic core particle 
and a regulatory particle, the 20S complex and the 19S complex respectively. Selection of 
proteasomal substrates is done by the 19S regulatory particle. The generated fragments are 
ranging from 3 to 24 amino acids (Holzhütter and Kloetzel, 2000; Luciani et al., 2005; Saric et 
al., 2004). Proteasomal active site contains trypsin-like, chymiotrypsin-like and glutamyl 
activities. Fragments longer than  6 amino acids are primarily treated by endopeptidases to 
generate shorter fragments (6 amino acids or less) that are processed to free amino acids by 
amino peptidases (Dorai et al., 2011). Aspartic proteases like Cathepsin D and E were reported 
to be present in the ER and lysosomes. Cleavages due to Xa-like serine proteases can also occur 
in the intracellular matrix (Du et al., 2008; Goldman et al., 1997; Sandberg et al., 2006). 
Both, the lysosome and the ubiquitin-proteasome system are the main mechanisms for 
intracellular protein degradation so far described. 
It is proposed that proteolysis is carried out in the cell in order to control misfolded and 
damaged proteins and as part of system regulation. It is also involved in enzyme activation and 
as resources management for amino acids reutilization (Goldberg, 2003). 
It was reported in 2000 by Schubert, among others, that more than 30 % of newly synthesized 
protein are retrograde transported into the cytosol for degradation by proteasomes where 
degraded proteins are proposed to be mainly products of unsuccessful folding or failures of 
protein aggregates formation (Schubert et al., 2000) . 
Towards the understanding of intracellular machinery, protein synthesis and degradation 
balance, named as “protein turnover”, have been studied in multiple organisms (Claydon and 
Beynon, 2012). To understand how the cells regulate their proteome, the meaning of protein 
half-lives in the cells and their variations is still a challenge that has to be revealed (Eden et al., 
2011). 
Particular interest can be focused to evaluate protein degradation in organisms modified for the 
industrial production of therapeutic proteins as monoclonal antibodies (mAb). These 
overproducing organisms have the intrinsic effect of overloaded protein production machinery 
as they have to deal with multiple copies of the transfected mAb vector  (Chusainow et al., 
2009).  Cells have to deal with synthesis, folding and transport of high intracellular 
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concentrations of the overexpressed protein, where degradation processes like endoplasmatic 
reticulumn associated degradation (ERAD) are activated by the accumulation of misfolded or 
improperly processed proteins (Stolz and Wolf, 2010). 
Today it is common to use stable isotope labeled amino acids (15N, 13C, 34S)  in cell medium 
(SILAC) with the combination of mass spectrometry to be able to quantify intercellular protein 
half-lives (Hughes and Krijgsveld, 2012). 
In the SILAC approach, cells are cultivated in medium enriched with amino acids with heavy 
stable isotopes, for example 13C,15N-Arginine (labeled arginine). Then, the cells are transferred 
to medium with light isotopomer (12C,14N-Arginine)(Kratchmarova, 2008). The protein 
dynamic is chased by extracting and purifying intracellular proteins, digesting them and 
measuring the resulting peptides by liquid chromatography coupled to mass spectrometry. The 
signal ratio decay over time of the labeled and unlabeled peptides is used to calculate the protein 
turnover rate for each identified protein.  
In order to use this approach with an overproduced mAb cell line a more complex systems has 
to be considered. In recombinant protein producers, there is a balance between product 
syntheses, degradation and secretion. Intracellular recombinant protein production could be 
described with simplified dynamics (Figure 2).  From cell media, amino acids are incorporated 
to cell (rupt) and used as building blocks for protein synthesis (Vsynth). The produced antibody 
is then secreted (qsec) or degraded to peptides (V1deg). Peptides present further degradation steps 
(V2deg), until complete degradation to amino acids (V3deg) for further uses in cell metabolism. 
Considering this and using a more complex set up, in continues bioreactor cultivation of Pichia 
pastoris, the decrease of heavy sulfur (34S) in intracellular recombinant protein was used to 
calculate antibody intracellular degradation resulting in 58% product degradation related to 
product synthesis, where just 35% recombinant protein was secreted (Pfeffer et al., 2011). 
In the approach presented hereafter, in order to calculate the degradation and secretion rates, 
not the intracellular antibody labeling is considered, but the labeling from intracellular antibody 
proteolytic peptides. Labeling patterns in fragments stemming from degradation are extracted 
from cells, quantified and then the degradation rates are inferred from modeling, this work was 
performed together with Jeremy Rimbon who was in charge of the bioreactor cultures design 
and intracellular degradation modeling. 
High resolution mass spectrometry was used to identify intracellular peptides coming from 
intracellular mAb degradation and the incorporation of stable labeled 13C-L-lysine in the 
peptide sequence was chased allowing us to present data about mAb intracellular degradation. 
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Figure 2.  Pathways of recombinant protein degradation. Amino acids are taken up from the 
medium l (rupt) and further processed for recombinant protein synthesis (vsynth). Intracellular 
recombinant proteins are susceptible to be degraded by proteasomal activity (v1deg) and 
subsequently by further cytosolic or lysosomic enzymes to single amino acids (v2deg and v3deg). 
At metabolic steady state, degradation rates are equal and synthesis rate is equal to secretion 
rate added to degradation rate (Figure from Rimbon et al., 2015, apendix D). 
 
In the present dissertation, multiple approaches to answer questions concerning systems 
biology, focused in improving cell factories productivity, were assessed by means of mass 
spectrometry. Improvement of intracellular metabolites quantification, supplemented 
dipeptides intracellular uptake and intracellular mAb degradation were the main topics 
considered. In the next sections the aims, experimental setups and results of the performed 
experiments will be described and discussed.  
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Aims 
HILIC-MS/MS as universal tool for polar intracellular metabolites quantification. 
 
Stablish a quantitative tandem mass spectrometric method for the quantification of intracellular 
metabolites that allow the simultaneous measurement of key metabolites needed for the 
calculation of metabolic fluxes, improving sensibility and chromatographic separation from the 
already available conventional methodologies. 
 
Evidence of dipeptide CHO cells uptake, extracellular and intracellular 
quantification. 
 
Considering the advantages of high resolution mass spectrometry, track the fate of dipeptides 
that are already known to boost mAb production when supplemented in CHO cultures. 
Evaluate the dipeptide uptake and intracellular metabolism in addition to their boosting effects 
in productivity and cell growth for a set of available dipeptides. 
 
Shedding light on intracellular mAb degradation in CHO cells. 
 
Using high resolution mass spectrometry, identify and quantify intracellular peptides from the 
proteolysis of a reference monoclonal antibody produced in CHO cells, in order to elucidate 
degradation rates by means of a 13C-Lysine labeling pulse-chase experiment in batch cultures, 
getting information about product losses due to intrinsic protein degradation. 
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Materials and Methods 
A short-review of the methodology is described below. For detailed information please refer 
to the published material of each specific topic. 
 
HILIC-MS/MS as universal tool for polar intracellular metabolites quantification. 
 
Optimization of chromatographic separation 
 
Metabolite chromatographic separation was optimized for an Agilent 1260 Infinity high-
performance liquid chromatograph (HPLC) consisting of a degasser, binary pump, a 
thermostated column and bio-inert thermostated autosampler (maintained at 5°C). 
The chromatography optimization was carried out using a Sequant ZIC-HILIC column (150 x 
2.1 mm, 5 µm) with guard column of the same material. Considering a standard mix of polar 
metabolites, part of the central metabolism (6-phosphogluconate, fructose 1,6-bisphosphate, 
glucose 6-phosphate, phosphoenolpyruvate, malate, succinate and citrate), chromatographic 
separation was optimized in terms of peak resolution and peak shape, considered variables 
were: mobile phase pH, buffer concentration (ammonium acetate and ammonium formate 
buffers were tested), flow rate, column temperature and gradient. 
 
Optimization of electro spray ionization (ESI) source and MS/MS transitions 
 
Liquid chromatography was coupled to an Agilent 6410B Triple Quadrupole mass 
spectrometer with single ESI ion source, Mass Hunter B.04.00 software was used to acquire 
and analyze the data. Optimized parameters were separated in factors that affect measurement 
of all the metabolites and specific optimization for each targeted compound. 
Using continuous direct injection, metabolite ionization was optimized. Looking to obtain the 
higher average intensities for the metabolites nitrogen gas flow, nebulizer pressure and 
capillary voltage were tested in their potential ranges to find maximum signal height. 
For 60 metabolites, transitions (precursor ion-daughter ion) were optimized for maximum 
signal height testing both positive and negative ionization modes. For each metabolite the 
fragmentation pattern was analyzed and changing the collision energy, the fragment with 
higher abundance was selected. Also, fragmentor voltage was optimized for each precursor ion, 
as it is specific for each substance depending on molecular weight and structure. 
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Validation of absolute metabolite quantification  
 
For each metabolite the linearity range was evaluated between 1 nM and 5µM, considering 
linear ranges when correlation coefficient (r2) is higher than 0.98. Instrument detection limit 
was calculated as the sample concentration corresponding to t(n-1) times the relative standard 
deviation of the measurement with lower detectable signal, were t(n-1) comes from the Student-
t test, assuming a 99% probability that the measurement is higher than zero. 
The difference in sensibility was evaluated for alkaline (pH = 9.2) and acidic conditions (pH = 
5.6), as a signal increment appears to improve detection under alkaline mobile phase. 
Instrument detection limits and signal intensity for 5 µM standards was used to show signal 
improvement. 
To quantify intracellular metabolites, calibration curves for the targeted metabolites were 
prepared in linear ranges. Also calibration using external calibration, isotopic dilution (13C-
Labeled algal extract used as internal standard) and standard additions were performed in order 
to challenge the chromatographic separation and discern the significance of matrix effects in 
intracellular extracts measurement. 
 
Quantification in bacterial extracts 
 
E.Coli K-12 MG1655 cells grown in minimal medium with 0,75% (w/v) D-glucose were 
sampled during exponential growth at biomass concentration of approximately 2 g/L. Samples 
containing 4 mg biomass were sampled by fast centrifugation and washed with 2 mL 0,9% 
(w/v) NaCl solution. Quenching was made by freezing the cell pellet in liquid nitrogen (-196 
°C) and stored at -70 °C. Extraction was made with defined amounts of boiling water during 5 
min kept at 100 °C in water bath and then cooled in ice. Separation of cell debris was made by 
centrifugation and extracts were stored at -70°C until measurement. Samples were prepared as 
standards in 60% acetonitrile and 10 mM ammonium acetate buffer. Injections of 5 µL were 
made to the HPLC with the Sequant ZIC-HILIC column at 40 °C with a flow rate of 0.2 
mL/min. Mobile phase conditions were A: 90% acetonitrile and B: 10% acetonitrile, both whit 
10 mM ammonium acetate buffer adjusted to pH 9.2. Gradient started with an isocratic hold of 
100% A for 1 min, followed by a linear gradient increment to 75%B for 30 min. Then, during 
4 min the gradient changed until 100% B. At the end of each run column was flushed in 100%B 
for 5 min and equilibrated at 100% A for 25 min. Mass spectrometer conditions were set to 
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nitrogen gas flow 10 L/min, gas temperature 350 °C, nebulizer pressure 30 psi and capillary 
voltage of 4000 V. 
 
Evidence of dipeptide CHO cells uptake, extracellular and intracellular 
quantification. 
 
Batch CHO cell cultures 
 
The IgG1 producing strain CHO DP12#1934 (ATCC) was used for all experiments. Pre-
cultures grew in TC42 TeutoCell medium with 200 nM methotrexate (MTX) and 4 mM 
glutamine to a density of 0.4×106 viable cells/mL. Aliquotes were used to inoculate the main 
batch cultivations, again using TC42 TeutoCell medium with 200 nM MTXas basal medium. 
Selected, single dipeptides (provided by Evonik Industries AG) were added to the main cultures 
installing concentrations ranging from 4-6 mM. 125 mL or 2 L shaking flasks with working 
volumes of 40 mL and 700 mL were used. Medium without dipeptides was used as control. 
Cells were incubated at 36.5°C, shaking at 140 rpm in 8% CO2 humidified air for 8 to 10 days. 
Samples were taken daily and cell densities were measured through Trypan blue coloration on 
Cedex (Roche). 
Characteristic cell properties were calculated to qualify the impact of dipeptide addition to 
culture performance. The cell specific substrate uptake rates qS,i of i time intervals were 
estimated in batch cultures according to: 
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with Δt as the observed time interval, , C ! the average cell density of this interval and CS,n and    
CS,n-1 as the measured substrate concentrations at time points n and n-1, respectively. 
Each cultivation was performed as biological triplicates. 
 
Product, amino acids and dipeptides determination 
 
Antibody concentrations were determined through sandwich ELISA. Amino acids and 
dipeptides were analyzed simultaneously by LC-MS after dansyl chloride derivatization.  
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Sample preparation for quantification of intracellular amino acids and dipeptides  
 
In 700 mL batch cultures, samples containing 32x106 cells were taken. Cells were centrifuged 
(1300 rpm,10 min, 4°C)  and cell pellets re-suspended in 50 mL cold PBS (Phosphate buffered 
saline). Cells were washed twice with 5 mL PBS and cell pellets stored at -70°C until cell 
extraction. Cells were extracted using the Bilig-Dyer method (Bligh and Dyer, 1959) as 
follows:  1 mL of 1:2 CHCl3:MeOH was added to the cell pellet, followed by 250 µL CHCl3 
and finally 250 µL water vortexed for 5 min before any addition. Phase separation was achieved 
by centrifugation (1300 rpm, 10 min, 4°C). The water layer was separated, acidified with 1% 
TFA (Trifluoroacetic acid), evaporated to dryness using a speed vacuum and stored at −20°C 
until analysis. 
 
Amino acids and dipeptide Dansyl chloride derivatization 
 
Dansyl chloride derivatization was used to improve amino acids and dipeptide reverse phase 
chromatography retention. The derivatization protocol of (Wu et al., 2013) was followed. For 
extracellular measurements, samples were diluted 1:1500 and to 10 µL of diluted sample 50 
µL borax buffer (0.1 M, pH = 9) were added. For intracellular measurements, samples were 
reconstituted directly with 60 µL borax buffer. 100 µL of 20 mM dansyl chloride (in 
acetonitrile) were added and the reaction was kept at room temperature for 2 hours. Solutions 
were quenched with 100 µL 1% formic acid and measured directly or stored at -20°C. 
 
LC-MS amino acids and dipeptide quantification 
 
Amino acids and dipeptides were analyzed using an Agilent 1260 Infinity Bio-inert LC system 
coupled to and Agilent 6540 Accurate-Mass Quadrupole. The LC system comprised a degasser, 
quaternary pump, and thermostated autosampler (maintained at 4°C). 10 µL of derivatized 
sample was injected to a reverse phase column and guard column (Aeris PEPTIDE 3.6 u 
XBC18 150 × 2.1 mm, Phenomenex) with a flow of 0.4 mL/min. Used mobile-phase A was 
water with 0.2% formic acid and B acetonitrile with 0.2% formic acid. The gradient was set to 
17% B at the beginning of each run, then it increased until 80% B in 10 minutes followed by a 
washing step and equilibration. 
Mass spectrometer was configured in Extended Dynamic Range, low mass range (100-1300 
m/z). Measurements were made in MS acquisition mode with acquisition rate of 2 spectra/s. 
JetStream electrospray ion source was configured with gas temp of 220 °C, and sheath gas 
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temperature of 350 °C, drying gas flow 10 L/min, nebulizer set at 30 lb per square inch gauge, 
and sheath gas flow of 12 L/min. Capillary voltage was set to 4000 V, nozzle voltage 0 V, and 
fragmentor voltage to 130 V. Used reference masses were m/z 121.0509 and 922.0098 and the 
instrument was recalibrated each 20 samples. Dipeptide and amino acids standards were 
prepared as mix with concentrations ranging from 3 - 4000 µM and calibration ranges with 
correlation coefficient better than 0.98 were used. 
Data was analyzed using Mass Hunter Workstation Software (Ve r.B.05.519.0, Agilent 
Technologies), extracting ion chromatograms of the more intense monoisotopic ion for each 
amino acid or dipeptide derivatives. The identity of analytes was confirmed by matches of 
retention time and mass accuracy (better than 1 ppm). The later was accessed by the ‘find by 
formula’ feature implemented in the ‘Mass Hunter Workstation’ software. 
 
Shedding light on intracellular mAb degradation in CHO cells 
 
Bioreactor batch culture and 13C-Lysine pulse experiment 
 
The anti-IL8 producing strain CHO DP12#1934 (ATCC) grew in TC42 TeutoCell medium 
with 600 nM methotrexate (MTX) and 4 mM glutamine was used for bioreactor precultures. 
Cells were seeded at viable cell density of 0.5x106 cells/mL in  1,3 L medium supplemented 
with 600 nM MTX and 6 mM glutamine, 45 mM glucose, 45 mM fructore, 3.7 mM galactose 
and 1 mM L-lysine in four bench-top bioreactors (DS1500ODSS, DAS GIP) controlled at pH 
7.1, 37 °C, and dissolved oxygen at 30%. Two pitched blade impellers at 150 rm and steel L-
sparger were used for agitation and aeration control. After 63h cultivation, 100 mL of medium 
containing 90 mM glucose, 90 mM fructose, 6.2 mM galactore, 16 mM glutamine and 19.6 
mM 13C-L-Lysine. After the pulse 2.8x108 or 5.6x108 cells were harvested by regularly until 
the minimal reactor volume had been reached. Cells were centrifuged (1300 rpm,10 min, 4°C)  
and cell pellets re-suspended in 50 mL cold PBS (Phosphate buffered saline) then pellets were 
washed twice with 5 mL PBS and cell pellets stored at -70°C until cell extraction. Cell densities 
were measured through Trypan blue coloration on Cedex (Roche).  
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Determination of substrate and product concentrations 
 
Glucose and lactate concentrations were measured using LaboTrace TraceAnalytics. Antibody 
Antibody concentrations were determined through sandwich ELISA. Amino acids were 
separated on a Hewlett-Packard GC-FID 5802 using an EZ:fast GC-FID physiological amino 
acid analysis kit (Phenomenex). 
 
Extraction of intracellular peptides and sample purification 
 
Cells were extracted using lysis buffer at 80°C for 30 min. Lysis buffer composition was 
optimized testing different detergents considering their compatibility with mass spectrometry 
measurements and their ability to disrupt cell membrane (observable with microscope). 
Optimized lysis buffer consisted of 2 mM hexadecyl trimetyl ammonium chloride (HTA), 50 
mM ammonium acetate, and 150 mM sodium chloride, pH = 7.6. To separate cell debris lysates 
were cooled to 4°C and 100 µL of 20% H3PO4 were added prior centrifugation (20 000 x g 
during 20 min). Intracellular peptides were purified with several methodologies until finding 
the one that allowed the identification of anti-IL8 proteolytic intracellular peptides.  Suspended 
intracellular peptides were extracted using 1 cc OasisTM  MAX (Waters) solid phase extraction 
(SPE) as described by Chambers with minor modification (Chambers, 2013). Cartridges 
conditioning was made with MeOH and equilibration with 1% TFA. Samples were loaded and 
then washed first with 5% NH4OH and then with 20% acetonitrile. Elution of the peptides was 
carried out with 30% acetonitrile, 1% trifluoroacetic acid (TFA) solution. Extracts were 
evaporated to dryness using speed vacuum and stored at -20 °C until analysis. 
 
Intracellular peptide identification 
 
Dried samples were reconstituted in 5 % acetonitrile and 0.2 % formic acid. Injection of 80 µL 
was made to an Agilent 1260 Infinity Bio-inert HPCL system coupled to an Agilent 6540 
Accurate-Mass Quadruple-Time of Flight mass spectrometer (LC-Q-TOF/MS) with Jet Stream 
electro spray ion source. Chromatographic column used was an AerisTM PEPTIDE 3.6 u 
XBC18 150 × 2.1 mm from Phenomenex, with guard column. Mobile phase flow was 0.4 
mL/min with A water and B acetonitrile both with 0.2 % formic acid. For peptide mapping 
elution was made using an isocratic hold for 5 min of 5 % B, then a linear gradient from 5 % 
to 60 % B over 120 min. For peptide quantification the program was shorted increasing from 
5 % to 20 % B in 45 min. After each sample, column was washed with 90 % B for 10 min and 
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then equilibrated at starting conditions. Data was collected in positive Auto MS/MS mode 
under the following conditions: drying gas flow 8 L/min and gas temperature 220°C, nebulizer 
40 lb per square inch gauge, sheath gas flow 12 L/min, sheath gas temperature 350°C, capillary 
voltage 4000 V, and fragmentor voltage 135 V. The collision energy was set by formula with 
4.5 slope and 10 offset. Reference masses were m/z 121.0509 and 922.0098 and the instrument 
was recalibrated each 20 samples. Using the “find compounds by molecular feature” algorithms 
of the Mass Hunter Workstation Software (Ver.B.05.519.0, Agilent Technologies) a list of 
possible peptides was obtained. The data was exported and analyzed using PEAKS Studio 7 
(Bioinformatics Solutions, Waterloo, Canada). Peptides fragmentation data was analyzed by 
de novo sequencing and then peptide sequences were aligned using PEAKS DB with the CHO 
proteome and the anti-IL8 sequence [40, 41].  
Identified peptides were quantified using synthetic peptides (Intavis, Germany) as standards 
and their full labeled L-lysine (13C6,15N2) isotopologes as internal standards. 
Extracted ion chromatograms (EIC) of monoisotopic ions of each peptide isotopologe were 
integrated, and peak areas used to calculate isotopologe fractions and concentration for each 
time point. 
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Results and discussion 
ZIC-pHILIC coupled to tandem mass spectrometry for the quantification of 
intracellular key metabolites in bacterial cultures. 
 
Metabolomics is presented as the downstream product of genomics and proteomics, with which 
is possible to reveal, in a comprehensive manner, cellular metabolism and metabolic regulation 
(Oldiges et al., 2007; Horgan and Kenny, 2011; Luo et al., 2007). 
Absolut quantification of intracellular metabolites represents a key contribution in the 
elucidation of cellular machinery. Identification of kinetic models in vivo is carried out using 
stimulus-response experiments, in which sudden change of an extracellular metabolite 
concentration, drive away cells metabolism from steady state. Pulse experiments in batch or 
feed batch fermentations combined with fast sampling protocols and intracellular metabolite 
quantification, during the transient state, gives the information needed to evaluate metabolic 
fluxes (Magnus et al., 2006; Oldiges and Takors, 2005). Reversible reactions, parallel and 
cyclic pathways (e.g. glycolysis vs. pentose phosphate pathway) are evaluated introducing 
isotopic tracers (e.g. 13C-glucose). When feeding the cell with 13C-glucose the 13C label 
becomes distributed over the entire metabolic network, the isotopomer distribution of each 
metabolite is determined by mass spectrometry or nuclear magnetic resonance (NMR) and 
mathematical models are used to calculate metabolic fluxes distribution (Woo Suk and 
Antnoniewicz, 2013). 
Comparison of metabolic fluxes at different growth phases can provide crucial information 
about targets for genetic engineering and improve process monitoring and cell productivity 
(Woo Suk and Antnoniewicz, 2013). Metabolic engineering makes use of Metabolic Flux 
Analysis (MFA) to rationally perform genetic changes in microorganisms aiming to produce 
fine chemicals (Nielsen, 1998). 
As it is the central control for carbon flux distribution, central carbon metabolism (CCM) is the 
main target for metabolic engineering optimization. In the CCM substrate degradation, energy 
regeneration, and biosynthetic precursors supply are regulated in order to guarantee cell 
growth. The glycolysis perform the essential breakdown of sugars generating ATP, the 
pentose-phosphate pathway (PPP) generate NADPH needed for bio-reductive biosynthesis and 
the tricarbolylic acid cycle (TCA) divert carbon flux to generate building blocks precursors 
(e.g. amino acids) and the production of chemical energy as ATP, redirecting the produced 
reducing agent NADH to the oxidative phosphorylation pathway (Figure 3). 
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The presented analytic methodology intends to quantify intracellular pools of CCM 
metabolites, sugar phosphates as glucose-6-phosphate or ribulose-5-phosphate from the 
glycolysis and PPP, carboxylic acids as oxaloacetate or a-ketoglutarate from the TCA cycle 
and proteogenic amino acids as some amino acids derivatives. Also adenosine, guanosine, 
cytidine and uridine nucleotides were included in the same quantification methodology as they 
participate as products, substrates, effectors or energy donors in many cellular reactions. 
Moreover, fluctuations in nucleotide pool sizes can produce alterations in transport processes, 
macromolecular synthesis and cell growth (Atkinson, 1977; Buckstein et al., 2008). The 
position in the CCM of each measureable metabolite is described in the figure 3, were the 
metabolites measured with the presented methodology appear as grey shaded. 
The novelty of the ZIC-pHILC method resides in the use of the zwitterionic hydrophilic 
stationary phase under alkaline conditions which boosts the detection limits and 
chromatographic performances of many key CCM metabolites, the presented method was also 
tested for the intracellular quantification of target metabolites pools using E.Coli as reference 
organism.  
ZIC-pHILIC chromatographic separation 
 
Chromatographic separation of polar metabolites has been limited since the last decades to gas 
chromatography (GC), capillary electrophoresis (CE) and different modes of liquid 
chromatography (LC) for which reverse phase ion paring and hydrophilic interaction 
chromatography (HILIC) shows to be the best candidates.  
GC is limited as just can be able to separate volatile molecules. For GC there is a need to use 
derivatization techniques that allow the measurement of just compounds having hydroxyl, 
amine or thiol groups that react with silylating reagents (producing trimethilsilyl or tert-
butyldimethilsiliyl derivatives) (Halket, 2004). 
On the other hand, CE is based on differential transport of charged molecules in an electric 
field through a conductive medium. CE buffers generally are not compatible with MS 
ionization systems because their lack of volatility and ion suppression that cause a deterioration 
of signal sensibility (Iwasaki et al., 2012). 
In cross-platform comparison experiments, where quantitative analysis of primary metabolism 
was evaluated, liquid chromatography, because of its robustness and versatility, has proved to 
be the recommended option for analysis of intracellular metabolites from which the HILIC 
retention  performed better when resolution of constitutional isomers was needed (Bu et al., 
2009;  Luo et al., 2007). 
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Figure 3. Central carbon metabolism: Glycolysis, TCA cycle and PPP metabolites. Grey 
shaded metabolites represents the analytes quantified with the ZIC-pHILIC tandem MS/MS 
stablished methodology. 
 
The Zwitterionic polymer based HILIC (ZIC-pHILIC) separation is based on the formation of 
a water rich layer partially immobilized on the stationary phase.  Partitioning of polar molecules 
between the mobile phase and the water layer is accepted as the principal retention mechanism 
for HILIC. The zwiteionic structure of the 3-sulfopropyldimethylalkulammonio moiety (Figure 
4) from the stationary phase for a ZIC-pHILIC chromatographic column allow the water 
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binding to the surface and add charged metabolites selectivity as the negatively charged 
sulfonic group and the positive charge of the quaternary ammonium cation contribute with 
electrostatic interactions independent of mobile phase pH (Hemström and Irgum, 2006). For 
silica based HILIC the recommended pH range is 3-8 but for polymeric columns the pH range 
is augmented from 2-10 increasing the possibilities of mobile phase preparation and metabolite 
retention selectivity. 
 
 
Figure 4. Diagram of the ZIC-pHILIC retention mechanism. 
 
 
The chromatography performance at acidic (pH= 5.6) and alkaline (pH= 9.5) conditions was 
evaluated using a 5 µM metabolite standard mix and two ZIC-pHILIC columns. In order to 
guarantee a fair comparison of both conditions two different columns (same lot number) were 
used to avoid column deterioration because of the pH change as different mobile phases were 
used. 
Using both pH conditions the chromatographic resolution of constitutional isomers was 
possible with good to adequate peak shape and tailing (Figure 5). 
Amino acids and organic acids presented similar chromatographic performance giving 
symmetric peaks with Gaussian distribution, peak broadening was observed for aconitic acid 
which could be corrected changing the solvent gradients to optimize the method for the specific 
metabolite. 
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Figure 5. Constitutional isomers chromatographic separation. Measurement of 5 µM 
metabolite mix with the ZIC-pHILIC methodology using alkaline conditions (pH = 9.5)  
(Figure form Teleki et al., 2015, apendix C).  
 
 
Better chromatographic performance was obtained for alkaline conditions when peak 
symmetry and tailing effects of sugar phosphates and nucleotides were compared. All the tested 
nucleotides, including ADP and ATP, performed better under alkaline conditions (Figure 6). 
The first pKa of nucleotides ranges from 3 to 5, meaning that under alkaline conditions (pH = 
9.5) the negative charge prevails in the metabolite form. On the other hand, under acidic 
conditions the amine group of the nitrogenous base will be protonated. The higher electrostatic 
interaction of positively charged metabolites with the sulfonic group of the stationary phase 
could be responsible for the loss of chromatographic performance under acidic conditions 
because of stronger interaction that slows metabolite partitioning equilibrium. Negatively 
charged metabolites lack of extra electrostatic interaction, therefore would have no interference 
in partitioning mechanism, performing chromatographically better. 
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Figure 6. Differences in nucleotides and sugar phosphates chromatographic performance at 
different pH conditions. A) Alkaline conditions; pH = 9.5). B) Acidic conditions pH = 5.6). 
(Figure not in Teleki et al., 2015, apendix C, but generated from data).  
 
 
Effect of pH in metabolite signal/response in ESI-MS/MS 
 
Between others atmospheric pressure ionization sources, electro spay (ESI) is the principal 
used interface between the liquid chromatography and the mass spectrometer. Only charged 
molecules in gaseous phase can be selected or analyzed by mass spectrometry, consequently 
metabolites coming in the LC mobile phase have to be vaporized and ionized a priori the 
entrance to the mass spectrometer. 
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Figure 7. Electro spray ionization source operated in positive mode.  
 
 
Analytes solution is pumped through the capillary tip charged with a very high electric field. 
As a high voltage (2-4 kV) is applied between the capillary tip and the mass spectrometer plate, 
electrochemical reactions (Table 1) occur generating hydronium or hydroxide ions (depending 
of the operating mode) which induce proton transfer to or from the metabolites. Charged 
molecules polarize forming a Taylor cone where repulsion between charges causes the jet to 
break up into small charged drops. Continuous solvent evaporation and coulomb fission of the 
small drops lead ultimately to gas-phase ions (Figure 7). (Konermann et al., 2013; Banerjee 
and Mazumdar, 2012). 
 
Table 1. Expected electrochemical reactions occurring in the electro spray chamber with their 
standard potentials (Kertesz, 2007). 
Solvent Positive ionization  mode Negative ionization mode 
Water 
Oxidation reactions E° (V) Reduction reactions E° (V) 
2H2O  O2 + 4H++ 2e− 1.23 2H2O + O2 + 4e−  4OH− 0.40 
2H2O  H2O2 + 2H++ 2e− 1.77 H2O + O2− +e−  HO2 −+ OH− 0.20 
H2O  HO! + H++ e− 1.72 2H2O + 2e−  H2 + 2OH− 0.07 
  2H2O + O2 + 2e−  H2O2 + 2OH− -0.13 
  H2O+O2 +2e−  HO2− +OH− -0.83 
 
Within the concept of electro spray ionization, under positive mode, formation of hydronium 
ions, due to electrochemical and proton transference reactions, generate positively charged 
metabolites, while negative mode will generate negatively charged analytes, as produced 
hydroxyl ions deprotonate metabolites. As a common rule, the pH of the mobile phase should 
increase the generation of positive charged metabolites for acidic conditions and alkaline pH 
should improve negatively charged ions formation. This phenomenon should be observed as a 
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signal increment in positive mode under acidic conditions and in positive mode under alkaline 
conditions. For the analyzed metabolites, both conditions were evaluated in order to improve 
method sensibility, looking forward to have the lower detection limit for each metabolite. 
Under alkaline conditions, indistinctly of the polarity mode used, almost all metabolites 
presented higher sensibility. For injections of standard metabolite mixes, with the same 
concentrations, using a mobile phase with basic pH, peak areas were from one to 20 times 
higher, even when measured in positive mode. Just L-arginine presented higher signal under 
acidic conditions (Figure 8). 
 
 
Figure 8. Metabolites peak areas under alkaline conditions (pH = 9.5) relative to peak areas 
under acidic conditions (pH = 5.6). Grey bars are metabolites measured in negative mode and 
black bars under positive mode (Figure from Teleki et al., 2015, Appendix C). 
 
In electrospray ionization studies, the observation of protonated ions when they are expected 
to be present in low concentrations in strongly basic conditions is called “wrong-way-round 
ionization”. Studies using amino acids and caffeine demonstrated that the bulk solution pH not 
always has an influence over molecules ionization mechanisms, even more, electro spray 
ionization depends from the substances used for setting up solution pH. Under alkaline 
conditions using ammonium acetate buffer, it has been stated that collision induced dissociation 
(CID) of ammonium gaseous adducts: [NH4++M]+ (g) → NH3 (g) + MH+(g), favors the proton 
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transfer to metabolites. Even so, it is stated that the mechanism of electro spray ionization needs 
further research (Mansoori et al., 1997;  Kelly et al., 1992; Zhou and Cook, 2000). 
As a corollary, when using ESI-MS, mobile phase pH has to be set in order to increase specific 
metabolite ionization according to the measurement target. For our method optimization, it was 
interesting that not just the zic-HILIC chromatographic performance was improved under 
alkaline conditions but signal intensity increased, allowing low method detection limits (MDL) 
on the nanomolar order. 
For example, for molecules measured in positive mode, under alkaline conditions O-Acetyl-
serine presented a MDL for of 33 nM versus 286 nM at acidic pH. Also, nucleotides as NADP 
and NAD presented respectively lower MDL 2 times (7.6 nM Vs 13.1 nM) and 50 times (31 
nM Vs 1500 nM) under basic conditions. 
The presented alkaline ZIC-HILIC method allow the measurement of key CCM within low 
detection limits, this as a result of better chromatographic performance and the increment of 
signal sensibility thanks to the ionizations improvement explained by the  “wrong-way-round 
ionization” theory. 
 
Targeted intracellular metabolite absolute quantification by alkaline ZIC-HILIC MS/MS 
 
The quantification method was applied to the evaluation of targeted intracellular metabolites 
concentrations. Exponentially growing E.Coli biomass was sampled and extracted with the 
methodology presented above to perform the quantification.  
In mass spectrometry one of the major problems comes when there is a need to use an internal 
standard to compensate matrix effects and sample manipulation errors (dilutions, sample 
purification or metabolite extraction). Matrix effects mainly affect analyte ionization, as ion 
suppression or augmentation could produce quantification bias. 
Due to the specificity of molecules ionization (not all molecules ionized with the same 
efficiency) the internal standard should be an isotopologe of the same analyte (13C, 15N or 2H 
labeled), that would allow it to coelute with the analyte, as they should have the same retention 
efficiency, and have the same influence from the matrix effects, as coelute also with the same 
matrix components. Even when isotopologes would be the ideal internal standards, they are 
expensive and not always commercially available. Isotope dilution using 13C full labeled 
biomass extracts comes as an economically affordable option to evaluate multiple metabolites 
as an optimal internal standard mixture (Wu et al., 2005; Vielhauer et al., 2011). 
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An additional methodology is standard additions, were there is no need to use a labeled internal 
standard but commercially available high purity metabolites, which are added systematically 
to the samples to generate a calibration curve within the sample, this way the matrix effects are 
considered as the calibration curve is prepared within the matrix.   
The extracts were quantified by different absolute quantification methodologies (external 
calibration, isotope dilution and standard additions) in order to evaluate the influence of the 
intracellular matrix over the analyte signal and the ability of the chromatographic method to 
eliminate matrix effects produced by coeluting compounds avoiding the use of expensive or 
unavailable internal standards. 
For the targeted metabolites no significant differences between the quantification methods were 
observed when ANOVA analysis was performed. Just for NAD the isotope dilution 
quantification appears to present an over estimation of the intracellular quantification 
presumably because of the low 13C-NAD signal present in the algal extracts (Table 2). 
 
Table 2. Intracellular concentration of targeted metabolites. Standard deviation calculated 
from four analytical replicates. F(crit) = 4.256. 
 
Metabolite 
External 
Calibration IDMS 
Standard 
Additions 
One-way 
ANOVA 
 µmol/g(CDW) µmol/g(CDW) µmol/g(CDW) F P value 
L-Leu 0.36 ± 0.02 0.37 ± 0.01 0.40 ± 0.02 3.560 0.0726 
L-Lys 0.83 ± 0.05 0.87 ± 0.02 0.88 ± 0.05 1.622 0.2503 
L-Val 1.08 ± 0.06 1.12 ± 0.03 1.06 ± 0.07 1.379 0.3002 
NAD 1.7 ±  0.1 2.00 ± 0.05 1.7 ± 0.1 9.193 0.0067 
Gly 6.7 ± 0.4 6.8 ± 0.2 6.8 ±  0.3 0.121 0.8876 
L-Ala 7.0 ± 0.3 7.2 ± 0.1 6.4 ± 0.2 1.778 0.2235 
 
 
The use of an alkaline ZIC-HILIC mass spectrometric method proved to be a solid option for 
the absolute quantification of intracellular metabolites. As the presented method was tested 
quantifying target metabolites in intracellular extracts it was observed that there was no need 
to use complex standardization technics as isotopic IDMS (isotopic dilution mass s or standard 
additions, which are time consuming and expensive. It was possible to quantify using the 
simplest approach, external calibration. 
For these metabolites the matrix effect, that could produce over or sub estimation of metabolite 
pools concentrations, didn’t have a significant effect, as reflected in the p-value from the 
ANOVA test, where the calculated concentration with the different quantification methods 
were similar within probabilities higher than 5%. 
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It is important to note that even when, for these metabolites, matrix effects were not significant 
it doesn’t guarantee that this case applies for all the measurable metabolites with the alkaline 
ZIC-HILIC methodology. This means that for other targeted analytes the evaluation of matrix 
effects should be performed and this is also true when different organisms should be used, or 
other intracellular extraction methodology is applied, as matrix components would be different. 
The presented methodology was perform using a tandem instrument, a triple quadropole mass 
spectrometer. This instrument is highly recommended for lowering the detection limits of 
analytes but present also a limitation: it has to be configured just to perform targeted analysis.  
A MS/MS analysis requires ions preselection and this selection is limited by the 
chromatographic method.  
A triplequadrupole system requires time to switch between transitions and time to make a 
measurement that belongs just to one metabolite at each time (transient). The frequency at 
which a triplequadrupole change between transitions and the time that it takes to read one 
transient, limits how many metabolites can be measured at the same retention time. Metabolites 
coming at the same retention time could not be measurable in one single run, depending how 
many metabolites have been targeted. 
Considering this, a HILIC combination with tandem MS presents a disadvantage. HILIC 
retention mechanism cause a narrow metabolite retention window. Alkaline ZIC-HILIC 
chromatographic separation 50 % (25 metabolites) of the analyzed metabolites have a retention 
time between 21 and 25 min, a retention window of 4 minutes. This could limit the selection 
of metabolites to measure when setting up a MS/MS method for these 25 metabolites in a single 
run. 
To overcome this problem it is possible to extend the optimal chromatography of the alkaline 
ZIC-HILIC method to a high resolution mass spectrometer (HR-MS) as a Quadrupole-Time of 
Flight (Q-TOF). HR-MS allows the measurement of all metabolites coming at the same 
retention time, performing metabolite profiling, with the limitation that they can’t have the 
same mass (structural isomers, for example leucine and isoleucine), where this separation is 
achieved by the chromatographic method, as its retention separates isomers at different 
retention times. Metabolite profiling with HR-MS allows the observation of all the intracellular 
metabolites in the sample even when they are not part of the targeted metabolic routes. This 
will increase the possibilities to acquire information about the system that could be used to 
establish accurate organism metabolism models and extend the frontiers out from the CCM.  
In the past, HS-MS was stigmatized to have higher detection limits as a MS/MS system because 
of their lower acquisition rate (it takes more time to acquire a transient as for a MS/MS system), 
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even so, new technologies are increasing ionization efficiencies and ion transference are 
lowering the HR-MS detection limits to the range of Tandem instruments used to perform 
Metabolic Flux Analysis (MFA). 
In the next section HR-MS using a Q-TOF instrument was used to evaluate the intracellular 
concentration of amino acids and dipeptides for the evaluation of their uptake mechanism. The 
advantages of HR-MS allowed the intracellular measurement of proteogenic amino acids and 
complete overview about how the dipeptides pools change at the intracellular level at different 
stages of the culture. It was possible to identify more than 200 dipeptides, included the 
dipeptides supplemented in medium which were, for the moment, the only object of study. 
With the presented ZIC-HILIC optimized chromatography it was possible to separate 
interesting target polar metabolites of the central carbon metabolism, including constitutional 
isomers. The alkaline conditions contributed to the improvement of detection limits by higher 
“wrong-way-round” ionization efficiency decrease detection limits to nanomolar scale. 
This methodology allows the observation of intracellular metabolite pools, making possible to 
track how metabolites concentration change as response for determined stimulus, monitoring 
intracellular metabolism dynamics improving the understanding of intracellular metabolic 
networks. Analysis based in this quantitative information could be used for modeling changes 
in intracellular metabolic fluxes distributions leading to new metabolic engineering targets. 
The presented methodology has already showed important results, as has been already 
implemented in research fields as compartment-specific metabolomics where the methodology 
was already tested to obtain interesting data on cell metabolism (Matuszczyk, 2015). 
 
  
 __________________________________________________________________________________ 
36 
 
Tracking dipeptide fate in supplemented cell culture medium and at intracellular 
level. 
 
In order to understand cellular behavior completely, the analytics capacity has to be expanded 
from the primary metabolites of the CCM. Observation of metabolites or non-conventional 
nutrients that have an effect over cellular machinery are interesting objectives that can trigger 
new strategies for production improvement. 
Tracking dipeptides fate, supplemented in CHO cells medium, showed to be of interest in order 
to investigate their boosting properties for monoclonal antibodies production. It has been 
demonstrated that dipeptides such as Alanine-Glutamine (AQ) or Glycine-Glutamine (GQ), 
including others, have boosting effects in mammalian cells, affecting growing rates or mAb 
production, but still there isn’t a clear understanding about how they affect cells phenotype or 
even a mechanism that explains if they are uptake into cell cytosol. 
Using the advantages of high-resolution mass spectrometry coupled to liquid chromatography, 
the simultaneous measurement of low concentration metabolites is possible. This way, 
dipeptides, at the intracellular level, have been already evaluated as biomarkers for non-small-
cell lung cancer (Wu et al., 2013), which encouraged the idea of tracking supplemented 
dipeptides into the mAb producing cells. 
As part of the suggested methodology, dansyl chloride derivatization (Figure 9) has been used 
to improve dipeptides retention. The dansyl derivatization reduce dipeptides polarity 
introducing a bulky dansyl group, making dipeptides more suitable for straight forward 
separation, using reverse phase chromatography. Another advantage of adding this 
derivatization step is that the dansyl group incorporates an easily protonable amine group 
increasing the dipeptides ionization efficiency, in turn increasing signal intensities when 
analyzed by ESI-MS, having better detection and quantification limits for dipeptide absolute 
quantification. This way, all metabolites presenting phenolic or primary and secondary amine 
groups react under alkaline pH with the dansyl chloride forming stable derivatives with 
improved retention in reverse phase moieties and extra high intensity for electro spray 
ionization sources, allowing lower detection limits, which is always important when attempting 
to analyze intracellular matrixes  (Guo and Li, 2009). 
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Figure 9. Dansyl chloride derivatization of amines and phenols at room temperature (RT). 
 
 
Using the dansyl derivatization, the applied reverse phase chromatographic separation, together 
with the advantages of using high-resolution mass spectrometry, the simultaneous 
quantifications of dipeptides and amino acids pools was possible. Chromatographic separation 
was optimized to take just 15 minutes simultaneously quantifying the 30 metabolites of interest 
each run, including 20 proteogenic amino acids and seven dipeptides (Figure 10). 
 
 
Figure 10. Extracted ion chromatograms for quantified metabolites in a 30 nM standard mix. 
Extracted ion correspond to m/z of dipeptide and proteogenic amino acids dansyl derivatives. 
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All the metabolites presented linearity ranges with correlation coefficient (r2) better than 0.98 
in concentration ranges from 2 to 100 nM for external calibration curves. Quantification limits 
were around 6 nM for all the quantified metabolites. 
As part of the evaluation of the analytical method partial derivatization was observed. This 
because substances containing tyrosine, lysine or cysteine can be derivatized in multiple 
functional groups, and if they are not completely derivatized it could represent an error in the 
absolute quantification of intracellular and extracellular dipeptide pools (Figure 11). As 
expected, as an excess derivatization agent is used, just full derivatization was observed for all 
compounds, as needed for absolute metabolite quantification (Figure 12). 
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Figure 11. Full dalsyl derivatization reactions for lysine, cysteine and tyrosine. These amino 
acids possess two reactive functional groups. Just fully derivatized compounds were used for 
quantification. 
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Figure 12. Extracted ions chromatograms for the full derivatized (A) and partially derivatized 
(B) dipeptide L-glicine-L-tyrosine. No significant signal was observed for the partially 
derivatized compound. 
 
 
From the available dipeptides tested, offered by Evonic Industries partnership, L-Glutamine 
containing dipeptides as L-alanine-L-glutamine (AQ) and L-glycine-L-glutamine (GQ) were 
studied. This was because of their already known boosting properties that are assumed to have 
to do with the extra glutamine supplementation.  Tyrosine containing compounds as L-alanine-
L-tyrosine (AY), L-glycine-L-tyrosine (GY) and L-proline-L-tyrosine (PY) were evaluated as 
tyrosine dipeptides present higher solubility as tyrosine increasing these amino acid availability 
in medium. Other peptides were applied too: L-alanine-L-cysteine (AC), L-alanine-L-proline 
(AP), and L-proline-L-cysteine (PC). From which cysteine containing peptides were forming 
dimers as disulfide bridges were present in their structures (AC-CA and PC-CP) challenging 
the dipeptide uptake system. Parallel to the dipeptide supplemented culture replicates of CHO 
cultivated in medium without extra dipeptide addition were performed, this was in order to 
establish a basis for comparison, this cultures were named as “Control” cultures.  
Once the methodology was stablish, CHO cell culture medium was supplemented or not 
(Control) with dipeptides and samples withdrawn over time allowing chasing supernatant 
dipeptides concentration. Also cell pellets were extracted performing tree times washing steps 
(in order to avoid medium contamination) to track intracellular dipeptides fate. 
For the evaluation of their boosting properties, sets of dipeptides were grouped depending on 
their improvement capacity. Some dipeptides performed an increment in specific cell growth 
rate, mAb production rate or maximal product final concentration. 
A 
B 
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Of first interest are the results about extracellular dipeptide dynamics, from which two different 
uptake kinetics were observed, grouping dipeptides in two possible uptake mechanisms. Also 
supplemented dipeptides were found at the intracellular level, ratifying, for the first time, with 
a consistent methodology, that dipeptides are indeed uptaked by the CHO cells. In the next 
sections data concerning the two differently marked dipeptide uptake kinetics in CHO cells is 
shown and discussed as the intracellular measurements confirming that dipeptides are 
intracellularly degraded. 
 
Tracking dipeptides in the extracellular medium 
 
Nutrient incorporation into the cells divert in transmembrane transport mechanisms. Cells 
maintain their functionality by conserving concentration gradients between the cytoplasm and 
the cell exterior. The cell invest energy in maintaining lower ion concentrations intracellularly 
by active transport ion secretion to the extracellular medium. Maintaining this concentration 
gradients takes about one third of the required energy for mammalian cells, which is justified, 
as the gradient drives the transport of most nutrients into the cell by passive transport or 
secondary active transport. 
Passive transport of biological membranes is achieved mostly by facilitated diffusion, where 
an integral membrane protein, presenting a polar channel in its quaternary structure, enables 
the transport of polar molecules, overcoming the thermodynamic barrier of trespassing a 
hydrophobic layer, assisted only by its concentration gradient.  
The cell uses energy (ATP) to maintain ions gradients (ie. H+, Na+) between the cytosol and 
the extracellular medium, these ions are then used as coupled carriers, in which a specific solute 
is transported simultaneously with the ion allowing these carriers to use the energy stored in 
the electrochemical gradient (secondary active transport). 
Two are the main characterized dipeptide transport systems: PepT1 and PepT2. PepT1 and 
PepT2 are known to incorporate oligopeptides in the cells, in humans,  as H+ driven symporters 
(Covitz et al., 1996). PepT1 is characterized by a low-selectivity (KM in mM range) and PepT2 
by its high affinity (KM in µM range) which makes PepT1 to enable fast oligopeptide import 
under relatively high peptides concentrations while PepT2 should be active under peptide 
limiting conditions (Newstead, 2014). The existence of such dipeptide importers in CHO-K1 
is still not clear, but recently PepT1 and PepT2 were assigned in the CHO-K1 genome entitled 
as part of the “solute carrier family 15” (Slc15a1, Slc15a2) (Hammond et al., 2012).  
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Monoclonal antibody producing CHO cells cultures were supplemented with different neutral 
dipeptides presenting a range of molecular weights from 203 to 434 Da (Table 3).  Dipeptides 
were constituted by pairs of one hydrophobic (A, P, G) and one hydrophilic (Q, Y, C) amino 
acid, giving to each dipeptide different polarities and steric properties. From them, two dimers 
with disulfide bridges were tested (AC and PC) challenging the transmembrane transport 
systems. 
 
Table 3. Dipeptides used as supplements in CHO culture medium. 
 
Name Formula Abbreviations Molecular 
Weight (Da) 
L-alanyl-L-glutamine C8H15N3O4 AQ 217.22 
Glycyl-L-glutamine C7H13N3O4 GQ 203.20 
L-alanyl-L-tyrosine C12H16N2O4 AY 252.27 
Glycyl-L-tyrosine C11H14N2O4 GY 238.24 
L-prolinyl-L-tyrosine C14H18N2O4 PY 278.30 
L-alanyl-L-proline C8H14N2O3 AP 186.21 
L-alanyl-L-cysteine C12H22N4O6S2 Ala-CysCys-Ala 382.46 
L-prolinyl-L-cysteine C16H26N4O6S2 Pro-CysCys-Pro 434.53 
 
With the validated high resolution mass spectrometry methodology, quantification of 
dipeptides concentrations were measured and as a result the dipeptides pools during the culture 
were tracked in the cell culture medium acquiring a profile of the uptake rate of each dipeptide. 
By measuring absolute concentrations in medium it was possible to observe the uptake kinetics 
for each supplemented dipeptide. 
Considering the structure diversity of the studied dipeptides, it was interesting to find that just 
two dipeptide uptake phenotypes were observed. Some dipeptides presented a really fast 
uptake, being consumed completely in the first five days, from the beginning of the lag phase 
and depleted completely in the middle of exponential growing; the others were slowly 
consumed during all the ten days of culture, almost with steady uptake rates (see figures 13, 14 
and 15). 
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Figure 13. Growth curves for the different dipeptide supplemented CHO cultures. The viable 
cell concentration was monitored for each culture during the lag, exponential and final phases. 
Each culture is compared to Control culture (not supplemented medium). Error bars represents 
the standard deviation of biological triplicates. 
 
These two kinetics resemble, for CHO cells, what has been known so far for other mammalian 
cells, the presence of PepT1 and PepT2 like transporters. As with PepT1 high import rates are 
observed at the beginning of the culture for peptides AP, GY, AQ and AY, which presents 
uptake rates from 1.5 to 3 µmol x 10-5/cells at the beginning of batch fermentations, resembling 
a diffusion-driven import, as higher dipeptide concentration coincides with a faster uptake rate 
which falls down as the dipeptides concentrations are depleted.  
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Figure 14. Grouped dipeptides with faster dipeptide uptake rates. Error bars describe the 
standard deviation of three biological replicates (Figure from Sánchez-Kopper, et al.; appendix 
E). 
 
On the other hand peptides as GQ, PY, AC-AC and PC-CP presented a slower-almost constant 
depletion rates about 1/10 (0.1 µmol x 10-5/cells) of the dipeptides with faster uptake. Apart 
from GQ all the peptides with slower uptake coincides with the bulkier dipeptides, as PY, AC 
and PC are the dipeptides with higher molecular weight, which could be the reason for their 
slower uptake rate. Surprisingly GQ is the tested dipeptide with the lower molecular weight 
and still it is part of the slow uptake dipeptides. This confirms that the dipeptide uptake systems 
present in CHO cells also presents a specific substrate selectivity resembling amino acids 
uptake, where  amino acids transport systems i.e. System A, System N, and ASC work just for 
specific amino acids sets (Hyde et al., 2003). 
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Figure 15. Grouped dipeptides with slower dipeptide uptake rates. Error bars describe the 
standard deviation of three biological replicates. (Figure from Sánchez-Kopper, et al.; appendix 
E). 
 
Observing the differences between the two phenotypes, it could be possible to infer that two 
different uptake mechanisms could be involved in the dipeptide transmembrane transport. 
There is a need to confirm the presence of oligopeptides transporters in CHO, especially when 
it is possible that dipeptide uptake in CHO cells is carried out by means of PepT1/PepT2 like 
systems. For our proposes, the differences in specific uptake rates obtained (figures 13 and 14) 
may be a result of their different transporters affinities, and is a confirmation that at least two 
different dipeptides transport systems are present in CHO cells. 
 
Intracellular dipeptide concentration as confirmation of uptake 
 
Considering the advantages of actual systems of high resolution mass spectrometry, as they 
allow to have really low detection limits, even in complex matrices as intracellular extracts, 
amino acids and dipeptide intracellular concentrations were measured to confirm that 
dipeptides were indeed transported inside the cells elucidating also if the amino acids 
intracellular concentrations, coming from the supplemented dipeptides, were higher in control 
samples as a result of the dipeptide uptake and their intracellular degradation. 
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For the measurement of the intracellular concentration, because of the dipeptide availability, a 
selected subset of dipeptides was used. Because 2 L batch cultivations (700 mL working 
volume) were needed in order to take samples with relatively high cell numbers without 
affecting cell growth, higher amounts of each dipeptides were needed to obtain the same 
concentrations in medium as in the uptake kinetics experiments (4-6 mM). The dipeptide subset 
was considered by choosing from the available dipeptides representatives of the groups A (fast 
uptake) and B (slow uptake). AQ and AY were chosen as members of A, while AC-CA served 
as an example of B. It should be ideal if the dipeptide GQ could be also consider as a 
measurement of intracellular kinetics but the available amount of dipeptide wasn’t sufficient 
to prepare enough medium for a 2 L batch cultivation. 
To revalidate the extracellular kinetics the supplemented dipeptide concentration in medium 
were also measured. Dipeptides as AQ and AY presented again a faster uptake and the dimer 
AC-CA decrease its concentration with slower rate (Figure 15a, 16a, 17a). 
The supplemented dipeptides were also found in the intracellular extracts, being degraded as 
they are imported. Concentration of the dipeptides with faster uptake rates (AY and AQ) 
diminish its concentrations as they were depleted in medium but in the case of AC, uptake was 
slow and constant and kept a constant intracellular concentration over the culture. Constitutive 
amino acids: alanine, cysteine and tyrosine, presented higher intracellular concentrations as in 
control, meaning that dipeptides are degraded by peptidases inside the cell (Figure 15b, 16b, 
17b). 
As the dipeptides were consumed, and intracellularly degraded, the concentration of their 
constitutive amino acids in medium increased to higher levels compared to control. Alanine is 
already known to be formed in mAb producing CHO cells from pyruvate as a consequence of 
glutamate transamination to produce a-ketoglutarate to fuel the TCA cycle and its excess 
exported to medium (Altamirano et al., 2013) (Hansen and Emborg, 1994), but here we 
observed that, in comparison to the control, alanine was secreted in higher concentrations, 
reaching levels of the initial dipeptide concentration, meaning that almost all the alanine, 
uptaked in the form of dipeptide, was expelled to medium without further metabolization. The 
same case appears to happen with tyrosine and cysteine as their concentration in medium 
trended to increase as their respective dipeptides were intracellularly degraded. L-Glutamine, 
present in medium from the beginning of the fermentation, a steady reduction with an 
intermediary slow-down between 3-5 days, this was consequence of its metabolization priority 
as this amino acid is used by CHO cells as energy source. 
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Figure 16. L-alanyl-L-glutamine (AQ) and constitutive amino acids concentrations in 
extracellular (A) and intracellular (B) levels measured in CHO supplemented cultures. Open 
circles represent concentrations found in control culture. Error bars describe the standard 
deviation of three analytical replicates. Extracellular data from single measurements. (Figure 
from Sánchez-Kopper, et al.; appendix E). 
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Figure 17. L-alaninyl-L-tyrosine (AY) and constitutive amino acids concentrations in 
extracellular (A) and intracellular (B) levels measured in CHO supplemented cultures. Open 
circles represent concentrations found in control culture. Error bars describe the standard 
deviation of three analytical replicates. Extracellular data from single measurements. (Figure 
from Sánchez-Kopper, et al.; appendix E). 
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Figure 18. Alanine-Cystine-Alanine (AC-CA) and constitutive amino acids concentrations in 
extracellular (A) and intracellular (B) levels measured in CHO supplemented cultures. Open 
circles represent concentrations found in control culture. Error bars describe the standard 
deviation of three analytical replicates. Extracellular data from single measurements. (Figure 
from Sánchez-Kopper, et al.; appendix E). 
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Amino acids export to medium is performed by mammalian cells to refuel intracellular limiting 
amino acids. Neutral amino acids are exported from the cell by the ASC transport systems 
(from Alanine, Serine, Cysteine) by means of a tertiary active transport mechanism, in which 
the cell takes advantage of the amino acids imported by secondary active transport to exchange 
them for other amino acids without affecting global intracellular pools (Kyriakopoulos et al., 
2013) (Figure 19). 
 
 
Figure 19. Tertiary amino acids transport. As a result of the ion gradient generated by primary 
active transport (AT) the ion gradient is used to import amino acids as alanine (Al) which are 
used also to be exchanged, by means of tertiary AT, for other amino acids (AA) by the sodium 
dependent ASC antiporter. Figure modified from (Hundal and Taylor, 2009). 
 
This behavior of amino acids export has to be considered closely when thinking in dipeptide 
supplementation. The amino acids incorporated to the cells as dipeptides should be amino acids 
of highly metabolic demand, as the glutamine case, otherwise give the impression like there is 
a waste of resources for the cell, as it is forced to use the extra concentration of imported amino 
acids, by means of dipeptides sources, to activate other import mechanisms as the ASC system, 
between other. Being the ACS system, for example, a sodium dependent antiporter, that use 
the energy stored in the sodium gradient, and this energy is “indirectly wasted” by the cells 
which could have a negative effect in cell grown and titter production. 
Considering the whole perspective, by means of high resolution mass spectrometry, it was 
possible to observe extracellular and intracellular dipeptide dynamics. Extracellular 
measurements showed the possibility to have different dipeptides import mechanisms, as two 
marked uptake rates were observed for dipeptides sets. Intracellular measurements confirmed 
the dipeptide uptake, and show that the constitutive amino acids intracellular pools were in all 
settings higher compared to the control and stay constant over the time, showing that dipeptides 
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are intracellularly degraded. Glutamine was the only amino acid coming from the dipeptide 
supplementation that was fast consumed, because of its importance as alternative energy source 
and nitrogen donor.  
Considering this scenario, dipeptide measurements showed that, in CHO cell cultures, 
dipeptides are taken up, degraded inside the cells and their constitutive amino acids are 
metabolized or secreted afterwards, presenting specific kinetics depending of dipeptide 
constitutive amino acids (Figure 20). 
 
 
 
Figure 20. Dipeptides transport. Dipeptides are transported by different mechanisms with 
different uptake rates (qs1 and qs2) into the intracellular matrix where they are digested and their 
constitutive amino acids are either used () for cell metabolisms or expelled from the cell () 
(Figure from Sánchez-Kopper, et al.; appendix E). 
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Supplemented dipeptide boosting properties 
 
The differences in dipeptide uptake kinetics and how their constitutive amino acids are used by 
the cell may have an impact on cell grow and mAb production, giving dissimilar improving 
properties for each dipeptide. For each dipeptide supplemented culture the maximal specific 
growth rate, maximal mAb production rate and maximal final mAb concentration were 
evaluated to observe their performance boosting properties. 
Dipeptides with faster uptake rates trends to have higher growth rates in comparison to the 
slowly uptaked, been GQ the dipeptide with the lowest growth rate, 7% less respect to the 
control. From all the dipeptides just AQ presented a 2% increment in the maximal specific 
growth with a significance level of 94% (Figure 21). This data means that in comparison to not 
using dipeptides in culture, cell growth rate was not significantly affected by the supplemented 
dipeptides. 
 
Figure 21. Specific growth rates for CHO cultures supplemented with dipeptides. Black bars 
correspond to dipeptide group A showing fast and bi-phasic consumption. Grey bars 
correspond to dipeptides group B revealing slow, steady dipeptide uptake. Ctrl correspond to 
control. Error bars describe the standard deviation of three biological replicates (Figure from 
Sánchez-Kopper, et al.; appendix E). 
 
Even so, there were some dipeptides that prolonged cell viability in the cultures. For example, 
even when with GQ cells had the slowest growth rate, cells lived longer as the control, and this 
was also the fact for AC and GY dipeptides (Figure 22). 
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Figure 22.  Cells viability of dipeptide supplemented CHO cultures. Each culture is compared 
to Control culture (not supplemented medium). Error bars represents the standard deviation of 
biological triplicates. 
 
In murine hybridoma cells it was observed that when using 6 mM GQ or AQ in medium the 
ammonia and lactate production rates were reduce, with a more significant effect for GQ. This 
would explain, if the same happens in CHO cells, the extended culture life by using GQ 
supplementation as reducing ammonium and lactate decrease their toxic effects of inhibition 
of glutamine catabolic pathways and glycolysis (Christie and Butler, 1994; Lao and Toth, 
1997). It is clear that dipeptides affects CHO cells growth and a detailed study about how 
dipeptides affects the central carbon metabolisms is needed, a closes look into changes in 
metabolic fluxes will reveal the real effects of each dipeptide and would allow to improve how 
the dipeptides could be used to optimize cell grow, always thinking in also improve product 
formation. 
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When comparing product formation in the dipeptide supplemented CHO cultures, mAb 
production rates trends to be lower when using dipeptides in medium. All the supplemented 
cultures but the AQ and GY presented lower mAb production rates as the control, where AQ 
outperformed with about 34% higher production rates and GY presented the same value as the 
control (Figure 23A). 
Important to note is GQ, which even when performed with a 50% lower mAb production rate 
was the only dipeptide that boosted final product concentration, producing 12% more as the 
control (Figure 23B). This would agree with the common observation that when CHO cells 
growth slower their productivity for monoclonal antibodies would be higher. This also seems 
to be true for other dipeptides as PC, GY and AY, where even when their maximal production 
rates are lower than control they reach, at the end, the same control titer concentration. In the 
other hand AY and AP cultures presented faster growth and slower mAb production rates 
having, as consequence, at the end, the lowest final product concentration. 
 
Figure 23. Maximal mAb production rates (A) and maximal mAb concentration obtained (B) 
for CHO dipeptide supplemented cultures. Obscured bars correspond to dipeptide group A 
showing fast and bi-phasic consumption. Grey bars correspond to dipeptides group B revealing 
slow, steady dipeptide uptake. Ctrl correspond to control. Error bars describe the standard 
deviation of three biological replicates (Figure from Sánchez-Kopper, et al.; appendix E). 
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Two best dipeptides with boosting properties outlook from the set of tested dipeptides: AQ and 
GQ. Both dipeptides presents glutamine in their structures whish once incorporated into the 
cells are a source of energy and nitrogen that is, as discussed above, immediately metabolized. 
The differences between the dipeptides lays in using alanine or glycine as counterpart amino 
acid. This difference produce the dipeptides to be uptaked with different kinetics, AQ is fast 
uptaked but GQ presented a slow and constant uptake rate, given different boosting properties 
for each dipeptide. AQ increase cell mAb production rate by means of a faster cell growth and 
GQ even when its supplemented culture presented the slowest growth rate and slowest mAb 
production rate, was the culture with higher titer final concentration. 
Since decades AQ and GQ are applied as enhancers for mammalian cell cultures (Minamoto et 
al., 1991) (Christie and Butler, 1994). Both dipeptides revealed to boost cellular performance, 
nevertheless on very individual ways. 
The reason why GQ perform better in terms of final product concentration could be observed 
closely in figure 24. 
 
 
 
Figure 24. Boosting properties comparison for AQ and GQ. A. Dipeptide concentration in 
medium. B. Fitted curves of specific mAb production rates and cell growth for AQ and GQ 
supplemented cultures. Fitted data and dipeptide concentrations from measurements of three 
biological replicates (Figure modified from Sánchez-Kopper, et al.; appendix E). 
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As specific mAb production rates and cell growth for AQ and GQ supplemented cultures were 
fitted from the data obtained from biological triplicates it can be seen that AQ culture presented 
a productivity peak in the first two days of culture, which falls down in the middle of the 
exponential phase, once the dipeptide was depleted. In the other hand for GQ culture, its slow 
uptake, produce a constant production rate, during the same period of time as AQ productivity 
peak, moreover, the dipeptide availability at the end of the culture, extend cells viability, which 
maintain production longer, giving as a result the higher final product concentration. 
Apparently, while GQ basically supports growth-decoupled product formation AQ enables 
maximum cell-specific peak productivities. 
The knowhow of the individual dipeptide uptake and its effect over product formation dynamic 
opens new perspectives for an interactive bioprocess optimization. Optimizing dipeptide initial 
concentration, for example increasing AQ at the beginning of the culture, may prolong its 
productivity peak effect; combining other amino acids as asparagine, which is the only amino 
acid, besides glutamine, that is uptaked and directly metabolized as an aspartate source fueling 
the TCA cycle by its transformation to oxaloacetate (Dean and Reddy, 2013); or testing also 
tripeptides effects, as for example XQN (asparagine (N) and glutamine (Q) based tripeptides), 
where the third amino acid (X) could be selectively optimized for either fast or gradual uptake. 
Monitoring of dipeptide kinetics should be at the center of medium and process optimization 
and knowing each dipeptide could have their own conditions to implement their boosting 
properties, there is a need to consider also clone characteristics, process conditions, produced 
mAb, medium nutrients concentration, feed strategy and bioreactor configuration. 
Furthermore, this study shows that we are still at the beginning of understanding the impact of 
oligopeptide consumption on cellular physiology and unravelling underlying regulatory 
mechanisms. Current results do show that dipeptides are taken up, degraded inside the cells 
and metabolized or secreted afterwards. However we do not know yet which regulatory 
regimes may be induced after dipeptide consumption that may further affect cellular activities.  
Further studies should be done to contribute to knowledge-based process optimization in the 
future. 
Mass spectrometry showed a key role in defining dipeptide uptake. Combining the presented 
dipeptide tracking methodology with the developed ZIC-HILIC-MS method, as a universal 
tool for polar intracellular metabolites quantification, it would allow following dipeptide 
supplementation effects in primary metabolism giving a complete view about cellular behavior 
and complementing the understanding of CHO cells from a systems biology perspective. 
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 Monoclonal antibody intracellular degradation in CHO cells. 
 
By means of mass spectrometry, two levels of the cell metabolism were considered to be 
studied in this dissertation at this point: 1.The establishment of an analytical methodology for 
the analysis of intracellular metabolite pools, covering almost 90 metabolites of the central 
carbon metabolism, which would allow the examination of metabolism dynamics and observe 
how cells react to determined stimulus. 2. The dipeptides uptake kinetics, as a start for medium 
optimization for the mAb production in CHO cells. Each section opens the possibility to 
explore multiple phenomenon of the cell machinery from central carbon metabolism to 
boosting substrates uptake (dipeptides). This section takes a further step, from small molecules 
as metabolites and dipeptides to the produced monoclonal antibody. By means of mass 
spectrometry the proteomics level is reached, where the mAb intracellular degradation was 
monitored, in view of how many of the product is lost by cell proteolysis could be selectively 
optimized for either fast or gradual uptake 
Therapeutic proteins directed to be used against diabetes, cancer, hemophilia, and hepatitis, 
amongst others, presented in 2010 sales of US$108 bln. From this, with a year on year market 
increase of approximately 48%, corresponding to monoclonal antibodies (mAbs) which are 
manly produced using Chinese Hamster Ovary (CHO) cells as expression system (Proteins, 
2012)(Walsh, 2014). Since intracellular protein degradation (proteolysis) is known to happen 
by means of the lysosome system or the ubiquitin-proteasome mechanisms, and it has been 
stablish by Schubert et al. that more than 30% off newly synthesized proteins are estimated to 
be retrograde transported into the cytosol for degradation, the evaluation of specific mAb 
intracellular degradation come into scope as a matter of interest. 
In mammalian cells (myeloma), Yee et al. found that half-lives of endogenous proteins varied 
from 1 to 140 days (or more) while it was only about 2 h for recombinant proteins (Yee et al., 
2010). Comparable studies also including degradation rates have not been published so far and 
are not yet accessible for mAbs in CHO. 
With systematic and exhaustive work, application of sample preparation protocols, high 
resolution mass spectrometry instrumentation, and proteomics software, it was possible to 
identify intracellular peptides produced by proteolysis of a model mAb, follow their dynamic 
fate with the incorporation of 13C-Lysine in their structure, resembling SILAC experiments, as 
a 13C-Lysine pulse was accomplished at the exponential phase in batch CHO cultures, allowing 
for the first time the calculation with quantitative results, the percent of mAb degraded 
intracellularly in its production by CHO cells. The experimental design used for the 
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intracellular degradation determination followed the schema of figure 25, as each step 
presented their challenges, a section for each step will be consider to present their results and 
discussion. The design starts with obtaining enough dipeptides coming from the mAb 
intracellular degradation, where not just the need of extracting enough peptides to reach 
detection limits was the principal issue but eliminate interferences that avoid their proper 
identification.  The peptide purification methodology succeeded, as it was possible to identify 
peptides matching the Anti-IL8 monoclonal antibody sequence, with the help of proteomics 
software. Then samples were withdrawn and analyzed from cultures experimenting protein 
labeling with a 13C-Lysine pulse allowing to track the label incorporation into the identified 
peptides and the later modeling for mAb degradation rates calculation. 
 
 
Figure 25. Experimental design for the determination of the mAb intracellular degradation. 
This figure describes the steps needed for the calculation of the mAb degradation: A. 
Optimization of the cell lysis and intracellular peptides extraction and purification protocols. 
B. Identification of extracted peptides coming from the mAb. C. 13C-Labeling pulse for the 
measurement of degradation kinetics. D. Modeling for determination of degradation percent. 
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Extraction and purification of intracellular peptides: Lysis buffer 
 
The extraction of intracellular peptides and their separation from cell debris started the 
challenge of the estimation of intracellular mAb degradation.  According to our focus lysis 
buffer should maximize the number of the intracellular extracted peptides, be mass 
spectrometry compatible and not interfere with peptide chromatography. 
Looking for a mass spectrometry compatible lysis buffers, different detergents were tested to 
find one detergent that, even when present in low concentrations, efficiently lyses CHO cells, 
while not interfering with peptide mapping chromatographic and allowing the identification of 
intracellular peptides generated from mAb degradation. 
Detergents critical micelle concentration (CMC) was used as the main parameter to calculate 
the minimum concentration needed to affect cellular membranes. Considering this, twice the 
CMC was used to secure micelle formation. Lysis buffers solutions were prepared with 
ammonium acetate, because of its volatility, as LC-MS friendly component which do not 
present precipitation at the electro spray ion source. Lysis efficiency of each detergent was 
evaluated by observing cells at the microscope (Figure 26) and comparing cell integrity with 
cells suspended in PBS (Phosphate-buffered saline) and in a commercial lysis buffer for protein 
extraction from mammalian cells (M-PER™ Thermo Fisher Scientific). Cells treated with 
sodium deoxycholate (SDC) were destroyed as no cellular wall was left, lysis with 
Hexadecyltrimethylammonium chloride (HTA) and M-PER™ buffers the result was similar as 
empty cells were observed in comparison to healthy cells suspended in PBS. These experiments 
were performed and presented as part of Andreas Wahnl master thesis (Wahl, 2014). 
From the tested detergents, two presented the best qualities to be used in intracellular peptides 
extraction: sodium deoxycholate (SDC) and Hexadecyltrimethylammonium chloride (HTA). 
These detergents fulfill the condition to be non-polymeric detergents, since polymeric 
detergents as Triton X-100 or Brij- 35 cause ion suppression over all the chromatogram as they 
present diverse molecular sizes that elute at different retention times. 
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Figure 26. CHO cells suspended in detergents of PBS solutions. Cells were suspended in 500 
µL of each solution and incubated for 30 min at 0 °C. HTA: Hexadecyltrimethylammonium 
chloride, SDC: sodium deoxycholate, PBS: Phosphate-buffered saline, M-PER: Mammalian 
cells proteins extraction reagent (Figure from Wahl, 2014).  
 
Recently, SDC was evaluated as one of the preferred detergents for protein extraction because 
of its straightforward removal faculties as it can be easily removed by acid precipitation. Even 
so, when acid precipitation was applied, the number of extracted peptides was reduced when 
comparing detergent removal by means of two-phase solvent extraction, presumably because of 
peptide and proteins co-precipitation as they could be occluded in the SDC precipitate 
(Scheerlinck et al., 2015). 
For our case, HTA presented the best conditions for intracellular peptide extraction. HTA is a 
non-polymeric cationic detergent with a low CMC (0,92 mM), did not show any coeluting 
signal in peptide mapping (the detergent elute at the column washing step) and allow the 
detection of a higher number of compounds as indicated on Figure 27 (compounds are 
molecular signals that present characteristics of peptides determined with the “Find 
Compounds by Molecular Feature” algorithms  of the Mass Hunter Software”). 
HTA has been used as an active ingredient of lysing reagents for blood cell analyzers which 
perform white blood cells differential determination by impedance analysis; so far it has not 
been applied to the preparation of intracellular extracts (Lapicola and Edmondson, 
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1988)(Giovannelli and Abballe, 2005). Further efforts on evaluating parameters as buffer pH, 
detergent and salt concentration could lead to an optimized protocol using HTA improving 
peptide extraction from mammalian cells, as an alternative to the more complex and expensive 
MS-compatible lysis buffers in the market,  notwithstanding this optimization was outside the 
scope of the present research, for this reason no further optimization was performed and the 
lysis buffer was used as presented for the rest of the intracellular peptides analysis. 
 
 
Figure 27. Peptide mapping chromatograms for intracellular extracts with HTA and SDC lysis 
buffers. Extracted cells from shaking flasks cultivations.  
 
Extracts concentration and sample clean up 
 
Once the lysis buffer was stablished, how to increase concentrate samples to improve peptides 
detection and sample purification were also matter of concern when looking for specific 
peptides belonging to the produced mAb. Performing measurements of cellular extracts didn’t 
accomplish any peptide identification that matched with the target mAb, therefore there was a 
need for sample concentration and further purification. 
Solid phase extraction was applied to intracellular extracts using different stationary phases, 
where peptides retention and purification was accomplished using non polar (C18), and 
different ion exchange cartridges. Strong and weak anion and cation exchange solid phase 
extraction were used as an alternative to the C18 phase due to the presence of polyethylene 
glycol (PEG) in bioreactor samples. PEG was present in the bioreactor samples and as it 
presents similar retention as peptides is simultaneously concentrated and it appears over all the 
chromatogram. In the measurements, PEG caused ion suppression and concealed peptide 
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signals giving as consequence the non-identification of intracellular peptides. On the figure 28 
the chromatograms of cell extracts treated with different solid phase extraction phases are 
presented. 
 
 
Figure 28. Peptide mapping total ion chromatograms of intracellular extracts purified with 
different solid phase extraction phases. C18, MAX (Strong anion exchange), MCX, (Strong 
cation exchange), WAX (weak anion exchange) and WCX (weak cation exchange). PEG 
appears as peaks homogenously distributed over the chromatogram. 
 
As expected solid phase extraction using C18 phase concentrated also the polymer, showing 
the higher PEG peaks. Strong cation exchange (MCX) cannot eliminate the contamination but 
complete clean-up was achieved with weak cation exchange (WCX). Using the purification 
protocols weak anion exchange (WAX) wasn’t able to retain peptides and the identification of 
mAb proteolysis products was possible just for MAX (strong anion exchange) and WCX (weak 
cation exchange), with the first it was possible to identify more peptides coming from mAb 
intracellular degradation. All the posterior sample purification was performed using MAX as 
four peptides were identified using this protocol. Peptide purification and extraction protocol 
was optimized using different conditions of cartridge equilibration, washing steps and elution, 
the conditions tested for protocol optimization are described in the Appendix A.  Due to the 
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high specificity of ion exchange solid phase extraction further optimization could be performed 
in order to detect a higher number of peptides belonging to target monoclonal antibodies. 
Peptide structure and their physicochemical properties vary accordingly to their sequence, each 
peptide could have their own specific solid phase extraction protocol which makes it difficult 
task to find a general method for their purification, as pointed for the quantification of 
therapeutic and endogenous peptides (Chambers, 2013). 
 
Identification of mAb degradation peptides  
 
High resolution mass spectrometry is the actual main tool for protein and peptides 
identification. Trypsin digestion and posterior peptide mapping using LC-MS systems is used 
for the most protein quantification and proteomics studies (Hughes and Krijgsveld, 2012). 
Peptides can be identified as their fragmentation because collision induced dissociation follows 
a known and predictable pattern. Principal peptides fragments formed from electrospray 
ionized molecules correspond to a, b and y ions, named after the Roepstorff and Fohlman 
nomenclature (Figure 29) (Papayannopoulos, 1995). 
 
Figure 29. Peptides fragmentation pattern labeled with Roepstorff and Fohlman nomenclature. 
 
Using auto MS/MS measuring configuration, the high resolution mass spectrometric 
chromatograms for cell extracts purified with MAX-SPE were evaluated for matching peptides 
sequences belonging to the produced antibody (Anti-IL8 monoclonal antibody). 
In the auto MS/MS configuration the instrument first looked into the total ion mass spectra for 
possible compounds that look like peptides. Peptides are composed by C, H, O, N as their most 
common elements, and some also present S (as when methionine or cysteine amino acids are 
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present). This composition gives peptides a particular signal, just observed when high 
resolution mass spectrometry (HR-MS) is used. HR-MS allow to observe for each substance 
their characteristic isotopic distribution, which can be defined as the relativized intensity of all 
the masses that one molecule could present due to its constitutive elements natural isotopic 
abundances. 
For a small organic molecule containing just C and H, carbon presents in nature two stable 
isotopes with their respective natural abundances: 12C (98.93 %) and 13C (1.07 %), and 
hydrogen presents: 1H (99.9885 %) and 2H (0.0115 %), so just three masses are possible for a 
molecule like C6 H12: 84.0939 (12C6 1H12), 85.0973 (12C513C1 1H12 or 12C61H12H11),  and 86.1008 
(12C513C1 1H12H11); giving its characteristic isotopic distribution,  which can be predicted 
(Figure 30A). For a peptide, a more complex signal will be obtained as it considers 16O (99.757 
%), 17O (0.038 %), 18O (0.205%) for oxygen, 14N (99.632%), 15N (0.368%) for nitrogen and 
32S (94.93 %) 33S (0.76 %) 34S (4.29 %) 36S (0.02 %) for sulfur. For example, the peptide 
angiotensin II (C50H71N13O12) presents the calculated isotopic distribution of figure 30B. 
 
 
 
Figure 30. Isotopic distributions for example molecules. A. Small molecule. B. Angiotensin 
II peptide.  
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Once in the chromatographic run the instrument detects a signal of a substance with the isotopic 
distribution of a peptide it selects the molecular ion to performs the acquisition of a 
fragmentation spectra (MS/MS) recording as much spectra as the instrument acquisition rate 
allow. 
The acquired data was then submitted to a data analysis workflow (Figure 31), to look for 
peptides signals that presents a fragmentation spectra that confirms their amino acids sequence 
to be part of the produced antibody. 
 
 
Figure 31. Proteomics data analysis workflow used for mAb intracellular peptides 
identification. 1) Data is scanned by the “Find by molecular feature” algorithms. 2) The 
compounds assigned as peptide and with available fragmentation spectra are exported to 
PEAKS proteomic softhwar for de novo sequencing. 3) The peptide sequences are matched 
with protein databases. 
 
The data was first evaluated by the “Find by molecular feature” that looks for compound signals 
that presents a “peptide like” isotopic distribution and extract a MS/MS spectra for each 
compound, when available. Here the instrument limitation about its MS/MS acquisition rate 
plays a key role, because there is a maximum of fragmentation spectra that the instrument can 
measure for each second, which means that not for all the peptides coming at the same retention 
time, a MS/MS spectra will be measured. Indeed, just about 30% of the compounds tagged as 
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peptides presented a MS/MS spectra. This re-iterates the complexity of searching for specific 
peptides in an intracellular matrix. 
The data just including compounds with fragmentation information was then exported to the 
proteomics software PEAKS. The software is able perform de novo sequencing, which consist 
in taking the fragmentation spectra from each peptide and assigning an amino acids sequence 
matching the parent ion mass and its consecutive mass losses, agreeing with the fragmentation 
possibilities (Figure 29, Figure 31-2). 
The de novo generated peptides sequences software were aligned with the Anti-IL8 
sequence and the recently published CHO cells proteome database (Hsei et al., 2005)(Baycin-
Hizal et al., 2012). 
In order to grant peptide identification and avoid false positives, strong criteria were set, so 
only sequences assigned with mass accuracy better than 10 ppm, at least five fragments (a, b, 
or y ions), assigned by PEAKS software, in MS/MS spectra and correlation with predicted 
charge states were considered, as proposed previously for peptidomics studies (Gelman et al., 
2012).  
This way, it was possible to fully identify about 200 peptides (mass accuracy better than 5 ppm, 
and more than five assigned fragments in their MS/MS spectra) belonging to 40 CHO 
endogenous proteins. Nonetheless four peptides were identified as fragments from the heavy 
chain of the Anti-IL8: HYTQKSLSLSPGK (F1), HYTQKSLSLSPG (F2), PAVLQ (F3) and 
EVQLVQSGGGLVQPGG (F4). Their position in the antibody structure and sequence are 
shown in figure 32. 
 
Figure 32. Identified peptides from the Anti-interleukin-8 overlaid in the model of a mAb and 
the Anti-interleukin-8 sequence. Model from (Padlan, 1994) and Anti-interleukin-8 sequence 
from (Hsei et al., 2005). 
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From the identified peptides just F1 and F2 presented L-lysine in their sequences as needed for 
the evaluation of degradation rates using a 13C-Lysine pulse chase experiment. The complete 
assignation of MS/MS spectra for F1 and F2 is reviewed in the Appendix B. Peptide 
identification was finally complete when synthetic standards were purchased and their retention 
times matched with the obtained from intracellular extracts. 
In order to have a complete understanding of how the Anti-interleukin-8 is degraded in the cell, 
identification of more mAb peptides would be needed. This proved to be a challenge even when 
using high resolution mass spectrometry, peptides presented low concentrations and the matrix 
complexity, were peptides coming from proteolysis of endogenous proteins, which have 
predominant concentrations, occlude MS/MS spectra acquisition, so few peptides with low 
abundances could be identified.  
In figure 33B it can be observed how at F1 retention time other more intense signals are also 
present, and in figure 33C how at higher retention times peptides are not fully separated because 
of sample complexity. Further efforts have to be performed as improving chromatographic 
separation with advanced technologies as Two-Dimensional Liquid Chromatography in order 
to improve intracellular peptide identification (Görg et al., 2004). 
 
 
Figure 33. Intracellular peptides chromatograms. A. Total ion chromatogram for compounds 
in purified intracellular extracts. B. Mass spectra of coming compounds in F1 retention time. 
C. Extracted ion chromatogram of identified peptides corresponding to proteolysis of 
endogenous CHO proteins and Anti-interleukin-8 monoclonal antibody. 
 
 
 __________________________________________________________________________________ 
67 
 
CHO batch cultures and 13C-Lysine pulse 
 
For the evaluation of proteins stability, intracellular degradation rates are generally estimated 
using SILAC (stable isotopically labeled amino acids) where cells cultivated in medium with 
13C labeled amino acids are drastically changed to unlabeled medium, then extracted 
intracellular purified proteins are digested, and their peptides abundances measured using mass 
spectrometry, where the change with the time of the labeled/un-labeled ratio of selected 
peptides is used to calculate protein degradation rates (Kratchmarova, 2008). 
Moreover the performed experiment was thought to evaluate mAb degradation under 
production-similar conditions, without abrupt changes that affect cellular growth and add 
additional variability, as medium exchange used in SILICA. In the present approach batch 
reactors were inoculated with CHO DP12#1934 (Anti-IL8 monoclonal antibody producer), and 
after 63 hours of culture a 13C-Lysine pulse was accomplished at the exponential phase. As 
shown in figure 34, no abrupt observable effects were present on growth and cell viability once 
the pulse was started. After pulse, samples were acquired to extract intracellular matrix and 
evaluate the presence of peptides originated from the mAb degradation. Bioreactor cultures 
and 13C-Lysine were performed by Jérémy Rimbon as part of his doctoral work and further 
details are presented in his dissertation (Rimbon, 2016). 
 
 
Figure 34. Bioreactor batch cultures of CHO cells. (A) Antibody production. (B) Growth curve 
and cell viability, 13C-Lysine pulse start marked as vertical line. Experiment was made with 
four biological replicates (Figure from Rimbon et al., 2015, appendix D). 
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Intracellular peptides pools quantification and 13C labeling trace 
 
Samples from the 13C-Lysine pulse cultures were extracted and purified as commented above. 
The extracted F1 and F2 peptides were quantified using full labeled lysine synthetic 
counterparts (L-Lysine-13C6,15N2) as internal standards. Calibration curves presented lineal 
tendencies in the concentration range from 2 to 50 nM with coefficient of determination (r2) 
better than 0,998 which guaranty that the concentration is estimated with a 99% of confidence 
and matrix effects were compensated as internal standard was used. Main problem was the low 
peptides concentration found in the samples, where even when samples of around 300-500 
million cells were extracted (sampling volumes between 75 and 250 mL), and concentrated to 
a final volume of 150 µL an injection volume of 100 µL was needed to guarantee detection, 
making it impossible to measure replicates; biological replicates being the basis for statistical 
validation of the experiment. 
The signal for the dipeptides was sufficient in all samples to be able to distinguish between the 
different isotopomers formed during the 13C-Lysine pulse experiment. As the 13C-Lysine was 
incorporated to the antibody, the antibody degraded and the newly generated peptides (F1 and 
F2) possessed also the labeled amino acid. Thanks to the high resolution mass spectrometric 
measurement it was possible to differentiate masses for the formed isotopomers, for F1:  
HYTQKSLSLSPGK (unlabeled, F1K0), HYTQK*SLSLSPGK+HYTQKSLSLSPGK* (one 
labeled lysine, F1K1), HYTQK*SLSLSPGK* (two labeled lysine, F1K2); and for F2: 
HYTQKSLSLSPG (unlabeled, F2K0) and HYTQK*SLSLSPG (ones labeled, F2K1). The 
quantification and ion-extract chromatograms were performed with the [M+3H] for F1 and 
[M+2H] for F2 ions meaning that the difference between the m/z of the isotopomers was about 
2 and 3 m/z units respectively, this was possible because of the high resolution instrumentation 
and that no other signals for coeluting substances were found with similar masses in the 
samples. Extracted ion chromatograms were achieved for each isotopomer and their peak areas 
were used to evaluate the labeling ratio of each over time allowing to calculate peptide 
formation rates that could be translated to antibody degradation rates as explained in the next 
section (Figure 35).  
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Figure 35. A. Extracted ion chromatograms for monoisotopic species of mAb identified 
peptides in sample 22 h after pulse (K  = 13C-Lys). B. Tracking isotopomers ratio for F1 after 
pulse (Figure from Rimbon et al., 2015, appendix D).  
 
 
Monoclonal antibody intracellular degradation 
 
With the information obtained from the intracellular peptide quantification, the isotopic 
labeling tracked during cell culture and considering the extracellular mAb concentration to 
calculate secretion rates, the intracellular degradation percent of the produced mononclonal 
antibody in CHO cells was estimated. Modeling and parameters fitting was performed by 
Jérémy Rimbon as part of his doctoral work and further details are be presented in his 
dissertation, a brief summary will be presented below (Rimbon, 2016). 
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Figure 36. Description of labeling distribution in F1 and F2. Gray circles encode each amino 
acid, except lysine. Labeled and unlabeled lysines are encoded by black and white circles, 
respectively. Single-labeled F1 is assumed to distribute itself equally (0.5/0.5) into F2  (Figure 
from Rimbon et al., 2015, appendix D). 
 
As the identified fragments were from the same antibody region (C-terminal heavy chain) and 
the transformation between them is one amino acid loss, they were considered as originated 
from subsequent degradation steps. The monoclonal antibody is degraded (v1deg) forming F1, 
which is degraded to F2 (v2deg) continuing until complete degradation to amino acids (v3deg).  
The isotopomers formed due to this degradation chain are described in figure 36 and their ratios 
could be described by equations 1 and 2. 
 
0111211 KFKFKF fff ++=  (1) 
 
02121 KFKF ff +=   (2) 
 
Assuming that the described network is in equilibrium (steady-state) the antibody synthesis 
(vsynth), degradation (v1deg) and secretion (vsec), as the degradation cascade should follow the 
subset of equations 3 and 4. 
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When analyzing the F2 dynamics (figure 36), it can be proposed that if the F2 pool size (x2), 
expressed in pmol/108cells, stays constant, its isotopomers distribution will change over the 
time following the model described for equation (5). 
 
 
 
Fragment 1 isotopologes rations (fF1K0, fF1K1, fF1K2) were estimated from fitting the experimental 
data using equation 6 and 7, where the constant term  is specific for each isotopologue 
and  is a time constant, specific to the whole peptide pool. 
 
fF1K 0(t) =1- fF1K 0
asym × 1- exp -
t
t
æ!
è!
ç!
ö!
ø!
÷!
æ!
è!
ç!
ö!
ø!
÷! (6) 
÷÷
ø
ö
çç
è
æ
÷
ø
ö
ç
è
æ--×=
t
t
ftf asymKiFKiF exp1)( 11  for i = 1 or 2 (7) 
 
Notwithstanding the straightforwardness of the model, equation 5 resulted in a linear 
correlation with respect to the parameter vdeg and the degradation rate was calculated, based on 
the chosen model, by linear regression. 
Noteworthy; the estimated degradation rates result reproducible in the four biological replicates 
(Table 3). The average degradation calculated under the presented culture conditions was 3%, 
not significant compering with the 60% degradation reported for Pichia pastoris producing the 
antibody fragment Fab3H6 (Pfeffer et al., 2011). 
 
Table 4. Calculated degradation rates for biological replicates. Units are given in 
pmol/108cells/h. Upper and lower bounds indicate 95% confidence interval. 
 
 n d e g(pmol/10
8cells/h) qs e c
(pmol/108cells/h) 
µ(h-1) 
Reactor 1 22±3 634±12 0.0296±0.0005 
Reactor 2 25±7 574±18 0.0230±0.0006 
Reactor 3 25±5 1071±68 0.0204±0.0004 
Reactor 4 24±8 858±37 0.028±0.001 
fasym
t
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It has been stated, for high producing cells, that an increase in productivity could represent a 
significant burden on the cellular load of energetics, protein synthesis and secretion, generating 
stress that could trigger intracellular protein degradation. Even considering that measured mAb 
production rates were found to be 13.7 to 25.7 pg/cell/day, thus being far below performance 
values of 50-100 pg/cell/day of top producers, we were able to prove that also under the ‘rather 
smooth’ production intracellular mAb degradation occurs. Impact of intracellular mAb 
degradation may be more pronounced under challenging top producing conditions when 
additional stress may effect cellular performance (Kantardjieff et al., 2010)(Templeton et al., 
2013)(Tabuchi and Sugiyama, 2013b). 
High resolution mass spectrometry together with a fair designed production-like oriented 
labeling experiment allowed to chase intracellular protein fragments coming from mAb 
degradation with which the minor but still existing intracellular mAb degradation rates were 
detected showing the applicability of the analytical approach as well as the suitability of the 
simple model-based estimation. 
This novel approach for monitoring intracellular antibody degradation, based on the evaluation 
of proteolytic products, could be further taken to evaluate high productivity settings were the 
mAb degradation should be more significant, due to cell machinery overload, where the 
evaluation of the effects in industrial biopharmaceuticals production could lead to new keys of 
bioprocess improvement. 
Considering the three approaches presented in the present dissertation: intracellular metabolic 
pools analysis, supplemented dipeptide uptake kinetics and monoclonal antibody intracellular 
degradation measurement; it could be summarized that each could contribute to understand 
deeply how cells work and from each one, new perspectives of how improve cells 
productivities, emerge. Combining all the presented methodologies in one experiment would 
allow to observe the cell from a complete perspective, from the mechanism of nutrient uptake, 
to how cell process them and how cell metabolism react, up to in what manner this defines 
product formation and influence on bioprocess productivities. 
Summarizing, mass spectrometry has shown to be crucial to obtain information leading to a 
deeper systems biology understanding that could be focused to improve bioprocess 
productivities. 
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Conclusions and future perspectives 
 
From the absolute quantification of bacteria metabolome for the optimization of productive 
metabolic routes, medium optimization by dipeptide uptake, to the characterization, under 
production like conditions, of antibody based biopharmaceuticals turn-over; mass spectrometry 
has been a key stone to understand cell machinery in specific questions regarding bioprocess 
optimization. 
Using tandem mass spectrometry and validating an alkaline ZIC-HILIC chromatographic 
method, the simultaneous quantification of a vast set of metabolites of interest was stablished. 
Metabolites comprising Glycolysis, TCA cycle and PPP were quantified with excellent 
chromatographic performance and lower detection limits in comparison to the acidic 
commonly used conditions. 
With new instrumentation generation and advances in chromatographic materials, each year 
new methodologies emerge to fulfill metabolomics needs, looking to lower detection limits and 
their straightforward implementation. In order to ensure objective comparison of the 
continuously emerging quantification methodologies there should be a standardization and 
systematization of validation protocols. It is clear that microorganism, culture conditions, 
sampling and metabolite extraction protocols have an impact to the final value obtained as 
absolute metabolite concentration. For this reason it has to be of importance to the 
metabolomics community the access to reliable resources that allow a fair comparison. 
Intracellular concentrations databases, reference materials or standardized protocols or even 
participate in interlaboratory tests, as is of common practice for analytical laboratories that 
want to validate their results for nonacademic purposes, may be part of metabolomics studies 
validation. Considering this, a new challenge for the presented alkaline ZIC-HILIC 
methodology arise: validation for more metabolites and generation of a “culture-sampling-
extraction protocol which establish a metabolite intracellular concentration database under 
specific grow conditions”. So far, databases exists as ECMDB for E. Coli or YMDB for yeast 
but the envisaged data for metabolites intracellular concentrations are defined by collecting 
data from diverse experiments, not focused on using the same analytic methodology, but 
referenced to approaches with other motivation than standardization. Resulting data bases 
display a wide range of concentrations for each metabolite which makes the data not suitable 
for validation proposes. Therefore, there is a need for a generated database, accessible to the 
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scientific community and that could be held as reference for incoming methodologies that look 
for the evaluation of metabolic routes in microbial cell factories. 
Not just metabolic routes, but how nutrients are incorporated into cell metabolism has been 
also of interest for bioprocesses optimization. Nutrients as amino acids, building blocks for 
production of biopharmaceuticals proteins and hormones precursors, participate in cell 
signaling and regulation having an impact in cell productivity. Using certain dipeptides as 
supplements, instead of monomeric amino acids, in defined medium, is already known to boost 
cell growth and mAb productivity in mammalian cells. Even so, no information about the 
mechanisms of dipeptide metabolization was available, it was not confirmed if dipeptides were 
extracellular degraded or directly incorporated into cell cytosol for posterior metabolization. 
Using mass spectrometry as main tool, it was possible to track a variety of dipeptides, with 
different boosting effects, at intracellular level.  It was shown that dipeptides uptake occurs, 
then degrades and their constitutive amino acids used for cell metabolisms or secreted to 
extracellular medium. It was also possible to observe two different uptake kinetics, meaning 
that different mechanisms could be involved in dipeptide uptake and that these mechanisms 
differ depending on dipeptide constitutive amino acids. For future perspectives the knowhow 
of the individual dipeptide uptake and product formation kinetics opens the door for an 
interactive process optimization. Consequently, monitoring dipeptide kinetics should be at the 
center of future medium and process development research in order to optimize specific 
processes. Consideration of cell-specific individual and time-varying nutrient demands has to 
be applied in different feed strategies taking advantage of single dipeptide boosting properties.  
We are still at the beginning of understanding the impact of oligopeptide consumption on 
cellular physiology and unravelling underlying regulatory mechanisms. Mass spectrometry 
allowed us to increase our knowledge of dipeptides dynamics and the understanding of CHO 
systems giving new perspectives for bioprocess optimization. 
By means of high resolution mass spectrometry it was also possible to determine intracellular 
behavior in a higher level of complexity. The specific intracellular degradation of a monoclonal 
antibody was observed and for first time partially quantified. Protein based biopharmaceuticals 
are indeed susceptible to intracellular degradation causing production losses. Here, the use of 
a stable isotope labeling by amino acids (SILAC) applied in a pulse chase experiment in batch 
bioreactor cultures allowed to track mAb intracellular degradation under production like 
conditions. Mass spectrometry methodology together with sample preparation improved the 
intracellular peptides identification and quantification, which gave information necessary to 
build up a model to calculate the specific mAb degradation. Further efforts have to be made to 
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unravel additional mechanistic information, as just one mAb fragment was evaluated, the 
presented model can just be considered a hint that degradation occurs, therefore there is a need 
to identify more intracellular peptides originated from titer degradation. Implementation of 
more extensive chromatographic separation as two dimensional chromatography and further 
optimization in sample purification protocols would increase the number of identified 
intracellular peptides that will give more information about intracellular mAb degradation, 
leading to the optimization of recombinant protein therapeutics bioprocessing. The stated 
methodology could be used for the determination of protein therapeutics proteolytic 
degradation in high yield bioprocesses, even aiming also to evaluate the extracellular 
degradation.  
In this dissertation the use of mass spectrometry as the main tool to gather information for 
systems biology is presented, giving as results a new metabolome analytic methodology, novel 
information about the mAb intracellular degradation and dipeptide uptake in mammalian cells. 
The present dissertation considers questions regarding different levels of cellular metabolism. 
Combining the different approaches, a complete overview about the cell function could be 
obtained. Tracking intracellular metabolite pools, nutrients uptake and their metabolization, 
how they are incorporated into the product (amino acids incorporated into the mAb), and how 
endogenous degradation mechanism affects production, could lead to an understanding and 
predict cell machinery, allowing further improvements in bioprocesses performance. 
Mass spectrometry has proved to play a key role in going further about bioprocesses 
optimization unknowns, mass spectrometry-based techniques and methodologies in genomics, 
proteomics, transcriptomics and metabolomics have been and will be a pillar for our future 
advances in systems biology. 
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Appendices  
Appendix A. Solid phase extraction protocol optimization. 
As with the MAX-SPE sample preparation it was possible to fully identify peptides from IgG, 
and almost all the PEG was eliminated, it was considered for the extraction of the samples from 
the labeled lysine pulse experiments. 
The extraction protocol was optimized in order to have the highest recovery percent for fully 
labeled peptide standards spiked in samples (Figure A1). The best method presented a 30% 
recovery for HYTQKSLSLSPGK, and 60% for HYTQKSLSLSPG. 
Because of matrix effects an accurate recovery has to be estimated using unlabeled peptides as 
standards, in order to have a statistic validation of the recovery. 
 
Figure A1. Tested protocols for the ion exchange extraction optimization using MAX-SPE. 
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Appendix B. Fragmentation signals assignation for identified peptides belonging 
to intracellular degradation of Anti-IL8. 
 
Table B1. Signal assignation for fragmentation spectra of peptide HYTQKSLSLSPGK. 
 
RT 
(min) 
Sequence Mass Score Height Diff (mDa) Diff (ppm) 
13.9 HYTQKSLSLSPGK 1444.771 59.68 5040 3.74 2.59 
Precursor ion: 723.3915 m/z; z= 2, CE = 39 V  
Diff (ppm) m/z m/z (prod.) Ion Sequence Z (prod.) 
-0.1 301.1295 301.1295 b2 HY 1 
6.8 70.0656 70.0651 P  1 
0.9 86.0965 86.0964 L  1 
4.1 110.0717 110.0713 H  1 
-40.9 564.3015 564.3246 y11-H2O TQKSLSLSPGK 2 
9.7 129.1035 129.1022 y1-H2O K 1 
10.1 564.3015 564.2958 b10-H2O HYTQKSLSLS 2 
-48.9 1145.597 1145.653 y11 TQKSLSLSPGK 1 
-1.7 388.2184 388.2191 y4 SPGK 1 
-1.5 301.1866 301.187 y3 PGK 1 
4.5 204.1352 204.1343 y2 GK 1 
1.3 1145.597 1145.595 b10 HYTQKSLSLS 1 
-1.5 301.1866 301.187 y3 PGK 1 
 
 
 
Table B2. Signal assignation for fragmentation spectra of peptide HYTQKSLSLSPG. 
 
RT 
(min) 
Sequence Mass Diff ( mDa) Diff (ppm) 
18.8 HYTQKSLSLSPG 1316.674 1.35 1.03 
Precursor ion: 659.3442 m/z; z= 2, CE = 39 V  
Diff (ppm) m/z m/z (prod.) Ion Sequence Z (prod.) 
0.8 138.0663 138.0662 b1 H 1 
5.8 301.1313 301.1295 b2 HY 1 
3.7 530.2378 530.2358 b4 HYTQ 1 
-1.7 173.0918 173.0921 y2 PG 1 
0.7 260.1243 260.1241 y3 SPG 1 
2.4 110.0715 110.0713 H  1 
13.5 136.0775 136.0757 Y  1 
19.5 60.0456 60.0444 S  1 
3.2 86.0967 86.0964 L  1 
2.2 70.0653 70.0651 P  1 
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Appendix C. Alkaline conditions in hydrophilic interaction liquid 
chromatography for intracellular metabolite quantification using 
tandem mass spectrometry. 
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Abstract 
Modelling of metabolic networks as part of systems metabolic engineering requires reliable 
quantitative experimental data of intracellular concentrations. HILIC-ESI-MS/MS method was 
used for quantitative profiling of more than 50 hydrophilic key metabolites of cellular 
metabolism. Without prior derivatization sugar phosphates, organic acids, nucleotides and 
amino acids were measured under alkaline and acidic mobile phase conditions with pre-
optimized MRM transitions. Irrespective of the polarity mode of the acquisition method used, 
alkaline conditions achieved best quantification limits and linear dynamic ranges. 90% of the 
analyzed metabolites presented detection limits better than 0.5 fmol (on column) and 70% 
presented 1.5 fold higher signal intensities under alkaline mobile phase condition. The quality 
of the method was further demonstrated by absolute quantification of selected metabolites in 
intracellular extracts of Escherichia coli. Additionally, quantification bias caused by matrix 
effects was investigated by comparison of calibration strategies: standard-based external 
calibration, isotope dilution and standard addition with internal standards. Here, we 
recommend the use of alkaline mobile phase with polymer-based zwitterionic hydrophilic 
interaction chromatography (ZIC-pHILIC) as the most sensitive scenario for absolute 
quantification for a broad range of metabolites. 
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Introduction 
Metabolomics addresses the identification and quantification of small molecule metabolites, in 
essence the reactants of biological systems, and enables the comprehensive analysis of complex 
biochemical networks systemic studies. While the genome and proteome represent upstream 
biochemical events, the metabolome reveals underlying regulatory mechanisms and therefore 
reflects, most closely, the actual cellular physiological state [1-3]. As such, metabolome 
analysis can be subdivided into targeted and non-targeted approaches. Non-targeted high-
throughput applications like metabolic fingerprinting aim at the rapid and qualitative or semi-
quantitative analysis of whole-cell metabolic patterns, reducing the analytical effort 
considerably [4-6]. On the contrary, targeted applications like metabolic profiling, are focused 
on the non-biased absolute quantification of a subset of metabolites of pre-defined metabolic 
pathways or classes of compounds [2,4,6]. In this context, monitoring of intracellular 
metabolism dynamics as a result of rapid changes in the extracellular environment within 
stimulus-response experiments can be used to investigate in vivo enzyme kinetics offering 
insights into underlying regulatory mechanisms [7-10]. Considering the enormous number of 
intracellular metabolites within various biological matrices and concentrations ranges over 
several orders of magnitude (pM - mM), a variety of different analytical methods have been 
investigated [2,6]. Utilized analytical methods vary widely from enzymatic assays [11] for 
targeted measurements to modern and more powerful soft ionization mass spectrometry 
(SIMS) coupled to liquid (LC) [12-19], gas chromatography (GC) [20-25] or capillary 
electrophoresis (CE) [28-30], as well as nuclear magnetic resonance (NMR) [26-27]. For 
comprehensive metabolite quantification studies a combination of multiple analytical methods 
is usually indispensable, resulting in data sets with varying precision and accuracy [1-2,6,31]. 
However for dynamic modeling of cellular metabolism, in connection with stimulus response 
studies, reliable quantifications of absolute intracellular concentrations in defined cellular 
states and time points are of crucial importance [7,10,25]. Compared to gas chromatography 
(GC), capillary electrophoresis (CE) and nuclear magnetic resonance (NMR), liquid 
chromatography combined with mass spectrometry (LC-MS) offers inherent advantages: LC-
MS does not require further derivatization like GC, is able to separate polar and non-polar 
compounds unlike CE with selectivity depending on column material, and offers a higher 
sensibility compared to NMR. Consequently LC-MS approaches are becoming highly accepted 
as the most universal analytical platform for reliable quantification of intracellular metabolites 
at present [2-3,25]. Recently, hydrophilic interaction liquid chromatography (HILIC) has 
become increasingly popular, as it enables the separation of charged and polar analytes and 
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exhibits excellent compatibility to MS detection [32-34]. Related studies focused mainly on 
silica based stationary HILIC phases, modified by various functional groups, enabling 
comprehensive quantitative analysis of metabolites under acidic and neutral mobile phase 
conditions [12-13,15-16]. Motivated by these encouraging studies we developed the approach 
further for exploiting its potential concentrating on so far non-addressed modes of operation. 
 
In this study we present an analytical platform based on two LC-ESI-MS/MS methods for 
quantitative profiling of more than 50 key metabolites of the cellular metabolism, comprising 
amino acids, sugar phosphates, organic acids, nucleotides and coenzymes. Metabolites will be 
detected by tandem mass spectrometry (MS/MS) on a triple quadrupole instrument in the 
multiple reaction monitoring (MRM) mode with high selectivity based on pre-optimized MRM 
transitions. Chromatographic separation is performed by polymer based zwitterionic 
hydrophilic interaction chromatography and the mobile phase pH effect with respect to analyte 
sensibility will be evaluated. Special focus will be given on method quantification limits, linear 
dynamic range and repeatability for a representative cross-section of 56 common intracellular 
metabolites in acidic and alkaline mobile phase conditions. Finally, the applicability of the 
method will be demonstrated by absolute quantification of selected metabolites in intracellular 
extracts of Escherichia coli showing consistence with previously published endogenous steady 
state concentrations. In addition occurrence of quantification bias caused by matrix effects will 
be presented comparing quantitative results obtained by standards-based external calibration, 
isotope dilution and standard addition as calibration strategies. 
 
Material and Methods 
 
Chemicals 
Metabolite standards, reagents and U-13C-labeled lyophilized algal cells were supplied by 
Sigma-Aldrich (Taufkirchen, Germany). MS grade water was purchased from VWR 
(Darmstadt, Germany). MS-grade acetonitrile was purchased from Carl Roth (Essen, 
Germany). 
Strains and growth condition 
E. coli K-12 MG1655 (purchased from DSMZ, Leipzig, Germany) was grown in minimal 
medium with 0.75 % (w v-1) D-glucose as sole carbon source. The minimal medium contained 
following components: 63.1 mM NaH2PO4, 26.9 mM K2HPO4, 10.0 mM (NH4)2HPO4, 
20.3 mM (NH4)2SO4, 6.2 mM Na2SO4, 1.0 mM MgSO4, 0.1 mM CaCl2, 0.01 mM thiamine 
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hydrochloride. Overnight precultures (12 h, 37 °C, 120 rpm) were inoculated from a 
cryoculture (50 % glycerol, Luria-Bertani (LB) medium) and were grown in 100 mL baffled 
shake flasks with 20 mL minimal medium (12 h, 37 °C, 120 rpm). Main cultures (37 °C, 
150 rpm) were inoculated in 1 : 100 dilution and grown in triplicates in 500 mL baffled shake 
flasks with 60 mL minimal medium (10 h, 37 °C, 150 rpm). 
Sampling, quenching and metabolite extraction 
Cells were sampled during exponential growth phase at a biomass concentration of 
approximately 2 g L-1. Amounts of about 4 mg biomass were sampled by fast centrifugation 
(20 sec, 20 000 g) and washed with 2 mL isotonic 0.9 % (w v-1) sodium chloride solution 
(20 sec, 20 000 g). Biomasses were quenched by liquid nitrogen (-196 °C) and temporarily 
stored at -70 °C. Subsequently, a defined amount of water (MS grade) was added to obtain an 
extraction concentration of 15 g L-1. Resulting suspensions were immediately pre-incubated 
for 1 min at 100 °C in a water bath for enzymatic inactivation and resuspended by short-time 
vortexing. Subsequently samples were incubated for 5 min at 100 °C in a water bath and 
afterwards chilled on ice-water. Metabolite extracts are separated from cell debris by 
centrifugation (10 min, 20 000 g) and stored at -70 °C [35]. 
Preparation of U-13C-labeled internal standard 
Commercially available U-13C-labeled lyophilized algal cells (> 99 atom% 13C, lot no. 487945, 
Sigma-Aldrich) were weighed into 2 mL reaction vessels in small amounts. Preheated water 
(100 °C) was added aiming for an extraction concentration of 90 g L-1. The resulting 
suspensions were incubated at 100 °C for 2 min in a water bath and resuspended by short-time 
vortexing. The procedure was twice more repeated and resulting samples were chilled on ice-
water. 13C-Metabolite extracts were separated from algal cells by centrifugation (10 min, 
20 000 g) and stored at -70 °C [25]. 
Optimization of chromatographic and source conditions 
Development of chromatography was performed on a ZIC-pHILIC column (Sequant, 150 x 
2.1 mm, 5 µm) with guard column (Sequant ZIC-pHILIC, 20 x 2.1 mm, 5 µm). The 
optimization of chromatographic conditions was based on a selection of highly polar 
intracellular metabolites within the central metabolism (6-phophogluconate, fructose 1,6-
bisphosphate, glucose 6-phosphate, phosphoenolpyruvate, malate, succinate, citrate). Bicratic 
chromatographic runs were evaluated in regard of selectivity and sensitivity of applied standard 
mixtures. Optimization was focused on pH of mobile phases (pH 5, pH 7, pH 9), buffer 
concentration (2-20 mM ammonium actetate), flow rate (0.05-0.20 mL/min), column 
temperature (20-60 °C) and gradient slope of polar eluent B (2,5-5% B/min) within a bicratic 
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elution mode. In addition, source parameters (ESI) were optimized with respect to maximal 
signal intensities, focusing on the nitrogen gas flow (7-13 L/min), nebulizer pressure (15-
60 psi) and capillary voltage (± 3000-4000 V). An overview of optimized chromatographic and 
source parameters is shown further below. 
Sample processing and optimized chromatographic conditions 
Standards and endogenous cellular extracts were analyzed on an Agilent 1200 HPLC system 
(Agilent, Waldbronn, Germany) consisting of a degasser, a binary pump, a thermostated 
column compartment and a bio-inert thermostated autosampler (Agilent 1260 Infinity Series), 
maintained at 5 °C. Samples and standards were prepared in 60 % acetonitrile (v v-1) and 
10 mM ammonium acetate buffer (adjusted to pH 5.6 or 9.2). An injection of 5 µL was 
separated on a Sequant ZIC-pHILIC column (150 x 2.1 mm, 5 µm) with guard column (Sequant 
ZIC-pHILIC, 20 x 2.1 mm, 5 µm) kept at 40 °C and with a flow rate of 0.2 mL/min. Mobile 
phases were composed of 10 % (v v-1) aqueous buffer solution (10 mM ammonium acetate) 
and 90 % (v v-1) acetonitrile for eluent A; 90 % (v v-1) aqueous buffer solution and 10 % (v v-
1) acetonitrile for eluent B, both adjusted to pH 5,6 (with acetic acid) or pH 9,2 (with 25% (v v-
1) ammonium hydroxide). Gradient elution was carried out by following program: isocratic 
hold 0 % B for 1 min, next a linear gradient from 0 % B to 75 % B for 30 min, followed by 
linear gradient from 75 % B to 100 % B for 4 min. At the end of the run the column was washed 
with 100 % B for 5 min and afterwards equilibrated to starting conditions by a linear gradient 
from 100 % B to 0% B for 10 min and 0% B for 15 min. 
Instrumentation and electrospray ionization tandem mass spectrometry (ESI-MS/MS) 
Data was acquired with an Agilent 6410B Triple Quad mass spectrometer (Agilent, 
Waldbronn, Germany) with ESI ion source. Negative (ESI-) and positive ionization mode 
(ESI+) were performed in separated runs in MRM mode depending on metabolite group. 
Source conditions were as follows: nitrogen gas flow rate of 10 L min-1 with a temperature of 
350 °C, a nebulizer pressure of 30 psi and a capillary voltage of 4000 V. Fragmentor voltages 
and collision energies were optimized in continuous direct-injection mode for each metabolite 
precursor-to-product ion transition. Dwell time was adjusted to 100 ms for each MRM 
transition. System control, acquisition and analysis of data were performed by usage of 
commercial MassHunter B.04.00 software. 
Linearity range and sensibility tests 
Linearity ranges of both method configurations (acidic and alkaline mobile phase conditions) 
were evaluated with regard to the amount of respective injected analytes. Multicomponent 
standard solutions were prepared from properly adjusted metabolite mixtures and were 
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assigned to three different groups depending on ionization mode and retention time. Focusing 
on small concentrations (≤ 5 µM) and depending on sensitivities of measured metabolite 
groups, a calibration range of 1 nM to 5 µM based on 12 levels were applied. Additional 
linearities of several selected metabolites were evaluated by usage of an extended calibration 
range (0.5 µM to 200 µM) based on 12 levels. Sensibility tests were implemented by measuring 
of 5 µM standards for each metabolite under acidic and alkaline mobile phase conditions. 
Absolute quantification in bacterial metabolite extracts (quantification strategies) 
The suitability of the method was demonstrated by quantification of absolute concentrations of 
selected metabolites in intracellular extracts of wild type Escherichia coli biomasses. In 
addition quantification bias caused by matrix effects was evaluated by comparison of 
quantitative results by external calibration, isotope dilution and standard addition. 
Multicomponent standard solutions for external calibration were obtained of defined non-
labeled metabolite mixtures. Depending on previously estimated concentrations (obtained by 
spiking experiments) metabolite-specific calibration ranges with 7 levels were adjusted. 
Quantifications based on isotope dilution were performed by constant addition of U-13C-
labeled algal extracts as internal standard to samples and external calibration standards. 
External calibration curves were prepared by linear regression of ratios of analyte peak areas 
and internal standard areas against the concentration levels of the respective analyte. Standard 
addition was performed by addition of defined amounts of respective standard directly to 
sample aliquots. Applied multicomponent metabolite mixtures were adjusted based on 
previously estimated concentrations of selected metabolites. Internal calibration curves were 
prepared by linear regression of non-spiked and incrementally increased analyte peak areas 
against concentration levels of the respective added standards. 
 
Results 
The objective of the present work was to develop a robust LC-MS/MS method for quantitative 
analysis of a broad range of analytes with high selectivity and sensitivity in complex matrix 
samples like intracellular metabolite extracts. To overcome matrix effects and co-elution of 
isomeric compounds, frequently present in intracellular matrices, a suitable chromatographic 
method is required. Recent developments in polymer-based HILIC stationary phases enable 
chromatographic separation of complex samples under alkaline conditions improving 
sensitivity and chromatographic performance. 
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Optimization of MS/MS parameters  
Measurements were performed on an HPLC-ESI-QQQ instrument in MRM mode with a metal-
free bio-inert HPLC system. Precursor-to-product ion transitions were optimized using 
continuous direct injection of pure standard solutions in positive and negative ionization 
modes. Suitable product ions, fragmentor voltages and collision energies were selected in 
regard of maximal signal intensities. Specific MRM transitions for a representative cross-
section of 56 common intracellular metabolites, including amino acids, carboxylic acids, sugar 
phosphates, nucleotides and coenzymes, as well as their U13C-analogues isotope dilution, are 
provided in the electronic supplemental material. 
 
Chromatographic performance under alkaline and acidic mobile phases 
Chromatographic performance was evaluated on retention time reproducibility, peak width and 
peak shape. To avoid potential column effects due to pH switches, two different columns from 
same sorbent lot, were used for acidic and alkaline conditions. Even when similar 
chromatographic quality was obtained for organic acids and amino acids, the peak shape was 
significantly improved for nucleotides under basic conditions. Only citrate and iso-citrate 
presented better resolution under acidic conditions. A selection of extracted ion chromatograms 
of isobaric metabolites is shown in Figure 1. A compilation of MRM chromatograms of all 
56 metabolites measured under acidic and alkaline mobile phase conditions is included in the 
electronic supplementary material. 
 
Evaluation of linearity and method detection limits for different mobile phases pH 
The linearity range for each metabolite was determined under acidic (pH 5.6) and alkaline 
(pH 9.2) mobile phase conditions. A range of metabolite concentrations was considered linear 
when the squared correlation coefficient (R2) was better than 0.98 for the average of tree 
calibration curves. In order to increase the predictive significance of the measurements, internal 
standards were considered for monitoring of instrumental fluctuations but not for normalization 
of obtained peak areas. 
Extending the calibration range from 0.5 µM to 200 µM, the linearity of instrument response 
with respect to the amount of the injected analyte, revealed to be specific for each metabolite, 
sample context and mobile phase condition. Figure 2 shows two different metabolite standards 
with exemplary deviations from linearity of applied calibration lines. Obtained metabolic-
specific linearity ranges differ significantly at lower concentrations (1 nM - 5 µM) between 
both conditions. The median for the lower linearity limits was approximately 30 nM for 
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alkaline and 120 nM for acidic mobile phase conditions. Within alkaline conditions 40 % of 
the metabolites show a linearity range between 5-20 nM as lower boundary and 5 µM as upper 
limit. In contrast to this, only 12 % of the metabolites fulfilled the same criterion under acidic 
conditions. An overview of metabolic-specific linearity ranges for acidic and alkaline mobile 
phase conditions is shown in Table 1. 
The method detection limit (MDL) was calculated as the amount of metabolite that results at 
statistically significant peak areas above background noise. MDL was based on the standard 
deviation of triplicates at the lower linearity boundary (lowest concentration of the linearity 
range) multiplied by the expansion coefficient (t = 6.96) for defining the 99% confidence level 
[36]. In column method detection limits were 0.01-3.7 fmol for alkaline conditions and 0.02-
14.7 fmol for acidic conditions. 89 % of the analyzed metabolites showed MDLs lower than 
100 nM (0.5 fmol on column) under alkaline conditions, while just 46 % of the metabolites 
fulfilled this criterion under acidic conditions (Figure 3). The lowest detection limit was 
achieved for malic acid in positive ionization mode (2.23 nM; 0,011 fmol on column) using 
basic conditions. An overview of the metabolite specific MDLs for acidic and alkaline mobile 
phase conditions are shown in Table 1. Comparing both conditions the most significant 
differences were observed for the di- and triphosphates nucleotides, NADP as well as for 
fumaric acid, isocitrate, aspartic acid and glutamine, showing approximately 20 to 50 times 
lower detection limits under alkaline conditions. 
 
ESI-MS responsivity under alkaline and acidic mobile phases 
Next, the impact of pH of mobile phases on ESI-MS responsivity was studied based on 
comparison of peak areas obtained by injection of 5 µM metabolite standards under both 
conditions. Special care was given to the preparation of 10 mM ammonium acetate buffer 
solutions to afford comparable ion strength under acidic and alkaline conditions. Either acetic 
acid or ammonium hydroxide were added in equimolar amounts to adjust the buffer system pH 
to 5.6 or 9.2. In order to compare both scenarios, averaged peak areas obtained by alkaline 
conditions were normalized by those of acidic conditions. Strikingly, 70 % of the metabolites 
presented more than 1.5 fold higher signal intensities under alkaline mobile phase condition 
(Figure 4). 
Absolute quantification in bacterial metabolite extracts 
For challenging the applicability of the approach, absolute concentrations of selected 
metabolites were quantified in intracellular extracts of E. coli biomasses. Because matrix 
effects are suspected to be a major source for inaccuracies and unreliability in ESI-MS-based 
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quantitative metabolomics [6, 16, 18], related impacts were evaluated as well. Quantification 
strategies were adjusted based on previously estimated concentrations of the targeted 
intracellular metabolites. Intracellular pool sizes were detected by standard-based external 
calibration, isotope dilution and standard addition for subsequent comparison. Standard-based 
external calibration and isotope dilution were applied by metabolic-specific calibration ranges 
in multicomponent mixtures. Standard addition was performed for each metabolite at 
concentrations corresponding to approximately two-, three- and fourfold of the estimated 
values. Results obtained from exemplary measurements of six intracellular metabolites with 
three different approaches are summarized in Figure 5. Corresponding correlation coefficients 
are shown in Table 2. 
Good (R2 ≥ 0.99) to excellent (R2 ≥ 0.999) linearity coefficients were found for all three 
calibration strategies. Four replicates were made for sample analysis, where calculated relative 
standard deviations of the measured concentrations were smaller than 9% for each metabolite. 
As depicted in Figure 5 individual sample analysis revealed a high similarity between 
quantitative results within the different calibration methods as confirmed by one-way ANOVA. 
With exception of NAD (< 10 %) the concentrations obtained by the three different 
quantification strategies deviated by less than 6 %. This finding is taken as an evidence for the 
successful reduction or even elimination of matrix effects due to co-eluting matrix ions thanks 
to chromatographic separation [12,13] while non-wanted, co-eluding matrix ions are known to 
strongly affect ionization yields of targeted analytes [13,16]. 
Although the set of investigated metabolites turned out to be straightforward quantifiable by 
external calibration with satisfying accuracy, other metabolites could require more elaborative 
calibration strategies. Even though that sample preparation and extraction protocols were not 
in the focus of this optimization, obtained results were consistent with previously published 
endogenous pool concentrations in E. coli under similar cultivation conditions. Notably, 
intracellular pool sizes are known to be significantly depending on strain context, cultivation 
strategy, sample preparation and assumed or investigated aqueous intracellular volumes [37-
40]. 
Nevertheless, the intracellular metabolite concentrations of L-alanine and L-lysine are in good 
agreement with the reported measurements of Bennett et al. (2009) and Yuan et al. (2006) [38-
39]. Measured NAD and L-valine pools are in the same concentration range but differ 
significantly [37,40]. Steady state concentrations of glycine and L-leucine have not yet been 
published for E. coli under comparable cultivation conditions. 
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Discussion 
From the analytical perspective, the ultimate goal of metabolomics is the reliable identification 
and quantification of all metabolites present in biological samples taken at distinct time points 
thus representing individual cellular states. Considering the complexity of metabolic networks, 
comprising a vast number of compounds covering a wide chemical diversity, quantitative 
analyses are still a great challenge. 
In this work, we present a robust HILIC-MS/MS method for quantitative analysis of a broad 
range of common intracellular metabolites with high selectivity and sensitivity. So far, the 
majority of related LC-MS studies utilize reversed phase (RP) [44-51] or hydrophilic 
interaction stationary phases [12-13,15-16,52-57]. Despite multiple advantages like robustness 
and straightforward implementation, RPLC typically lacks of adequate retention for non-
derivatized hydrophilic analytes on silica-based reversed phase stationary phases [33]. For 
example, RPLC approaches offers only poor retention performance for small molecules with 
acidic functional groups in their deprotonated form, and lowering the mobile phase pH to 
improve compounds retention, usually leads to unacceptable peak shapes of polar basic or 
zwitterionic compounds [58]. 
Consequently, complex multicomponent samples of polar analytes are analyzed either by two 
separated methods or using ion-pairing-agents like trifluoroacetic acid (TFA) or tributylamine 
(TBA) [44-51]. The later may cause handling and performance issues for coupled ESI-MS 
detection with respect to chromatographic reproducibility of polar compounds, ion suppression 
due to interfering ion-pair-agents or contamination of the mass spectrometer. 
In this context, HILIC chromatography is increasingly preferred, as it enables the separation of 
charged and polar analytes and exhibits excellent compatibility with ESI-MS detection [12-
13]. HILIC is characterized by the analyte partitioning between a water-enriched layer, 
partially immobilized on the stationary phase, and a predominantly polar organic mobile phase 
[32-34]. On the other side, polymeric material based columns support alkaline mobile phase 
conditions and acidic pH elution buffers for enhancing retention and chromatographic quality 
of polar analytes within multifunctional metabolite extracts. 
Although alkaline mobile phase conditions can distinctly enhance chromatographic quality of 
multifunctional metabolite extracts, so far, most chromatographic methods focus on acidic or 
neutral mobile phase conditions, regardless of applied stationary phases. Irrespective which 
approach is followed, it needs to fulfil the requirements for dealing with complex metabolic 
matrices. To be precise, the quality of the chromatographic method to separate isobaric 
compounds which lack specific MRM transitions is of crucial importance for achieving distinct 
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and accurate quantification of intracellular metabolites. The complete separations of isobaric 
pairs such as fructose-/glucose 6-phosphate, citrate/iso-citrate and L-leucine/L-isoleucine 
(Figure 1) are likewise examples frequently present in endogenous extracts which confirm the 
quality of the presented method. In this study we clearly show, that strong alkaline mobile 
phase conditions in HILIC chromatography achieve acidic performance data at least, mostly 
being even superior with respect to peak shapes and resolutions. An overview of extracted ion 
chromatograms of all 56 metabolites measured under acidic and alkaline mobile phase 
conditions is included in the electronic supplementary material. 
Regarding the ionization efficiency in ESI-MS, it has been assumed that signal intensity of 
measured analytes strongly depends on bulk solution pH, resulting in a direct relationship 
between ESI-MS response and equilibrium concentrations of ionizable species in the mobile 
phase. For example, amino acids are still preferably detected in positive electrospray mode 
under acidic conditions to promote ionization and hence increase analytes responsivity [44]. 
Likewise in negative ionization mode alkaline conditions are preferred for quantification of 
phosphorylated compounds such phosphopeptides to enhance the formation of 
phosphorylation-specific marker ions [63]. 
On this point related reports have demonstrated “unexpected” improved method sensitivity of 
various substances under alkaline conditions. Peptides measured in positive ionization mode 
presented higher signal-to-noise ratios when using ammonium hydroxide pH 10 mobile phase 
[59]. Besides, using high pH resistant RP-C18 columns it was possible to investigate the 
influence of mobile phase pH on ESI-MS-responsivities of a broad range of chemical entities 
of pharmaceutical interest, where analytes signals were significantly increased under basic pH 
conditions [58,60]. Studying electrospray ionization of amino acids, Mansoori et al. (1997) 
defined this phenomenon as “wrong-way-round” (WWR) ionization and outlined the absence 
of a simple and/or predictive dependency of analyte ESI-MS response on eluents pH [61]. 
During the last years different mechanisms were controversially discussed to explain this 
“anomalous” ionization behavior: electrolytic production of protons, proton emission from 
electrospray droplet surface layer, gas-phase proton transfers by strong gas-phase acids like 
ammonia, or gas-phase chemical ionization by corona discharge induction or by precursors in 
the same solution [60,62]. Independent of the highly valuable discussion about feasible 
molecular interactions, our approach achieved about 1.5 fold higher signal intensities under 
alkaline conditions (compared to acidic ones) for 70 % of the investigated metabolites. 
Furthermore responsivities of phosphorylated compounds were enhanced in negative 
ionization mode, as expected. The remaining 30% exhibited similar or even slightly improved 
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signal intensity, with the only exceptions being L-argininine and cyclic adenosine 
monophosphate. 
Furthermore, 90 % of evaluated metabolites show improved method detection limits lower than 
100 nM (0.5 fmol on column) with significantly reduced lower linearity limits at alkaline 
mobile phase conditions. 66 % of the metabolites reveal linearity ranges of 5-50 nM as lower 
boundary, whereas only 30 % of the metabolites meet this target at acidic conditions. The 
increase in signal intensities under alkaline conditions in negative mode, especially for 
phosphorylated compounds, agrees with the expected analyte behavior. On the other hand, 
metabolites measured in positive mode do not show the classical performance which could be 
explained by more efficient ionization through the aforementioned WWR mechanism. 
Summarizing, these results confirm that ESI-MS response depends on interfering effects 
including chemical nature of targeted analytes, pH, buffer types and organic modifier in the 
mobile phase. Consequently, more comprehensive and metabolite specific studies are 
necessary to unravel underlying mechanisms for identifying the most prominent parameters.  
The quality of the method was demonstrated by absolute quantification of selected metabolites 
in intracellular extracts of E. coli biomasses, using standard-based external calibration, isotope 
dilution and standard addition as calibration strategies. To verify metabolites stability under 
alkaline conditions, direct injection measurements of standard solutions were made lasting for 
during 14 h. Phosphorylated compounds and organic acids presented almost no signal decrease 
and amino acids less than 20%. Exceptions with higher degradation like L-glutaminine or 
erythrose-4-phosphate should be analyzed by isotope dilution as calibration strategy to 
compensate analyte loss. Detailed data of stability evaluation of investigated metabolites under 
alkaline conditions are shown in the electronic supplemental material. 
Sample analysis of six metabolites revealed consistent results with published intracellular 
steady state concentrations and exhibits a high similarity between calibrations methods, 
emphasizing a sufficient reduction of matrix effect due to suitable chromatographic separation. 
Nevertheless, the authors suggest to carefully evaluate specific matrix effects for preventing 
non-wanted bias on metabolite concentrations derived from straightforward quantification by 
standard-based external calibration. 
In summary, using alkaline mobile phases with ZIC-pHILIC chromatography emerged as a 
powerful approach offering highly selective and sensitive separation conditions for absolute 
metabolite quantification. As such, the technique should be applicable for a broad range of 
analytes in comprehensive metabolic studies, enabling simultaneous quantitation of dozens of 
metabolites in one single run.  
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Table 2 Calibration functions and corresponding correlation coefficients of investigated metabolites. 
 
Metabolite External calibration Isotope dilution Standard addition One-way ANOVA 
 Slope Intercept R² Slope Intercept R² Slope Intercept R² F P Value 
L-Leu 3.20E+05 3.80E+04 0.9910 4.01E-01 4.50E-02 0.9913 3.28E+05 2.55E+05 0.9986 3.560 0.0726 
L-Lys 2.41E+05 2.90E+04 0.9975 5.08E-02 4.10E-03 0.9969 2.35E+05 4.09E+05 0.9995 1.622 0.2503 
L-Val 1.42E+05 4.23E+03 0.9969 2.59E-01 3.40E-03 0.9975 1.45E+05 2.99E+05 0.9989 1.379 0.3002 
NAD 4.25E+04 -2.74E+03 0.9978 1.31E+00 -8.93E-02 0.9982 4.40E+04 1.36E+05 0.9994 9.193 0.0067 
Gly 1.91E+04 7.34E+03 0.9994 7.77E-02 -1.96E-02 0.9991 1.95E+04 2.60E+05 0.9999 0.121 0.8876 
L-Ala 6.93E+04 -5.56E+04 0.9977 5.03E-02 -3.82E-02 0.9984 7.06E+04 8.90E+05 0.9997 1.778 0.2235 
F (crit) = 4.256 
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Figure legends 
 
Fig. 1   Extracted ion chromatograms obtained with optimized HILIC method under alkaline 
(pH = 9.2) and acidic (pH = 5.6) mobile phase conditions focusing on isobaric compounds 
frequently present in intracellular matrices. 
 
Fig. 2 Standard calibration curves of malonic acid (A) and adenosine triphosphate (B) in the 
range of 0.5 to 200 µM under alkaline mobile phase conditions. Shown are typical source-
dependent deviations at the upper limit of calibration curves, occurring as concentration-
dependent signal suppression (A) or enhancement (B). Error indicators display standard 
deviations (n=3). 
 
Fig. 3 Metabolite distribution in different MDLs under alkaline and acidic mobile phase 
conditions. 
 
Fig. 4 Overview of metabolic-specific responsivities depending on mobile phase pH. Shown 
are relative peak areas obtained by measurement of 5 µM standards under basic conditions 
normalized to those at acidic conditions. 
 
Fig. 5 Absolute intracellular concentrations of selected metabolites in exponentially growing 
E. coli K-12 MG1655 quantified by HILIC-MS/MS under alkaline conditions (pH 9.2). 
Measurements are based on standard-based external calibration (white), isotope dilution (grey) 
and standard addition (black). Error bars describe the standard deviation of four replicates 
measurements. 
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FIGURE 1 
 
 
 
 
 
FIGURE 2 
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FIGURE 3 
 
 
 
FIGURE 4 
 
 
  
________________________________________________________________________________ 
114 
 
FIGURE 5 
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Appendix D. Monitoring intracellular protein degradation in 
antibody-producing Chinese hamster ovary cells. 
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Practical application 
The study presents a novel approach for monitoring intracellular antibody degradation based on 
proteolytic activities. The method was applied unraveling that intracellular mAb degradation occurs 
even under rather smooth production conditions. The technique can be equally used to study high 
productivity settings to evaluate putative degradation effects in industrial production of 
biopharmaceuticals.  
 
 
Abstract 
Intracellular proteolysis in mammalian cells is a native cellular strategy to recycle proteins and peptides. 
Whether or not this mechanism may hamper monoclonal antibody (mAb) formation in CHO was the 
key driver for this study. Exponentially growing, anti-IL8 producing CHO cells were fed with 13C-
labeled L-lysine. The fate of the labeling signal was tracked in intracellular peptides which were the 
proteolytic fragments of the mAb.  Signal analysis was performed in samples after cell disruption, anion 
exchange solid phase extraction (SPE) and Q-ToF mass detection. Four degradation peptides were 
found, with HYTQKSLSLSPGK and HYTQKSLSLSPG containing two and one L-lysine unit (K) 
respectively.  Labeling dynamics were used for model-based identification of the degradation rate in 
four biological replicates.  Degradation rates of 1.23 to 1.89 pmol/108cells/h were estimated 
representing about 0.18 % of the net mAb production.  Hence intracellular mAb degradation occurs 
even under the rather smooth production conditions installed. 
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1 Introduction 
The production of heterologous proteins is one of the key applications of mammalian cells, 
predominately Chinese Hamster Ovary (CHO), today [1]. According to recent market figures, 
monoclonal antibody (mAb) production alone sums up to 38 billion US$ in 2009[2]. Currently, 
biopharmaceutical manufacturers worldwide are yielding to optimize production performance using 
volumetric and cell-specific productivities as optimization parameters. This issue addresses the 
optimization of external factors, such as culture conditions, and internal factor such as expression or 
secretion systems, likewise. In this context, the questions may arise: How much mAb is already 
degraded inside the cells before it could be successfully exported into the culture medium? Is 
intracellular protein degradation a promising target for maximizing cell-specific productivities further? 
About 60 years ago, first evidences for intracellular protein degradation were found by Schoenheimer 
and Urey detecting heavy nitrogen (15N) labeled amino groups (-NH2) in multiple amino acids after 
labeled tyrosine was fed to rats[3]. 
The further discovery of the lysosome by Christian de Duve identified organelles able to degrade 
intracellular and extracellular proteins [4].  In lysosomes, acidic conditions are installed, enabling the 
protease-based degradation of fused proteins (microautophgagy), or even the digestion of whole 
organelles such as mitochondria, endoplasmic reticulum membranes, glycogen bodies and other 
cytoplasmic (macroautophgagy) under starvation conditions [5]. 
However, the discovery of lysosomes could not adequately explain phenomena like different half-lives 
of proteins [6], inhibitor-specific impacts on protein degradation [7], and the energy dependency of 
degradation [8].  
Only after the discovery of ubiquitin-proteasome activities, the missing links became visible. It was 
found that ubiquitin (or ATP-dependent proteolysis factor 1, APF1 as called before its identification), 
is covalently conjugated to protein substrates by an isopeptide bond formation (requiring ATP), and 
that multiple ubiquitination lead to protein degradation [8, 10]. The enzymatic cascade carrying out 
ubiquitination (E1, ubiquitin-acitvatin enzyme, E2, ubiquitin carrier protein and E3, ubiquitin protein 
ligase) was discovered by Hershko, Ciechanover and colleges. E3 was identifies as the specific-binding 
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enzyme, explaining the diversity of protein half-lives [11]. Furthermore, Hough et al. [12] discovered a 
high-molecular-mass protease (proteasome 26S) that degraded ubiquitin conjugates using ATP.  
The 26S proteasome is a multi-subunit enzyme complex consisting of a catalytic core and a regulatory 
particle (20S, 19S).  19S binds at the substrate to be degraded while the catalytic core generates 
fragments of 3 to 24 amino acids length [13, 14, 15]  via trypsin-like, chymiotrypsin-like and glutamyl 
activitities. Fragments longer than 6 amino acids are primarily treated by endopeptidases to release 
shorter fragments that are processed to free amino acids by amino peptidases [13, 16]. Aspartic 
proteases like Cathepsin D and E were reported to be present in the ER and lysosomes. Cleavages due 
to Xa like serine proteases can also occur in the intracellular matrix [17, 18, 19]. 
Both, the lysosome and the ubiquitin-proteasome are the main mechanisms for intracellular protein 
degradation described so far. They are supposed to control misfolded and damaged proteins thus being 
important for amino acid reutilization [20]. Schubert et al. estimated that more than 30 % of newly 
synthesized proteins are retrograde transported into the cytosol for degradation by proteasomes because 
they had been misfolded [21]. 
Multiple methods have been developed to study intracellular proteolysis: isotope-coded affinity tag 
(ICAT) [22, 23, 24], TAP [25], GPS [26, 27], bleach-chase [28] and ribosome profiling [29, 30, 31]. 
These techniques enable large-scale turnover studies investigating the relationships between protein 
function and stability. However they possess the inherent drawback of necessary fluorophore binding 
with not yet elucidated consequences on the transferability of results to intracellular conditions of non-
tagged proteins. 
Alternatively, stable isotope labeled amino acids (15N, 13C, 34S) can be applied (SILAC). For instance 
cells are cultivated in 13C,15N-Arginine containing medium before they are transferred into medium 
with light isotopomers (12C,14N-Arginine) [32]. The protein dynamic is chased by extracting and 
purifying intracellular proteins, digesting them and measuring the resulting peptides by liquid 
chromatography coupled to mass spectrometry. The signal ratio decay over time of the labeled and 
unlabeled peptides is used to calculate the protein turnover rate for each identified protein. As a result, 
the dynamic of endogenous proteins stability is estimated. 
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These approaches have proven their feasibility unraveling different phenomena of regulatory functions 
[33, 34]. However they also pinpoint on inherent sensitivities which need to be considered or improved 
for the quantitative analysis of intracellular proteolysis [25, 35, 36]. 
Among others, the thorough balancing of all components involved is one essential prerequisite (figure 
1). At (pseudo-) steady-state, product formation equals secretion and degradation, which requires a 
thorough monitoring of each component involved. Following this principle (34S) labeling in Pichia 
pastoris unraveled 58% intracellular product degradation [37]. 
In mammalian cells (myeloma), Yee et al. found that half-lifes of endogenous proteins varied from 1 to 
140 days (or more) while it was only about 2 h for recombinant proteins [38]. Related figures also 
including degradation rates are not yet published for mAbs in CHO so far. 
Therefore this contribution aims at shedding some light on intracellular mAb degradation in anti-IL8 
producing CHO DP12 cells serving as a model organism. Following the fate of 13C-labeled lysine mAbs 
during product formation, quantitative estimations of intracellular mAb degradation will be given by 
direct measurements of degradation products using high resolution mass spectrometry (LC-Q-TOF). It 
will be shown that intracellular mAb degradation occurs already in the exponential growth phase of 
producing CHO. 
 
2 Materials and Methods 
 
2.1. Bioreactor batch culture and 13C-Lys pulse experiment 
The strain CHO DP12#1934 (ATCC)- 42 passages in TC42 medium with 200 nM methotrexate (MTX) 
and 15 passages in TC42 with 600 nM MTX-termed hereafter as DP12-600 was cultivated. Cells were 
seeded from the same pre-culture at a density of 0.5×106 in 90% fresh medium (TC42 TeutoCell without 
lysine and sugars) supplemented with 600 nM MTX, 6 mM glutamine, 45 mM glucose, 45 mM fructose, 
3.7 mM galactose and 1 mM lysine in four 1.6 L bench-top bioreactors (DS1500ODSS, DAS GIP) 
controlled at pH 7.1, 37°C, and dissolved oxygen at 30 %. Agitation and aeration were controlled with 
two pitched blade impellers at 150 rpm and a steel L-sparger. The start volume was 1300 mL. After 63 
hours cultivation, 100 mL of 13C-feed has been promptly set into the bioreactors. The pulse solution 
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contained 50 mL of TC42 without sugars and lysine, and 50 mL of a sugar and lysine mix so that the 
concentration in the pulse mix were 90 mM glucose, 90 mM fructose, 6.2 mM galactose, 19.6 mM 13C-
lysine and 16 mM glutamine. Afterwards 2.8×108 or 5.6×108 cells were harvested from the reactors 
regularly until the minimal reactor volume had been reached. The minimal volume is the reactor volume 
under which impellers do not agitate culture broth any more. Cell densities were measured through 
trypan blue coloration on Cedex (Roche). The same procedure was followed for the cultivation of CHO-
K1 in one bioreactor without MTX. 
2.2. Determination of substrate and product concentrations 
Glucose and lactate concentration had been measured using LaboTrace TraceAnalytics. Antibody 
concentrations were determined through sandwich ELISA. Amino acids were separated on a Hewlett-
Packard GC-FID 5802 using an EZ:fast GC-FID physiological amino acid analysis kit (Phenomenex). 
 
2.3. Cell lysis and intracellular peptide purification 
Harvested cells from the bioreactors were centrifuged once to separate them from the supernatant. 
Afterwards, cell pellets were washed twice with cold PBS and freezed at −70 ◦C. For disruption, cell 
pellets were lysed using 1 mL of lysis buffer at 80 °C in 2 mM hexadecyl trimetyl ammonium chloride  
(HTA), 50 mM ammonium acetate and 150 mM sodium chloride, pH=7.6, and kept for 30 minutes at 
80°C to eliminate protease activity. Cell lysates were cooled to 4°C and 100 µL of 20% H3PO4 were 
added prior centrifugation (20, 000×g during 20 minutes). Supernatants were purified using 1cc Oasis™ 
MAX (Waters) solid phase extraction (SPE) as described by Chambers with minor modifications [39]. 
Cartridges were conditioned with MeOH and equilibrated twice with 1% TFA. Loaded samples were 
washed first with 5% NH4OH and then with 20% acetonitrile. Peptide elution was made using 30% 
Acetonitrile, 1% trifluoroacetic acid (TFA) solution. The samples were evaporated to dryness using a 
speed vacuum and stored at -20°C until analysis. 
2.4. Peptide mapping and identification by LC-QTOF-MS 
 
The used liquid chromatography system was an Agilent 1260 Infinity Bio-inert consisting of a degasser, 
quaternary pump and thermostater autosampler (maintained at 4 °C).  Dried samples were reconstituted 
in 5% acetonitrile and 0.2% formic acid. 80 µL were injected to a reverse-phase column and guard 
column (Aeris ™ PEPTIDE 3.6u XB-C18 150 x 2.1 mm, Phenomenex) with a flow of 0.4 mL/min. 
________________________________________________________________________________ 
121 
 
Mobile-phase A was water with 0.2% formic acid and B was acetonitrile with 0.2% formic acid. For 
peptide identification the elution program was: isocratic hold at 5% B for 5 minutes, then a linear 
gradient from 5% to 60% B over 120 minutes. After each sample the column was washed with 90% B 
for 10 minutes and then equilibrated at starting conditions. For peptide quantification the program was 
shortened. The gradient was increased until 20 % B in 45 min. Data were collected in positive Auto 
MS/MS mode on an Agilent 6540 Accurate-Mass Quadrupole (LC-Q-TOF/MS) with ESI Jet Stream 
Technology using the following conditions: drying gas flow 8 L/min and gas temperature 220°C, 
nebulizer 40 lb per square inch gauge, sheath gas flow 12 L/min, sheath gas temperature 350°C, 
capillary voltage 4000 V, and fragmentor voltage 135 V. The collision energy was set by formula with 
4.5 slope and 10 offset. The reference masses were m/z 121.0509 and 922.0098 and the instrument was 
recalibrated each 20 samples. 
Data analysis was made using Mass Hunter Workstation Software (Ver.B.05.519.0, Agilent 
Technologies), using the “find compounds by molecular feature” algorithms to get a list of possible 
peptides. Then the data was exported and analyzed using PEAKS Studio 7 (Bioinformatics Solutions, 
Waterloo, Canada). Peptides fragmentation data was analyzed by de-novo sequencing and then peptide 
sequences were aligned by PEAKS DB with the CHO proteome and the anti-IL8 sequence [40, 41]. 
2.5. Peptide quantification and labeling ratios 
Extracted ion chromatograms of the monoisotopic ions of each peptide isotopologues were integrated 
and peak areas were used to calculate isotopologues fractions in each time point.  
Peptides at the first time point after 13C-Lys pulse were quantified by internal standard calibration using 
peptides with one full labeled lysine (13C6,15N2) from Intavis (Germany) as internal standard and  
calibration curves with concentrations between 2-80 nM using synthetic peptides as standards. 
Isotopologues concentration at each time points were calculated through these concentrations together 
with isotopologues fractions. 
Seven replicates of standard spiked cell extracts were used for recovery percent calculation of the 
peptide purification methodology (anion exchange SPE).  
2.6. Modeling approach 
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For modeling the concentration c [pmol/mL] encoding the heavy chain of the mAb was used as well as 
fractions f [-] coding for the non-, single- and double- labeled fractions of the fragments F1 and F2. F1 
and F2 code for fragment 1 (amino acid sequence HYTQKSLSLSPGK) and fragment 2 (amino acid 
sequence HYTQKSLSLSPG) with peptide pool sizes x1 [pmol/108cells] and x2 [pmol/108cells] 
respectively.  The system was investigated in a steady state, i.e. peptide pool sizes, specific growth and 
secretion rates were assumed to stay constant in the observation period. Constant peak areas of the 
peptide pools were measured in samples (data not shown). The specific growth rate µmax, was 
determined analyzing the exponential phase according to equation 1. 
d cX
d t
= mm a x× cX        with cX being the viable cell density  (1) 
Likewise the extracellular accumulation of the antibody anti-IL8 containing the heavy chain 
(concentration e x t r a
H C
c ) was estimated with the help of the cell-specific secretion rate qsec as follows:  
X
HC
cq
dt
dc e x t r a
×= sec        (2)  
According to the occurrence of L-lysine (K), fragments F1 and F2 could be non (F1K0, F2K0)-, single 
(F1K1, F2K1) - or even double (F1K2) – labeled. The different isotopologues are illustrated in figure 
1. Hence, related labeling fractions add up to 1 (equation 3 and 4). For F1K1 there are two different 
indistinguishable populations which are considered to contribute equally to this ratio (figure 1).  
 0111211 KFKFKF fff ++=       (3)  
02121 KFKF ff +=        (4) 
Exploiting steady-state assumptions in the described network (figure 1), synthesis, secretion and 
degradation of antibodies equal according to: 
       (5) 
deg
3
deg
2
deg
1
deg nnn === v       (6) 
Individual fractions are modeled as follows:  
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fF1K2 and fF1K1 were fitted using equations 7, and fF1K0 using equation 8 based on the presented data set. 
The constant terms   and  are specific for each isotopologue. Their respective values are given 
in supplemental documents. 
 
The balancing of F2 was performed only consisting of the fractions: single ( 12KFf ) and non-labeled (
02 KFf ).  Noteworthy, the resulting model is linear with respect to the target parameter vdeg as indicated 
in the consolidated formula: 
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(9) 
Ratios are calculated from raw MS data. The degradation rate (n de g) is determined by a linear 
regression based on equation 9. 
 
3 Results  
The presented approach describes intracellular mAb degradation by identifying related fragments with 
the help of 13C-labeled lysine and by assuming constant degradation activity during the observation 
period. CHO cells were cultivated under controlled conditions when a labeling pulse with 13C-lysine 
was added to the exponentially growing culture. Intracellular peptides, being degradation products from 
the produced anti-IL8, were identified and quantified by high resolution mass spectrometry. The fate of 
the 13C labeling signal was exploited to identify formation and degradation kinetics of the mAb, even 
estimating absolute secretion and degradation rates via a mechanistic modeling approach. 
 
t
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3.1  Bioreactor batch culture and 13C-Lys pulse experiment 
Cells were inoculated from one pre-culture and were grown in a batch culture for 4 days at constant pH 
and dissolved oxygen concentration. They showed the expected phenotype: a short lag phase followed 
by exponential growth until cell densities of 3 - 4 *106cells/mL were achieved (figure 2). Cell viability 
was higher than 95 % during the whole cultivation (figure 2). Each cultivation was stopped before the 
cells may have entered the stationary phase. During the early exponential growth phase, the 13C-pulse 
was added after 63 hours and cellular response was monitored via subsequent sampling, as indicated in 
figure 2. The post-pulse cell growth rate was identified as 0.0204-0.0296 h-1 thus showing no significant 
kinetic consequence on the l-lysine addition as illustrated in figure 3. Final antibody titers varied 
between 800 (114 mg/L) and 1300 pmol/mL (180 mg/L) achieving product formation kinetics between 
575-1072 pmol/108cells/h (table 1 and figure 6). Hence, product courses closely followed cell 
formation, as expected. Secretion and growth rates were rather inversely correlated, i.e. reduced 
secretion rates are found at increased growth rates as indicated in figure (6).  
It was a key motivation of experimental design to analyze putative intracellular antibody degradation 
in exponentially growing cells excluding non-wanted substrate limitations or inhibitions.  As indicated 
by the time courses of nutrients, this has been achieved with respect to glucose, glutamine and the by-
products like ammonia and lactate. The majority of the amino acids were consumed during the 
cultivation except for alanine, serine, aspartate and glutamate which were produced (see supplemental 
figure 1). Initial lysine concentration was set at 1 mM to enable non-lysine limited cell growth until 13C 
labeling via L-lysine addition was performed. As indicated, post-pulse lysine concentrations were about 
1.5 mM thus ensuring non-limited cell growth similar to initial batch conditions. Individual lysine 
uptake rates of all cultures were similar except for reactor 1 representing an outlier. However, each 
culture was growing exponentially enabling the individual analysis on intracellular degradation kinetics 
as shown below.  
3.2 IgG peptide identification, labeling interpretation and peptide quantification 
Biomass samples from CHO cells cultures were used to develop the identification and quantification 
protocol for intracellular peptides and their degradation fragments.  The complexity of cell extracts 
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turned out to be the most challenging issue. Applying common peptide desalting protocols like C-18 
solid phase extraction (SPE) based on polarity based separation, unfortunately lead to the simultaneous 
concentration of polyethylene glycol (PEG). PEG was present in the samples as impurity from the 
bioreactor cultivations finally causing non-wanted peptide signal losses that severely hampered peptide 
identification due to overlaying PEG signals. PEG was observable in the whole retention window 
because of its multiple molecular weight as polymeric material.  Automated peptide screening based on 
MS/MS spectra acquisition was no longer possible. As a consequence, ion exchange solid phase 
extraction was tested, as it possesses the ability to separate charged peptides from non-charged 
compounds such as PEG. For optimization of this approach, ion exchange solid phase extraction was 
preferred as sample purification. Multiple stationary phases (weak/strong cation and anion exchange) 
and protocols were evaluated. While strong cation exchange yielded at non-optimum PEG removal, 
weak anion exchangers could not retain the peptides properly. Alternate weak cation and strong anion 
exchange studies favored the latter because of the higher number of peptides that could be identified. 
Consequently strong anion exchange was preferred and appropriate elution protocols were tested 
resulting at the present approach. 
For developing the peptide identification protocol, very restrictive fitting criteria were defined: Only 
sequences assigned with mass accuracy better than 10 ppm, at least five fragments (a, b or y ions), 
assigned by PEAKS software, in MS/MS spectra and correlation with predicted charge states, were 
considered for the intercellular quantification as proposed by Gelman et al. [42 ]. 
Obeying these criteria it was possible to identify four intracellular proteolytic peptides originating from 
the produced antibody.  The peptides HYTQKSLSLSPGK (Fragment 1, F1) and HYTQKSLSLSPG 
(Fragment 2, F2) showed mass accuracies of 3 and 1 ppm, respectively.  F1 is supposed to be generated 
during antibody degradation serving as the substrate of F2 for the subsequent degradation step (figure 
1). Noteworthy, F1 was identified as a unique sequence only present in anti-IL8 and not in the CHO 
proteome. This was assured analyzing non-mAb producing CHO as well. For identification, both, 
retention times and fragmentation spectra of the intracellular peptides were requested to match with 
their counterparts of synthetic references, purchased for challenging the findings. F1 and F2 are part of 
the Fc antibody fragment and are located at the C-terminus of the heavy-chain constant region. 
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Other identified peptides were EVQLVQSGGGLVQPGG and PAVLQ. However, these could not be 
chased via 13C-labeling because no L-lysine building blocks were included. 
The aforementioned batch cultivations were analyzed applying the peptide protocols developed. The 
13C-lysine labeling (K*) may result at four isotopologues, namely: non-labeled (HYTQKSLSLSPGK), 
single-labeled (HYTQK*SLSLSPGK, HYTQKSLSLSPGK*) or fully (twice) labeled 
(HYTQK*SLSLSPGK*) as mentioned in figure 1. Each isotopomer could be identified. As both single 
labeled isotopologues are isobaric substances they were considered in a common pool contributing 
equally to the peptide ratio. 
Taking peak areas from isotopologues extracted ion chromatograms as references; it was possible to 
calculate relative pool sizes of each species per sample (Figure 4).  By analogy, F2 was analyzed 
showing the labeling patterns of non-labeled (HYTQKSLSLSPG) and single-labeled 
(HYTQK*SLSLSPG) (figure 5). 
Final peptide quantification was made by internal standard calibration using synthetic peptides, 
possessing L-13C6,15N2-lysine, as internal standard. Calibration curves revealed squared correlation 
coefficient (R2) of 0.9989 for both peptides and detection limits of 2 nM in reconstituted cell lysates. 
3.3   IgG secretion and degradation rates 
Post-pulse labeling dynamics of the peptides were monitored by 2h-sampling intervals. The resulting 
labeling dynamics are given in figure 5. Note that F1 shows 3 labeling species while F2 only possesses 
2 (figure 1). As indicated in figure 5, distinct labeling patterns were smoothed with the help of equations 
7 and 8. F1 ratios were estimated by fitting experimental data (figure 5). These fitted data were 
introduced in equation 9 to ease its computation. Nevertheless, figure 5 also depicts the comparison of 
real experimental values with simulated labeling fractions applying the mechanistic model. 
Because the model of equation (9) is proportional to the parameter vdeg, linear regression could be 
applied for parameter fitting. Data sets of each cultivation were handled separately. Consequently, 
individual degradation rates could be identified as shown in table 1. Furthermore specific secretion rates 
are given. Noteworthy, degradation rates of the four biological replicates turned out to be pretty similar, 
showing only small variations between 1.23 and 1.89 pmol/108cells/h. Hence, compared to the antibody 
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formation rates observed, degradation values represent roughly 0.18% of net antibody production. As 
shown in figure 6 degradation rates are almost independent on mAb secretion rates.  
4 Discussion 
High resolution mass spectrometry has demonstrated to be a suitable tool for determining intracellular 
mAb degradation. The thorough application of sample preparation, instrumentation performance and 
proteomics software enabled the identification of intracellular peptides produced by proteolysis, and to 
follow their dynamic fate. Notably not only non-labeled but also single- and multiple labeled fragments 
could be measured and monitored in labeling pulse chase experiments. So far, intracellular analysis of 
labeled proteins was restricted to whole protein molecules [43, 44] and not yet applied to study peptide 
fragments. However, achieved measurement accuracies and sensitivities encourage using the approach 
further, for instance focusing on alternative process phases, products or cell lines. Noteworthy, the 
presented technique is not restricted to the given example. It may be applied for different scenarios as 
well, provided that the sequence of the degraded protein is known and reference fragments are available 
for establishing profound identity checks also enabling intracellular peptide quantification.  
For the given degradation problem, further efforts may be performed to increase peptide sensitivity thus 
enabling the putative identification of more fragments than shown in this study. Here we have chosen 
strong anion-exchange solid phase extraction for successfully removing non-wanted interferences like 
PEG thus identifying four proteolytic anti-IL8 peptides in complex intracellular extracts. Alternate 
sample preparation techniques such as offline fractionation or 2D chromatography may be suitable as 
well. However, their test was outside the scope of this study. Nevertheless, the given approach was able 
to identify more than 200 intracellular peptides not originating from anti-IL8 but from native CHO 
proteins. Although this may serve as a valid starting point for future studies per se, theses identifiers 
were not considered for calculating mAb degradation rates.  
It was a key motivation of experimental design to analyze intracellular mAb degradation under realistic 
production conditions not disturbing cellular performance by the investigative studies. Pulsing L-lysine 
at not yet growth limiting conditions exactly achieved this goal. As indicated in figure 3, growth and 
product formation kinetics of pulsed and non-pulsed cultures were pretty similar. For non- pulsed CHO 
the maximum growth rate and specific secretion rate of 0.0288 h-1 and 699 pmol/108cells/h were 
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measured while pulsed cultures achieved 0.0204 to 0.0296 h-1 and 574 to 1071 pmol/108cells/h, 
respectively. Obviously, environmental changes are not significant enough to cause alterations of the 
phenotypes. Hence the approach may be qualified as more gentle compared to conventional SILAC 
experiments, when cells were rapidly transferred from labeled to non-labeled medium regardless of 
kinetics [43]. 
Choosing exponentially growing cells for investigating intracellular mAb degradation kinetics may be 
regarded as a highly ambitious goal. Seth et al., Butler and Pfizenmaier and Takors pointed out that 
mAb production kinetics are typically non-growth coupled [45, 46, 47]. This phenotype was also 
confirmed by our own studies (figure 6A).  
Consequently the mAb production and secretion machinery in CHO may have not been working at its 
limits thus anticipating relatively low degradation rates to recycle e.g. misfolded proteins. As indicated, 
measured mAb production rates were found to be 13.7 to 25.7 pg/cell/day, thus being far below 
performance values of 50-100 pg/cell/day of top producers [48, 49].  Nevertheless these experimental 
conditions were chosen exactly to investigate whether under the ‘rather smooth’ production conditions 
installed intracellular mAb degradation occurs. The impact of intracellular mAb degradation may be 
more pronounced under challenging top producing conditions when additional stress may effect cellular 
performance. 
Indeed, average intracellular degradation rates of 1.49 pmol/108cells/h were measured representing 
0.18% of the net mAb formation. This value is significantly lower than the 58% published for Pichia 
pastoris [37]. Nevertheless it demonstrates that intracellular mAb degradation does occur even under 
the rather smooth production conditions investigated. The finding also outlines the sensitivity of 
analytical detection enabling to quantify even these low, absolute degradation amounts. 
Based on Saric et al. and Luciani et al. proteasomal activities are likely to result at peptides with 3 to 
24 amino acids [13, 50]. With 5, 12, 13 and 16 amino acids the detected mAb degradation peptides fully 
match to these limits. Dintzis outlined that protein assembling starts at N terminus yielding to the C 
terminus [51]. Considering that the quantified peptide sequence HYTQKSLSLSPGK is located at the 
C terminus of the heavy chain, decomposition of mAbs at a late stage of protein assembly is likely to 
have happened. Beckmann et al. pointed out that heavy chains are accumulating inside cells during 
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multiple passaging cultivation while light chains can be secreted [52]. This finding serves as a hint on 
excess intracellular heavy chain amounts in the anti-IL8 producer that may have finally induced their 
own degradation. The process may mirror the cellular strategy to equilibrate light and heavy chain 
presence at the same time recycling excess amounts for the sake of nutrient and energy economy.  
For estimating the energetic cellular efforts to produce finally degraded mAb the following scenario is 
considered: Translation of mRNA requires energy in form of ATP and GTP. The mAb heavy chain 
contains 451 amino acid residues meaning that its mRNA should consist of 451 codons at least.  The 
initiation of the translation consumes 2 ATP for mRNA scanning and its activation. Additionally 1 GTP 
for the activation of the methionine-tRNA complex is needed [53]. Binding amino acid during the 
elongation requires 2 GTP per amino acid [54]. One GTP is necessary for termination. Hence, the 
amount of energy (ATP) needed for the synthesis of 1 pmol/108cells/h can be estimated as 905 
pmol/108cells/h. Considering an average degradation rate of 1.49 pmol/108cells/h, this sums up to 1.35 
nmol/108cells/h. 
Degradation rates were estimated using the model equation 9. Although simplifying assumptions such 
as constant pool sizes and rates were made, it was possible to predict dynamics of the respected 
fragments fairly well showing average variances of model prediction of 10% (figure 5). This result 
seems to be remarkable with respect of the simplicity of the modeling approach chosen and with respect 
to its obvious matching to real mechanisms. The slight underestimation in the short post-pulse period 
might reflect discrepancies between real and model assumed intracellular 13C L-Lysine propagation e.g. 
resulting at not (completely) equilibrated F1K1 and F2K1 pools.  Notably the model allowed the 
simulation of degradation kinetics for four biological replicates with just one single degradation rate. 
Whether or not this simplicity can be maintained for more challenging scenarios such as for high 
performing recombinant protein producers remains to be shown. 
Summarizing, this contribution succeeded to present an analytical approach for chasing intracellular 
protein fragments as a consequence of degradation activities.  With 0.18% of net mAb formation, minor 
but still existing intracellular mAb degradation rates were detected showing the applicability of the 
analytical approach as well as the suitability of the simple model-based estimation.  
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Tables 
 
Table 1. List of degradation rates. Units are given in pmol/108cells/h. Upper and lower bounds 
indicate 95% confidence interval. 
 
 ndeg(pmol/10
8cells/h) qsec(pmol/10
8cells/h) µ(h-1) 
Reactor 1 1.23±0.029 634±12 0.0296±0.0005 
Reactor 2 1.52±0.046 574±18 0.0230±0.0006 
Reactor 3 1.89±0.088 1071±68 0.0204±0.0004 
Reactor 4 1.30±0.038 858±37 0.028±0.001 
  
 
Figure legends 
 
Figure 1. A: Pathways of recombinant protein degradation. Amino acids are taken up from the medium 
(rupt) and further processed for recombinant protein synthesis (vsynth). Intracellular recombinant proteins 
are susceptible to be degraded by proteasomal activity (v1deg) and subsequently by further cytosolic or 
lysosomic enzymes to single amino acids (v2deg and v3deg). At metabolic steady state, degradation rates 
are equal and synthesis rate is equal to secretion rate added to degradation rate. B. Description of 
labeling distribution in F1 and F2. Grey circles encode each amino acid except lysine. Labeled and non-
labeled lysines are encoded by black and white circles respectively. Single labeled F1 is assumed to 
distribute itself equally (0.5/0.5) into F2. 
Figure 2. Overview of cultivations. 13C-Lys pulse was added to the bioreactor as indicated by the line 
in A. A: cell densities and viabilities. B: product concentrations.  
Figure 3. Specific growth and secretion rates. Ref is a cultivation without addition of labeled lysine 
applying same conditions as in R1-4. Four biological replicated for labeling studies are performed (R1-
4) Error bars represent the 95% confidence intervals after linear regression using equation (1) and (2). 
 
________________________________________________________________________________ 
136 
 
Figure 4. Extracted ion chromatograms for monoisotopic species of mAb identified peptides in sample 
22 hours after pulse (Reactor 1). K* = 13C-Lys. Extracted ions: HYTQKSLSLSPGK (482.5964 m/z), 
HYTQK*SLSLSPGK + HYTQKSLSLSPGK* (484.6031 m/z), HYTQK*SLSLSPGK* (486.6098 
m/z), HYTKQSLSLSPG (439.8981 m/z), HYTK*QSLSLSPG (441.9048 m/z).  
Figure 5. Measured labeling patterns and modeling results.  A, D, G, and J: experimental data and curve 
fitting of F1 isotopologue ratios in reactor 1, 2, 3 and 4 respectively. Circles are measured values. Blue: 
F1K2. Green: F1K1. Red: F1K0. Continued lines are fitted curves using labeling enrichment and decay 
laws described in equation 7 and 8. All correlation coefficients were higher than 0.9. Parameter values 
of fitting functions are listed in supplemental documents table 3 and 4. B, E, H, and K: circles represent 
F2 ratios (blue: F2K1, green: F2K0) in reactor 1, 2, 3 and 4 respectively. Lines are simulated results of 
enrichments of F2 using estimated degradation rates (equation 9).  C, F, I, L: comparison of simulated 
(ordinates) and experimental (abscissa) data. Blue: F2K1, green: F2K0. Because of low sample volume 
and the need of high injection volumes it was just possible to inject each sample once. Therefore 
uncertainties could not be determined. 
Figure 6. Overall productivities related to growth rates (A) and degradation rates (B). Dots are 
experimental data. Lines are fitted curves to show a general tendency of each behavior. A: fitting 
function is an exponential function. B: fitting function is a linear curve. 
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FIGURE 2 
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FIGURE 6 
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Abstract: 
 
Market demands for monoclonal antibodies (mAbs) are steadily increasing worldwide. As a 
result, production processes using Chinese hamster ovary cells (CHO) are the focus of ongoing 
intensification studies for maximizing cell-specific and volumetric productivities. This 
includes the optimization of animal-derived component free (ADCF) cultivation media as part 
of good cell culture practice. L-glutamine (Q)– and L-tyrosine (Y)–containing dipeptides are 
well known additives for boosting the performance of CHO. However, little or even conflicting 
assumptions exist about their putative import and functionality inside the cells. This study 
monitored uptake kinetics and followed the intracellular fate of selected dipeptides. Mass 
spectrometry revealed that dipeptides were entirely imported, degraded inside the cells, and 
metabolized or secreted afterwards. Dipeptides can be grouped into slow- and fast-acting 
additives triggering strongly diverging growths and mAb production kinetics. It is shown that 
well-known additives such as L-glycine-L-glutamine (GQ) and L-alanine-L-glutamine (AQ) 
exert different kinetics. Consequently, individual dipeptide uptake kinetics need to be 
considered when optimizing CHO processes. 
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Introduction: 
Global biopharmaceutical markets are steadily increasing by 3-5 % per year. Markets for 
monoclonal antibodies (mAb), which are predominantly produced in Chinese hamster ovary 
cells (CHO), show even higher yearly growth rates (Walsh, 2010; Aggarwal, 2012; Aggarwal, 
2014). To cope with market demands, productivity of CHO-based mAb production has risen 
more than 100-fold since the 1990s (Birch and Racher, 2006; Wurm, 2004), currently reaching 
2–5 g/L (and more) in 12 day-cultivations (Schaub et al., 2012). Maximum cell-specific 
productivities were recently published by Tabuchi and Sugiyama (2013) reporting >100 
pg/cell/day. 
This rise of performance data is the result of successful strain engineering in combination with 
process optimization. The latter mirrors all activities of process intensification using batch, fed-
batch and continuous mode operations, with or without cell retention, in perfusion reactors 
(Jain and Kumar, 2008). Certainly, medium optimization plays a decisive role for establishing 
best growth and production conditions in intensified bioprocesses. In essence, medium 
optimization should always aim at providing the best nutrient composition, maintaining 
reasonable prices, reproducible quality and easy access. 
Although serum-containing media were frequently used in the early days of cell culturing 
(MEM or DMEM; Eagle, 1955; Ham, 1965), their use is no longer favored in 
biopharmaceutical processes nowadays (Butler, 2005). The previous application of fetal bovine 
serum (FBS) is strongly discouraged due to the inherent risk of contamination by fungi, 
bacteria, viruses or prions (“mad cow” disease; Wessman and Levings, 1999). Furthermore, 
complex media are a permanent source of performance variability (due to lot-to-lot 
discrepancies), generate additional efforts in downstream processing, and, last but not least, are 
more expensive than chemically defined compositions. The need for performance testing of 
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individual lots of serum prior to their use also contributes to significant costs increment and 
logistic burdens.  
The ongoing search for animal-derived component free (ADCF) media aims at compositions 
achieving equal or even improved productivity performances compared to previous complex 
media (Hayashi and Sato, 1976; Bottenstein and Sato, 1979; Nakabayashi et al., 1982; Keen 
and Rapson, 1995; Heidemann et al., 2000).  
As already outlined by Eagle (1955), growth of mammalian cells heavily depends on the 
availability of amino acids. This is particularly the case for dihydrofolate reductase (DHFR) 
deficient CHO mAb producers, which require L-glutamine addition. Because L-glutamine 
possesses poor properties of storing and heat-stability, its sole use has been supplanted by 
dipeptides such as L-alanyl-L-glutamine (AQ) (Minamoto et al., 1991). L-glutamine serves as 
a nitrogen and carbon source, potentially leading to the unwanted accumulation of the growth 
inhibitor NH4+. Consequently, the use of AQ in feed media, instead of L-glutamine, was 
successfully established (Atanassov et al., 1998; Kim et al., 2012; Imamoto et al., 2013). 
Moreover, glycyl-L-glutamine (GQ) additions were studied, revealing beneficial effects in 
murine hybridoma cell cultures (Christie and Butler, 1994).  
In addition to L-glutamine, L-tyrosine–containing dipeptides were investigated. The low 
solubility of this aromatic amino acid could be increased up to 250-fold in dipeptide 
configurations (L-tyrosyl-L-histidine (YH); Furst, 1998). Similar findings were reported within 
the field of parenteral nutrition by Daabees and Stegink (1979), and Grimble (1994), who 
studied L-glutamine–, L-tyrosine–, L-cysteine–, and L-tryptophan–containing peptides. 
Related concepts were transferred to cell culture applications (Konno al., 2008; Katayama et 
al., 2010; Imamoto et al., 2010). Recently, Kang et al. (2012) presented a comprehensive study 
about the industrial performance of CHO after dipeptide addition. Using L-tyrosyl-L-lysine 
(YK), L-tyrosyl-L-histidine (YH), L-tyrosyl-L-alanine (YA), L-tyrosyl-L-valine (YV), L-
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threonyl-L-phenylalanine (TF), L-histidyl-L-glycine (HG), and glycyl-L-histidine (GH), the 
tyrosine containing dipeptides caused positive effects on culture viability and product titer. 
Non-tyrosine containing cultures showed variable phenotypes. Other studies by Franek and 
Katinger (2002) and Franek et al. (2003) reported beneficial effects of L-lysine containing 
peptides. 
To summarize, although the history of dipeptide clearly outlines benefits for additives such as 
L-alanyl-L-glutamine or L-tyrosyl-X, a thorough mechanistic understanding of their 
intracellular functioning and fate is still missing. Fractionation studies by Christie and Butler 
(1994) indicated the strong impact of extracellular hydrolysis in murine hybridoma cells 
studying the utilization of L-alanyl-L-glutamine and glycyl-L-glutamine. On the contrary, 
Kang et al. (2012) recently anticipated that ‘…the observed fast clearance may reflect rapid 
transport of dipeptides into the cell rather than hydrolysis…’ Apparently, the picture of 
dipeptides utilization, their functioning and fate inside the cells is rather unclear. 
Hence, it is the motivation of this contribution to shed some light on the utilization of dipeptides 
by CHO cells. The L-glutamine containing additives L-alanyl-L-glutamine (AQ) and glycyl-
L-glutamine (GQ) were studied as well as tyrosine containing compounds L-alanyl-L-tyrosine 
(AY), glycyl-L-tyrosine (GY) and L-prolinyl-L-tyrosine (PY). For comparison, other peptides 
were applied too: L-alanyl-L-cysteine (AC), L-alanyl-L-proline (AP), and L-prolinyl-L-
cysteine (PC). Fundamental uptake kinetics were monitored for all peptides, and attention-
grabbing dipeptides were selected for thorough intracellular studies. 
 
Materials and methods 
Batch CHO cell cultures 
The IgG1 producing strain CHO DP12#1934 (ATCC) was used for all experiments. Precultures 
were grown in TC42 medium (TeutoCell, Bielefeld, Germany) with 200 nM methotrexate 
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(MTX) and 4 mM L-glutamine to a density of 0.4 × 106 viable cells/mL. Aliquots were used 
to inoculate the main batch cultivations, again using TC42 TeutoCell medium with 200 nM 
MTX as basal medium. Selected single dipeptides (provided by Evonik Nutrition and Care 
GmbH, Darmstadt, Germany) were added to the main cultures at concentrations ranging from 
4 to 6 mM. Shaking flasks (125 mL or 2 L), with working volumes of 40 mL and 700 mL, were 
used. Medium without dipeptides was used as control. Cells were incubated at 36.5 °C, shaking 
at 140 rpm in 8 % CO2 humidified air for 8 to 10 days. Samples were taken daily and cell 
densities were measured through Trypan blue coloration on Cedex (Roche).  
Characteristic cell properties were calculated to qualify the impact of dipeptide addition to 
culture performance. The cell specific substrate uptake rates qS,i of i time intervals were 
estimated in batch cultures according to: 
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with Δt as the observed time interval, C   as the average cell density of this interval, and CS,n 
and CS,n-1 as the measured substrate concentrations at time points n and n-1, respectively. 
Cultivations were performed (and analyzed), at least, in duplicate. 
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Product, amino acid and dipeptide determination 
Antibody concentrations were determined through sandwich ELISA. Amino acids and 
dipeptides were analyzed simultaneously by LC-MS after dansyl chloride derivatization.  
Sample preparation for quantification of intracellular amino acids and dipeptides  
In 700 mL batch cultures, samples containing 32 × 106 cells were taken. Cells were centrifuged 
(1300 rpm, 10 min, 4 °C) and cell pellets resuspended in 50 mL cold PBS (Phosphate buffered 
saline). Cells were washed twice with 5 mL PBS and cell pellets stored at -70 °C until cell 
extraction. Cells were extracted using the Bilig-Dyer method (Bligh and Dyer, 1959) as 
follows: 1 mL of 1:2 CHCl3:MeOH was added to the cell pellet, followed by 250 µL CHCl3 
and finally 250 µL water vortexed for 5 min before any addition. Phase separation was achieved 
by centrifugation (1300 rpm, 10 min, 4 °C). The water layer was separated, acidified with 1 % 
TFA (Trifluoroacetic acid), evaporated to dryness using a speed vacuum, and stored at −20 °C 
until analysis. 
Amino acids and dipeptide dansyl chloride derivatization 
Dansyl chloride derivatization was used to improve amino acids and dipeptide reverse phase 
chromatography retention. The derivatization protocol described by Wu et al. (2013) was used. 
For extracellular measurements, samples were diluted at 1:1500 and 50 µL borax buffer (0.1 
M, pH = 9) were added to 10 µL of the diluted sample. For intracellular measurements, samples 
were reconstituted directly with 60 µL borax buffer. Dansyl chloride (100 µL of 20 mM; in 
acetonitrile) was added and the reaction was kept at room temperature for 2 hours. Solutions 
were quenched with 100 µL 1 % formic acid and measured directly, or stored at -20 °C. 
LC-MS amino acids and dipeptide quantification 
Amino acids and dipeptides were analyzed using an Agilent 1260 Infinity Bio-inert LC system 
coupled to and Agilent 6540 Accurate-Mass Quadrupole. The LC system comprised a degasser, 
quaternary pump, and thermostated autosampler (maintained at 4 °C). Derivatized sample (10 
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µL) was injected to a reverse phase column and guard column (Aeris PEPTIDE 3.6 u XBC18 
150 × 2.1 mm, Phenomenex) with a flow of 0.4 mL/min. The mobile-phase A consisted of 
water with 0.2 % formic acid, and B, acetonitrile with 0.2 % formic acid. The gradient was set 
to 17 % B at the beginning of each run, then increasing up to 80 % B in 10 minutes followed 
by a washing step and equilibration. 
Mass spectrometer was configured in Extended Dynamic Range, low mass range (100-1300 
m/z). Measurements were made in MS acquisition mode with acquisition rate of 2 spectra/s. 
JetStream electrospray ion source was configured with gas temp of 220 °C, and sheath gas 
temperature of 350 °C, drying gas flow 10 L/min, nebulizer set at 30 lb per square inch gauge, 
and sheath gas flow of 12 L/min. Capillary voltage was set to 4000 V, nozzle voltage 0 V, and 
fragmentor voltage to 130 V. Used reference masses were m/z 121.0509 and 922.0098 and the 
instrument was recalibrated every 20 samples. Dipeptide and amino acids standards were 
prepared as a mix with concentrations ranging from 3 to 4000 µM, and calibration ranges with 
correlation coefficient better than 0.98 were used. 
Data were analyzed using Mass Hunter Workstation software (Ver.B.05.519.0, Agilent 
Technologies), extracting ion chromatograms of the more intense monoisotopic ion for each 
amino acid or dipeptide derivatives. The identity of analytes was confirmed by matches of 
retention time and mass accuracy (better than 1 ppm). The latter was accessed by the ‘find by 
formula’ feature implemented in the ‘Mass Hunter Workstation’ software. 
 
Results 
Analyzing extracellular kinetics  
Cell culture experiments were conducted to test the performance of batch cell cultures after 
addition of the individual dipeptides. Taking the cell-specific dipeptide uptake rate as a 
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criterion, two distinct phenotypes are being observed: group A, showing fast consumption, and 
group B, revealing slow, steady dipeptide uptake (see figures 1 and 2).  
AP, GY, AQ, and AY showed fast dipeptide uptake leading to complete dipeptide depletion 
after five days at the latest. Interestingly, this group revealed the highest daily cell-specific 
uptake rates of 1.5–3 µmol × 10-5/cells at the beginning of the batch phase. This phenotype 
may anticipate a diffusion-driven import with highest influx coinciding with highest 
concentration gradients between outer and inner conditions. 
On the contrary, GQ, PY, AC-CA, and PC-CP showed much slower, but rather steady dipeptide 
consumption rates. As indicated, average daily depletion rates were about 0.1 µmol × 10-5/cells, 
which represent 1/10 of the values obtained for the ‘fast’ dipeptides. Apparently, uptake 
mechanisms for members of group B differ from those of group A. 
Additionally, maximum cell specific growth and mAb production rates were calculated for 
each supplemented batch culture. Figure 3 indicates that the addition of peptides from group B 
tends to slightly reduce the maximum growth rates, whereas dipeptides with fast uptake tend 
to increase growth. This observation is in-line with the basic findings on mammalian 
production kinetics that often relate slow growth with increased mAb productivity. 
The analysis of cell-specific mAb production reveals that only AQ outperformed, with a 
maximum cell-specific mAb production rate 34 % higher than the control (revealing a 
borderline statistical relevance). Nevertheless, the finding matches the results obtained by 
Imamoto et al., 2013 (Figure 4A). The highest final concentration was obtained with GQ 
supplementation (+14 % total mAb production compared with the control) (Figure 4B). 
Interestingly, the production kinetics of the best boosting dipeptides, AQ and GQ, differ 
significantly. Figure 5 shows the relation between viable cell numbers and cell-specific 
productivities. Cultures supplemented with AQ revealed maximum productivity qmAb at the 
beginning, followed by abrupt decrease. On the contrary, GQ consumption yielded steady, but 
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lower, qmAb values, in combination with an extended period of high viable cell densities. Taken 
together, GQ addition achieved increased final mAb titers. 
Analyzing intracellular kinetics 
Further experiments were performed to elucidate the fate of dipeptides that were consumed by 
the cells. AQ and AY were selected as members of group A, enabling to revisit former studies 
(Christie and Butler 1994, Kang et al., 2012). AC-CA served as an example of group B. It was 
chosen as an example of an ‘inert’ component possessing a rather bulky structure with disulfide 
bonds. 
Batch cultivations were performed in 2 L shaking flasks (700 mL working volume) to allow 
sampling of relatively high cell numbers, without affecting cell growth. Samples of 32 × 106 
cells were taken, chilled, and three times washed (to eliminate unwanted extracellular matrix 
effects) before being extracted to analyze the intracellular concentrations of amino acids and 
dipeptides.  
Extracellular and intracellular concentrations of selected dipeptides and their constitutive 
amino acids are presented in figures 6, 7, 8 along with the concentrations found in the control. 
Uptake kinetics of AQ, AY, and AC-CA (figures 6a, 7a, 8a) showed the same dynamics as 
already depicted in figures 1 and 2. Again, AQ and AY turned out to be quickly consumed and 
the depletion of AC-CA was much slower. Interestingly, extracellular A levels steadily 
increased, whereas AQ (figure 6a) and AY (figure 7a) were consumed. Glutamine was already 
present in the basal medium. Consequently, a steady reduction of Q titers was observed, which 
revealed an intermediary slow-down between 3 and 5 days. Besides, extracellular tyrosine (Y) 
levels increased along with the alanine courses. 
These extracellular courses suggest that dipeptides were used by the cells. Glutamine (Q) 
appeared to be consumed internally, whereas A and Y were released, achieving almost identical 
amino acid levels compared to their molar fractions in the dipeptides. To understand whether 
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dipeptides really entered the cells or were cleaved (via extracellular proteases), intracellular 
measurements were performed (series B in figures 6 – 8). Indeed, AQ and AY were detected 
inside the cells with maximum pool sizes being measured at the beginning. Significantly high 
levels of separated amino acid constituents were observed too, suggesting that intracellular 
dipeptides were decomposed and their amino acids secreted individually.  
The basic phenotype of AC-CA uptake was similar to AY although slower. Again, alanine (A) 
turned out to be taken up in AC-CA and was likewise secreted. By analogy, cysteine (measured 
as cystine) revealed a secretion after intake. However, intracellular levels of alanine and cystine 
were significantly increased compared to the control. 
 
Discussion 
The fact that all dipeptides were measured in intracellular matrices represents strong evidence 
that dipeptides are imported, rather than degraded by extracellular peptidase activity (Kang et 
al., 2012). The different dipeptide uptake kinetics suggest the existence of multiple mechanisms 
for their import. Once entered in the cytosol, the dipeptides are degraded and their amino acids 
separated in two groups: One fraction is used directly, fuelling anabolism and/or cell 
metabolism, whereas the second fraction is exported (Figure 9). 
So far, the existence of distinct dipeptide importers in CHO-K1 is still unclear. In humans, 
PepT1 and PepT2 are well-known H+ driven symporters that play a dominant role for 
oligopeptide uptake. Covitz et al. (1996) measured that the native consumption of the labeled 
dipeptide glycyl-3H-sarcosine could even be doubled in transfected CHO cells harboring 
human PepT1. Recently, PepT1 and PepT2 were assigned in the CHO-K1 genome as well 
(Hammond et al., 2012), sometimes also classified as members of the “solute carrier family 
15” (Slc15a1, Slc15a2). Because PepT1 is characterized by low-selectivity (KM in mM range) 
and PepT2 by high affinity (KM in µM range), PepT1 is anticipated to enable fast oligopeptide 
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import under relatively high peptide concentrations, whereas PepT2 should be active under 
peptide limiting conditions (Newstead, 2014). 
Among oligopeptide transporters, only the PTR family (Steiner et al., 1995), which is also 
known as proton-dependent oligopeptide transport family (POT), shows gene sequence 
homologies within the mammalian genome (Daniel et al., 2006; Paulsen and Skurray, 1994).  
In general, POT systems possess a broad specificity for various peptides. For example, Ptr2p 
has been identified as the major oligopeptide importer in Sacharomyces cerevisae. This uptake 
system recognizes 8,400 types of di/tripeptides with affinities ranging from 48 mM to 0.020 
mM. (Ito et al., 2013). 
Summarizing, we propose that dipeptide import in CHO is either enabled via PepT1/PepT2 
like systems or via yet unknown uptake mechanisms. Consequently peptide-specific 
differences for affinities and uptake rates should occur. Indeed, individual dipeptide uptake 
rates differed by one order of magnitude, finally matching the grouping shown in figures 1 and 
2. Further efforts have to be made to identify and characterize dipeptide uptake mechanisms in 
CHO cells.  
It was observed that dipeptides like AC-CA, PC-CP, and PY were taken up rather slowly. 
Interestingly, these compounds have in common rather challenging di-peptide sizes or complex 
ring structures in the amino acids. In this context, the slow uptake rate of GQ is surprising. Not 
only is glycine a small molecule, but both amino acids also have rather linear structures that 
should not sterically hamper their uptake. Moreover, figure 2 depicts that G and Q can be 
imported very fast as part of GY and AQ. Apparently, it is not the impact of the individual 
amino acids G (glycine) or Q (L-glutamine) themselves that hampers their fast uptake as GQ, 
but their occurrence as a dipeptide that causes the specific uptake characteristics. This 
observation can be taken as a hint that dipeptide uptake is very specific and that estimations for 
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‘similar’ compounds based on reference substances may result in poor prognosis for the distinct 
cases.  
However, some common characteristics of dipeptide uptake can be extracted from the 
experiments: except for the rather bulky compound AC-CA, all other L-alanine (A) containing 
dipeptides were taken up very fast. This holds true for AP, AQ, and AY (see figure 2). 
Apparently, the presence of A in dipeptides eases their fast uptake (e.g. compare AQ versus 
GQ). This may also be true for L-tyrosine (Y), which is consumed fast in GY (compared to in 
GQ) and AY, but shows slow uptake properties for the relatively bulky dipeptide PY. Kang et 
al. (2012) also found performance improvements when Tyrosine (Y) containing dipeptides 
were added to CHO cultures. 
Once incorporated in the cells, the dipeptides are cleaved and used according to current 
demands (see figure 9). Although one intracellular fraction is metabolized, the other is secreted 
into the medium. Figures 6 – 8 depict the common observation that fast (AQ, AY), as well as 
slow (AC-CA) uptake profile dipeptides cause initial increase of intracellular pools, followed 
by their complete disappearance during the course of cultivation. Dynamics of intracellular 
pool rise reflect the decline of extracellular dipeptide levels. Notably, the reduction of 
intracellular dipeptide pools is accompanied by the increase of intracellular levels of the related 
amino acids. Intracellular L-alanine (A) and L-cystine pool sizes were significantly higher than 
in the control experiments without dipeptide addition. Only L-glutamine (Q) and L-tyrosine 
(Y) quickly fell down to their control levels after an initial increase that coincided with the first 
occurrence of the related dipeptides. By analogy, extracellular levels of the respective amino 
acids changed as well. Except for L-glutamine (Q), almost equivalent levels of added 
dipeptides were observed as free amino acids during the course of cultivation, which indicated 
their relatively low metabolic demand. On the contrary, Q was metabolized immediately inside 
the cells. This was also true for Y, but with a lower level of metabolization. 
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The export of amino acids such as A or C is achieved via the ASC system, that exchanges L-
alanine, L-serine and L-cysteine via a tertiary active transport mechanism from the inside 
towards the outside (Kyriakopoulos et al., 2013). ACS enables the refueling of intracellular, 
limiting amino acid pools via the export of amble ones. Trans-inhibition occurs in case of high 
extracellular concentrations of the designated export amino acid, whereas trans-activation is 
found for high driving concentration gradients between extra- and intracellular levels of the 
imported molecules. 
As indicated in figure 3, the addition of group 1 dipeptides (see figure 1) did not impair growth 
rates, even showing a slight improvement for AQ. On the contrary, group 2 dipeptides slowed 
down the cellular growth, with GQ as the most dominant effector. Regarding final mAb titers, 
the resulting picture is more diverse. Although AQ addition did not exceed the control level, 
GQ supplementation clearly outperformed by 15%. The reason for the benefit of GQ addition 
is given in figure 5. When comparing cell-specific mAb productivities of GQ and AQ, an early 
peak of productivity after AQ addition is unraveled. However, this maximum productivity 
could not be maintained and reduced quickly during the course of cultivation. On the contrary, 
GQ supplementation did not show any peak of performance, but coincided with extended 
periods of high cell viability. Consequently, volumetric productivities were improved after GQ 
addition, especially during phases of low cell growth.  
For many decades, AQ and GQ have been applied as enhancers for mammalian cell cultures 
(Minamoto et al., 1991; Christie and Butler, 1994). Indeed, both dipeptides boost cellular 
performance, each of them in their own way. Although GQ basically supports growth-
decoupled product formation, AQ enables maximum cell-specific peaks of productivity and 
accelerates growth. Understanding individual dipeptide uptakes and product formation kinetics 
generally opens the door for an interactive process optimization. Consequently, the monitoring 
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of dipeptide kinetics should be in the center of medium and process development in order to 
optimize each process considering cell-specific individuals and time-varying nutrient demands.  
Furthermore, this study shows that we are only beginning to understand the impact of 
oligopeptide consumption on cellular physiology and to unravel underlying regulatory 
mechanisms. Current results do show that dipeptides are taken up, degraded inside the cells 
and metabolized or secreted afterwards. However, we do not know yet which regulatory 
regimes may be induced after dipeptide consumption and further affect cellular activities. 
These studies are already under way and may contribute to a knowledge-based process 
optimization in the future. 
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Figure legends 
 
Figure 1. Grouped dipeptides with faster dipeptide uptake rates. Error bars describe the 
deviation of duplicates. 
Figure 2. Grouped dipeptides with slower dipeptide uptake rates. Error bars describe the 
deviation of duplicates. 
Figure 3. Specific growth rates for CHO cultures supplemented with dipeptides. Black bars 
correspond to dipeptide group A showing fast and bi-phasic consumption. Grey bars 
correspond to dipeptides group B revealing slow, steady dipeptide uptake. Ctrl correspond to 
control. Error bars describe the deviation of duplicates. 
Figure 4. Maximal mAb production rates (A) and maximal mAb concentration obtained (B) 
for CHO dipeptide supplemented cultures. Obscured bars correspond to dipeptide group A 
showing fast and bi-phasic consumption. Grey bars correspond to dipeptides group B revealing 
slow, steady dipeptide uptake. Ctrl corresponds to the control. Error bars describe the deviation 
of duplicates. 
Figure 5. Fitted curves of specific mAb production rates and cell growth for AQ and GQ 
supplemented cultures.  
Figure 6. L-alanyl-L-glutamine (AQ) and constitutive amino acids concentrations in 
extracellular (A) and intracellular (B) levels measured in CHO supplemented cultures. Open 
circles represent concentrations found in control culture. Error bars describe the standard 
deviation of three analytical replicates. Extracellular data from single measurements. 
Figure 7. L-alanyl-L-tyrosine (AY) and constitutive amino acids concentrations in extracellular 
(A) and intracellular (B) levels measured in CHO supplemented cultures. Error bars describe 
the standard deviation of three analytical replicates. Open circles represent concentrations 
found in control culture. Extracellular data from single measurements. 
________________________________________________________________________________ 
161 
 
Figure 8. Alanine-cystine-alanine (AC-CA) and constitutive molecules concentrations in 
extracellular (A) and intracellular (B) levels measured in CHO supplemented cultures. Open 
circles represent concentrations found in control culture. Error bars describe the standard 
deviation of three analytical replicates. Extracellular data from single measurements. 
Figure 9. Dipeptides are transported by different mechanisms into the intracellular matrix 
(slow-constant uptake qs1 and fast-variable uptake qs2) where they are digested and their 
constitutive amino acids are either used for cell metabolisms () or expelled from the cell (). 
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